var title_f19_5_19536="Metformin in type 2 DM I";
var content_f19_5_19536=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F55216%7EENDO%2F67969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F55216%7EENDO%2F67969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Metformin in overweight patients with type 2 diabetes mellitus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 412px; height: 304px; background-image: url(data:image/gif;base64,R0lGODlhnAEwAfcAAP///4CAgAAAAEBAQMDAwJC5nDAwMP+AgKCgoNDQ0CAgIODg4PDw8LCwsHBwcFBQUGBgYBAQEP8AAJCQkCBzOYCZzAAzmf/AwP9AQMjczsDN5qCz2azLtSBNpkBms/8QEFiWaxBAn/Dz+fL38//w8P8gIP+wsC58Rf8wMDBZrP+goODm8zyFUv/Q0FBzuWCAv7DA33SohP/g4P9gYP9wcIKwkHCNxtbl2/9QUEqNXmafd+Tu57rUwtDZ7JCm057Cqf+QkH8ZTBZfVy8pfIBZjIBJfF8fXwxLdSJQoBhjUb8cNTZ4YzA5jHB8tQ8vj0A1gr+MpqK30885TGCTib9NZsccDs96jfEHA19QjzZlmit3S4ShwKurlatbRe/j6a9Qb89JXI82YhJEmYB5rODW4wpHe28cVt8WI/Gno79shnGjie+DiSdwV6+gv99WY385bN8GE4CJvO+zucCtxvG3s79cds8JHBRbXSBgbytkgWWPZ9/G059jiT9Wou8yOb8sRpKqzc9ZbL98lm9Mhb88Vqs7Jd+Gk3Cgj1BiqWVPJ08jaUx+j1aScXykoiZrXcLR4D8mcliDoQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAACcATABAAj/AAEIHEiwoMGDCBMqXMiwocOHECNKnEixosWLGDNq3Mixo8ePIEOKHEmypMmTKFOqXMmypcuXMGPKnEmzps2bOHPq3Mmzp8+fQIMKHUq0qNGjSJMqXcq0qdOnUKNKnUq1qtWrWLNq3cq1q9evYMOKHUu2rNmzaNOqXcu2rdu3cOPKnUu3rt27ePPq3cu3r9+/gAMLHky4sOGaDBAECCAwcQAEDA5LDpwggoABCgQauCzAwOTPfRUISDCwgYAHAB4IaCCQwOLXBEDLdptAgALRqAMIYKybMQDXrwf4nk0cLYHOBDYr3g2g98HFCBkQiH3RwQAACAaQNphgAILi4GfW/77ee4IABwAcCJjwfHhB9asvDhDwO8CCg8fdPxdAPbzPFRoEqAFIG3jQA1OiNbAZAQvYRoBo9xkE3UGiCQBBawE0AMEArDVgH3YBRFbaAA+IVt992ZHI2nEObMgaAAtsCEECC8wHwXcxDjCjQBMMMIADEfr3UgUWFGkBQkQOSJEGFazAVAKbRfAddqIpMKWE+glk2gSWRaZbBPMJsAAC6wEQQWaldRaAibrF9oADa4p5nAIBbEZjBAYEEEEECYhmAJB46hkBABCcV2d/QrqkgQUeCLRBBTC44EIPK3hgwQsbACBCBR64AAMATMLwggefAhCpBy8E2GQPFQzI5IEauP/ggQ0iTDVhQYXGKMB3babHHwN4bkmQavfN1xx/MAaAGX/5AWBaAOZBoCx/vUY7LQGqPRBAbGHSl+hKizYKgKUdpGBBBz10YEEKNgCQQggVmMuqBSFYasEKG1jgQgX7JrmCvgC4cC8M+toAsFS3DsSAAJf5eWxsvRa6mYgCGQuAsW0ugCcChU7HXH66SbvYAr2G/NoCDECw2WoJTIfotyeFK5ClApkLQJIA9MBoBS9YUAHOBmvgw7oVZIqzpSLUG7DPFahra5bW6jlaycged1pBvTXAJrOnETCfxxAkN1ptBjRAgAMJ9EYA2WajDcEEZ5cJc0syj3uk3Tdb4OrOPzP/qXfeA3JapA0459tzppb+/PPTBk0skHpwItsrAAkWxMB8t9EXsQB4cm2ZlFqubMACC+DmrOgkf47e3B4xqbjiSg60wtApDEgz3kS2CkAIIWwg9KN/J+mDDRrku+/fIhQZQq1Du6CBqIxXtDCarEfF6et9F0SkkXjjvYK6LuQs8Lkw4JwkDOrqu+nfAPT8wkBNFxk+wllCZF791S+1uJAJ52/W/v7pn//IAsCbkOACMrDIBVrwEwEyxDoXyc52JiJBh3TnSgN0yM9kcAETHOACCCHBDD4ggRIAYSQXOEACLyCBA1hEAhhoIP4UYjGDNGshk5tIDhdCspcNZIf5uwAU/4hAhCcE4QMYwMAHEYICGB4ABzEEwAETSJADkkAhLbjAFQmCQIEcQAIgNMgCxUhFAGQxjACAoQwN0sMG4EhGpLGYdXREmkIJBwAMUNYDXpSAB/gIWQrTI2tI1gDr+KaPf2RQhqzDxw05IDI9bA4CegQBBtTIQhis3gGM4IHsLcQEahRIAlUggVLOAAAsbKIEPiADUNIAADSQgAlIgIFSSkAFaSwBCWXJwlJigIUubMEuUXDFEu7SBAD4YilZmcYo9kSAx7HMADSWpz1dzFt0csCZALAZBVzHABGo02g0Fs6vEQSc4mwZwwZgGQSQ81pzSic19eSZZjHMAKKZkZ9W5/+/A0Aidgz5ogsHQgI1ftEELPzlDFoIgA+UAAAo+AAsJdACEpTgoSU0ARBgKEIJACGLDI3oASXwyoxuNIYIbEEsXRjKZ2aJRTyy0LUsdjZ20qdZ4wlAoaC1q4cNJKc7bdazzMMrrjFmqPFRjzoZcxk8NhWImrzXQ774yoEAE5UtvOpVY+lKANTSlhJopkAMCkassjSKagylGlXwgQ808axrLMgNTTYyY5lmj5v5zccuAxuq9ec4wlmMxxgDMskZVa+LMexgAdBUxpIHkAM0xN0cIoNVgrAFKpTAKUmpAq0ytAUlpCgAFspAACRQrTH8IgivelHTalasYpUACswKW5f/2pA5AGDb2bqjud1o7aanYc2eEECACRC3a+YcyHCLe1zC7uY4D/Aa18Jmp9pEVwGDsud1HHusbQXxAAeggrimCtYYLhQDbh2pC68KgBLIViDChGETYbvWEs7gqqREgS4ZiFqIwpCEcPUJNHF7unteEo/dNNE1B9VHhimANerpHKIabBuz7ZUxEV7QnDg3JQT4iTTaFUhTS3c1TSqRCPODCGYPoIIterDFpl2iDJaIShpLUQXgZSCLvYhLAODYBDMOI2aBQMUdJxOXJABvCkFoZNsW5YYZrAh4k1YqmDnwJ1CO8kTAO6vqXVnLVjlAGFJQK9Z9GcxRucAFVAAGCxzI/8szRHNSUphE95YQA34Ygg/8d2Y5H+UAGOgsGgFgg/HC2c9QAa9BfLC8AfYZ0TpJIXgnPWklyq4CIUhBlfP3aEjjBAczoLSoQagB9wGUz3H2NE4KusWDwOBdTUJzp1X9EkmDdwY4SEgPQrBnP8+a1i0BNKUHTRARdKDXvk41sF+iaIak4H2Q/vWyVdJshbwgBaqW9rRRUm2E+KADZY62sre9km4XhEkheLOntU3ukphbVOZ69qbF3e6adDtputs2u+stkm5Lqt775jdIqr2BRrc74ALPiK2FLRAb9I7fCE/4RYQ96QusIAUpcBLExy1xj3S74O1KeMQ7TpFqr+DhEv8fOckdYmtL1yzkKef4yi2C64o3HNskV/nMF4ICYsMgBBrvuM53npCwEuTk8xa5zIkekQvMliDs2vnQmc7FGZxyIDbA+cynTnQT4KCJKLjvQBgd9JVzfedsJbYGPNCBTBH97B239S1l9wJ4hVvqS6e6QShOA2RuKgQvKLtMMpCBEQjkBhnYQUN4AAIQ3MAiIKiBVeAu8Y93wAOnngkFKPADAOxg8wVACAVAIJDP56AAiq9IAThAlJZFyDGQQQjl6y1pl2vq2DrZPAsAUAPQC4QDje88ByjAAtTHYPSsv0EMIm/4DBTgBhxIfAF4sPwbMF7yAFg9AJxPfRDwgCeVwe3/ZubjGQwFJ+96T6YSbcwpkDi/APCPv/znn4GEEJ8CPDgBCygQ+t7XQAec13sn4Hg5QHw1sAMncHoJmH0UcAL8lwGbBwINyAL7x3qjx4ADuHmplxMrc1RXoxovAhyLcUfpBxHm9i+CtxEFAALz14LyV3+iBwI6cAInUAD8BwD6B38XeIHbd4M/gH+8RwE3YIPf14OhJ4FGCAAXaIP113swiBN6oh68wRzOgSUlaIIDNRCdFBLwlxGjxwMUUAM2GHrEF38WSHpJyIQM6HwUAIMQeIQUkIRL2IZrmBO14SFUmIf1M3vt1m3oc3cd0YUYcYGFN4YAAIAFkAEcQIYskHhv/wgAN0ABOpABLHACdZiESPiIc1h/agiFDPOJPIUe6sEeVniFCOFBlGZ7xpZ0FPF+88eCXoiGDBh6IxADDliDDCiEjwgAHLB/OfB4nfiImXiDm3iJN7EA01EoEEA6DgIh7WGKB2FRNDBq8GNoF7GCLviEckEjAsGNElGFHmYbmfRD6EdygJYQKKiCoccXJKgsJcGHkFZZZWQQW6iOe9EdZ+IjYPKO5ShxtjcQ5VMBNgBuHCGIeWE1nxgBLzIS8AhmB2QCNFACrTYQHfACP8OKFmGQeuEA48iQ/QhsF0ADGKBKKIABfWcQG9ABXLiOe8EAE/AaHekRDZk/YYdQE3kQbf+3kn3RLY3lkXonTDeJJCqpk3yBHNMxQSIxk6xjdQyRkjmZETzggrDIF3mSEkoJMyTwAaWFEE7pdhlxAycghi2ojXnhAHSyGDHZEVeZKEn2dAfRlRwxAizQeYXBk9vlkzN3ATggAThAbI7SAU/JETkQA4fRMi6DlCGxluGBAzQQlAAAlx4RAzkwGR5CMogJEooJHlqJkoDplR3xAyxgeIcBH9hyISSRmcQhTAUBmRfhivJXAyfweJIRASrjGneZlB8pZ080EKyJEYPpgkUoGfwxAASwIfy4cjTwAch0e8iWEZQoJAOAT6pBiniZcDKAAihQRu3HETrAkuARfp1BMbj/KXEm8AFVJRDpuBEIKJpCsjYngZqScQDKWRD1uBExQJhC8gCeoTG5+RDwWRgk8HVbKRDfBogXMQInsIHhER/pcZuJ2Z+s0wIogAMTuXaBqREFoAPfwqAQdJoQ+i0tAAQfkIUAsAIuAC8f0Yjf8gAR4ACjeJzA5nVthQHLqSkGQysa4ZqSCTN9ck/i+aDLVgI0MKA3EwIukIIZyYLxR5bhkQAtc5lASmsq8FAEkZKY5xEaOTc+YpUfCh4l0GMCkTTNWZDeOTcKwqW0BgRUOhD/BhJZCjN2CaN+xiRjEARF8DoOZ6AbIYb+M0c+wk/jiWgvoAh3ij2QAhIjAJvBCY0C//GfeGECTJAGKHEDOQACCso6UMIfCkCdgYpmyTlZJfEDuJhB4BQBNSWn/sMkGrAH2DkHWjcSI6ADKhplq0Gc7uihUdY0T1AkHvBsJUGJOsCeGRQBPaI1plmd/lMBb6CcAJJvIlEAJ0CXYKYbn+hDH+GocOEFWFAE8zgSOwACv4hoPbJHJoGtbQEDluI8HsEBYtmCYSmsYOaeKGGua0ECfOAEcuARGQACxeeCNbCoYMYAK+OgyAqiUqAEFuCZGLEDtlimy0YmBqAc79mle6EBhaYul/cCGCkRI2CDMQCv01YnmkGxDEGvZeECiKAEUkCkGMEBA3ip5LYmi+FNj4Gq4f8RAnbQmBxBibMqcp/4iQR7rSR7FyRgBSFQoxnxrSfAeiQngjBps7PRAoRgBCmGEbXIfyDLqBxhsl4Bb+uSKhh6AjEAs1qrlkMbFycXBH/glxXRiyDApGUrk2cLFylgBhS6EcMnrXHbqZ/RBExwQnhLAUy7twVrGDLwBSFABhwxfINLuHxrGCZwBk6wsQQRlS7Ygr3XuI7bEAvwkhMgIrD3o+QoGSSQnEMAcwqBoO16ufBXA5q7uQzRLeU3fp0he3OLFhKKAU3wqgqhAxoKux/RAAzAAKJBAHeVGgyKNbdrFkAAB3XgcEhqEKKatcC7ERDiHFWovIOxAS/QB7yqsQv/MQK9yAKvW70bYR7ogb245bQkWBcLR2lrEAchMARBIAjRWxAdO4AAa74coR6mib6+Qorsu7xhtn6TFghGoC9QcJIMsQPQ+rb8GxKqcZYM0oxi8ox2UW3oGgI2cL8GwbAUEAOyGcEg8bPMEY5WYrt1kUVKJALfdmx6ihDKF8JkS8IwwbU+EZIY4F4lgAFuMAj1QrkGsa81WMM2fMME3BQtAEVjFCuXom6LBwI1SL1HHBM4jBMhigNt1ZemAmsxjBA8QIEcQMVVbMVJDBQQSWla/AE48FG8yWsSgYB6W8ZQeMY9EaAjSmlurD3pNhE5gH10rBNXrBJpzMaOWRAvgC4T/1EDkxnIOzHIJyFCI8rACiECLkBmEYF4sGnEjiwTkFwSF9DDh2wQIpACHvDFlbt8+8cCkbe/nVwTnzwS8gm4DdEDvtoQopqII/zKPBHLICGhKMCyusbBDhEDLLDLvOxkVSGiJNqUKBe+OZADZJzMN+HLHEFLJcC2CZEvCivDLICf1AwU1owRHCSfMzDKb5mwDCG+0RrOQjHOE6ECUORLOIC0DcHNqcsBAOh97vzOdnwSU1oCH9StD4HPByG+AKgDY9zPQwHPDhHQYEoRBk0QCC2JC83QROHQCwHRGDHRvyeBCj3NGN3L/xwSMvABtGwRHs2LnCfSI63MRIEC52kRSf+jsIz70kqh0QhBA255EW06EDeN00mh06g4aclJ0BPBaHcX1EKNFDpdAqFGafYsESuAaZpGEEzd1Eeh0VPKEU4MtlgtuFqd0yV9EV+aESLglBVQK4hHeAWQuWNN1j3R1RWxA4uoBmyQBEmwf7rXeJHnunEt1zxx1hIxhAUoBHhwCISXAcgc2E4Bz3T9ENTHAlpwB2UAw459FfBM2AuRAT8AgDkwBVmgL5mX2dFTExy0ZjOwpkP8A5JJAYPJAVvwLh1s2lphrh4ERei1TEmEAweAtJ792oP5A/X3dynQzbY9eWVtEFlJA0CgZsIsvsIdA8RNED3QM+qa3FyBrTiQawn/oXwJWN0GscG1rd1d4ajl6ZjimwNi29ia8sI+gMrmXRX/mZVTDd45cNEFsQIORyrzHRb/2d0FwQHsLcII8dVQ/N9egZop9AGtNr76XWwb4MUKPhZKeQFAMANgNwPIJL5ijBDXnWnIXeELvrwqoOGyNQPPLRAVDQLlm9bv8gIJTuIAfrYz5lYrPhAVHdIHEeLHLd80vt0kewELJXapjHzwKgLPEy+AN+NBbuFdqgIRpUIEcQOwOZcbyL29WiSmbAMbAORPXuIXceMoENE7AJphucsWCikaAOZhLhYIR+SadQGuKYExALAmiqJvLhf7ZgJTTkU6EANmmOQ36uZ7Xhba/yYDOxzRI0ABVIxpR3rodCFtVDWRHfu7A6Hk5XN5pS3pbjFroYwBW1nRjhAJPMN2vDorI+7pn65sMqDFPRYFjcAIFCAER4AEqFIBPqABTs7qk55qInrO4rsEFv0Ihu7rc/FlTocCdKDPFLAEEY7sgeFAInQFXQCAQpAHUSDteRG6CSFAaFAIiVDrt77q3B4XtFt+GCwQGaAHkrgIYnCh524XxwuCAzHAAlG6VcAFgNCZ874X6jscTutdJtDDbeDv/w7wevhJyAQD5p7wcwHALwrxoNEgCvAgF6wQA/8aHN/xHv/xIB/yIj/yJF/yJn/yKJ/yKr/yLN/yLg/y1roXKP+clj8UWC9/8yNo8zjv8j6y8zjf8z7/8kAf9CzfvuCBw1yL9MutEEm/9Gmh9J7s9Coc9VQfQFK/7i8B9VWPxO0Z8ysxHTIB9mHv9Soh9jBh9hSf9mq/9mzf9m7/9nAf93L/Et7eEgnwkrEHE45x9QqjGAvJEvIKI54ruiQR+HikGHwPFunuEj8btCkRfphB95uxGYCKEmnTk7Jr+bpxl5BPPZ9R78mrEjjCMDAhGlCqEgDsjCoRJncpvMQLWSTB+gNh+sUR8C4RN4lfG5mDGi6hG+iRXGXfk7Of8SYBWN1oG6YjG7bfEtlxHi9xHAYgNjRPEg1yGZZB9iJh/AQBwCj/of3QL/2yIfFy4xLAvxLj0V0vkTbh2BLa/zgWEvzbdf7ZOxkWj/FBkhLJEQDwcf8rARAKBDQwIIAAAIQJFS5k2NDhQ4QICDwQ4ADiRYwXE0wQYIAAAwAUFQQIcDDjSY0cPYIUSNAgSpgxZc6kWRMlAoEKENjkuaCgAAUNeA4FkKBghJ1EbQoAGkDpzAFMmR6UytTp04tRpR40KgApVrBhxY4lW9bsWbRp1a5l29btW7hx5c6lW9fuXbx59e7l29fvX8CBBQ8mXNjwYcSJFS9m3NjxY8hkExCgTDkBggEJbDYYkHmugwFQLcbErDnyadRxtUodQCDAgpoLOr6eG3Vm/4CkGG0DcA079W/gaCdDEACBwGTaCAJwdsAAgmfeDwY0V0h8AIIFJRvsTPCcOgDcAa4nePAAZMLsBLYDAD0AgmblDcqb5vxAIEL5AyYgdC3fvPikcAOAgfacmqiz/QgQqKTeBgTtPQCyawC0qxhKoCTeAtDsQOowG+ABodJbLz/jgjORsAAEuCrFg6JSQKAIXASgAQEecKBGhQpSwAECvBJggAUiMCAAIRFiyoAIgCoIAoV6TDK0kRyIQAEAXNRxxtnuo9HGisDz6igkBYDtRwAUiCAAB6gMAALxBEAAgSeVewnJAJBcoMcfk8xNIdkeCEnMLW/008YABLrTx+tqDP/ggQpPdLSvFFd8ybYenbKNIpLuS6hS3roEgCOhbtSMTBYBIHNTT3kDLckqBUCooD9hu1QAkJD0kqrQSiUzggjYhI2BCR4oyFJXb02gSxon4JTGRhWKqs8/M3U1uwEEosxTlQR8dFu+IkWoVEpVbLVVkkhqUlxOb1WX1JdO5U9cLEGEdTfb6HXV3nVzbTc08mD0KYIJOCL2W4M4rdRgeBlCoKOByC03SAMQIO7aCttMlVuM6/JW3XAH5ugB9ZhE1UB4jwXZTCP1xfVcSZe7D99IG7hP4C3ztfk6AqI6VgECbiS2gQtfmnIiASZDV9wHIjgPIQaSjAChj0PuEeSoKIb/mseF/cx467k2BtdVTncrlCmt3yW5Qpw6Mo3dlUdmWseXi7WNARc1lbJGkHRV2dTQKAJqp4V/FLeBJCcotSudOj0bgF4ZIm408ATCkTghC4ZXZrKX5npzzk881rccxex8dNJLZ6iBZoty13TWW3f9ddhjl3122mu3/Xbcc9d9d9579/134IMXfnjiizf++OIrMwkj0OiarqHSkJc+saoiMI2hU5VDKV2YdntI24VKnX58wpj6FEcPQQRg4ZEW0D7C5yCMbz4ArHOquw/3XOC56RhQUMXlgQcBFxIg1DrjgOy8xHCaI18D82K+HvXNAWNbwI1ilADbQIxIT7MSUACg/yMgzQYCZePNANZUHDj9aE8+chWZHlcn1xgkRXtyYA3tYpWC7IRa1uIbQmzDETZVbTew4tTOHDABBkosKqHxXkI64sS+KeogkSqODa14F6Z0RodCkti+fOiqFLGJJAvAV7o4kyQDKORGPCJTE1MGxQFB4CeoA8rqrnjHt5gPVVRrF8/I6KpjGaABPcOg3MBWo0FCYJC8ctZAFsbEgVyvh2+EgLJuZLiBUGQ/eORkW/SYEMoVZIpMKSR+fmKAP37xixHwyZEkmYAnkYlwAtjkG99IJK9YhEVNK1onfflLYAZTmMMkZjGNeUxkJlMpF1rOWRLAwJO8CSsMUE5S7lQZ0P9JUizUBB/qEKA5bW4zPglBHRKZphzQqSU7EwDdAgzXFm+eB1i02Zx4Epk6opiLPeHMiD6VEjACQMAiriGJCSO0MLMAVKCq6lloDlqssgDUoD0jwATS+MEJyIyfZCGAIHECEs40QChroWjzqpRRBUDzUQmgUkJAMhGQfYszTLoMQtxZFOmMdDnu8aEJ3QcbmJoEAf4BqnQgkDd8DkU+C1EAUFOUlqUqpFgxVEvOFNK0olxUYmtBkw8P0lS5uIoBLVUk17rKp6YuAKxuCgl2nvYpCPhkAXSjyk4esBMIGIeual0AX6vUnAnQFDaBBU9SbbIoSa5JqmhBbJNaaiS1KDb/IuozCn8cmha1KpJfCnhOAFR6FgWV8FuGNZE/obai/RTLXHctkztNKB6nqNYp+mzNO8Gzn9aIFljCyhVpadIzyDUtnRAtC3Bd6pHFCielCbnMRcsjnssKB0TP8R8q6+fbbSLXqoXlGgJIyF3uyraEGASPcSgzptGCtzX6NFdurWoAJFrVtFiBqGSdqJZiMSBiCyGuZBQQztwWhQAIgBxa1MceZTl0u2rRb1LIe1uuNc0kCwDaRT0j3jJdhzfLLYqp0nvW1lS2Sppxb2hotb7eYsUkoR0QK/lrlhVTqcHYc+Z/mQsS4boUrGphE0JY6+KzpmXGCVHaBzfqKPIYoDNT/zTAkCAL3gk8FgFKFqSHueuTzOS2Tk6u0kGsihP3pPgpdRqAAUxjXxSrkCxkNjN4YtQZ+CyRhmCpVmdCQ5AyJ2UCnRkpg3k7GqN86LNjIZKd4dPkAitT0YtmdKMd/WhIR1rSwyMA6Cp9EedARyYBhAs398QASyuPLJ6+aqgrUxZu9jmeNjXckSUDvguxE564AWfnTsU9heizkgOiSXThotDR5Kxi5eovVoBt2WGTpNjGTrCBeGRSBwyVZ2shSM+0BiI4DVosJXVoAky6ueIcJK8rcg9IOlMSzjoFM3H9Vnbc5x8GiGeTTnGfvOMSVdgqTGRlwbdBF7JV0Pq6v/M1y/+Bd+zVPEbkObYmzwIY5ZQJzig0ea00fAdsHhb/6DX9s+hH1rphj6eTqw+43nxzXJbGpveqLj4LmlmcEA2r5cABbrHI0/LyBXPtXut1ypmUrd6DxHTEVu6yaIsONofSnC3GVXlC0DwWpoPX6fsuC0uXpt8AYmbpI4HAtBHS47ZgfVO+zhjSwytq2rbIJLmFaIkRbvaiw6W+jTr5Wea+cpuHhaXXG3JEDKDtsfhPrefJq1v6bnRw59pSm9QMiA8yAYuM9clF3y7bja70m/PnsaZ9elhi7PRGdV7vNn7bnqYM+IiKrPBh32+TyI4x4pqLAcIygJ+wjMGDOKfJI227l5P/TpXLc5qxVDZNtRTg0LoTmvg+fBHyWV6WOnfGzYY2lZKftxYlH7VTdp4zyt/sGQcgSdOTJn/5zX9+9Kdf/etn/1CumXebCD8vrvmmTQMg64hgSDLKO8+FrGk4+cOK7CiXq+I7dEKLVCs19Gg1tSinpXEn7AKOnMG8pouJ17uLRXGN0Oio7ViuNemoACQK5ciUKQIZk4g2Diwuj6CM43Ion5AI+AMLiboKYUuIaJOZEFQxHrEo/BgAkeIcfRqq8pAVnwKPcuONBniO3IufvPkU3xggI9Q+1eA98BiN3LIuAjsLtYqQx1qIIyousrMRh4KA7gu4b/E3xVsLrGqt0aEt/8BiEoojEKfgDCNcAJYKif0AGg/bNcapoDm8wAYcCXPJLDq0spwbCw3bM+nIjQqSQqiLEXarH4lwqAh4kBgUC/siuJhDC+8SCpbqLNQDjrQTLX3yuafSJ1cZoQbwDUCikq0yxWVbCwLDDIsgjyQcAJCYKkBUChZbEwYQuwHJmT7bJpDgwa3arl7SurSwOtD7t13UuynjDesCu60ZRfm6ioJhQVRUuAgAvi6LqWzMQbQoMiM7sC98q4kwi5hjr0Y5RLLYuTKrRKKLxdFLrEY5vbZoje1yx22xxlyxQsYDL7BBiIgrFsxoKf1ACFdDi2kbq/25CtZSny/kqMe6wyoRCpCTEL2neCZpdD0f24mOUi5t8id8XEYcczEgS7RtwYnEcbvbm70m85NtJDNcJLqvGBDa+662CDQNg8nr48lQrIlNXB8lG42cDEqawLM2Gzumob6ziL6kaz4jsT6VFAuldDAlM4/220qu7Eqv/EqwDEuxHEuyLEuzPEu0TEu1XEu2bEu3fEu4jEu5nEu6rMvYCQgAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Kaplan-Meier plots of any diabetes-related endpoint in 753 overweight patients with type 2 diabetes mellitus in the United Kingdom Prospective Diabetes Study who were randomly assigned to either intensive therapy with metformin or to conventional treatment with diet; drugs were added if there were hyperglycemic symptoms or if the fasting blood glucose concentration was greater than 270 mg/dL (15 mmol/L) Another 951 overweight patients received intensive therapy with a sulfonylurea or insulin and are included in the analysis. Metformin was associated with a 32 percent reduction in any diabetes-related endpoint compared to conventional therapy (P = 0.002) and had the same relative benefit compared to intensive therapy with other therapy (P = 0.003).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from UK Prospective Diabetes Study (UKPDS) Group, Lancet 1998; 352:854.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Metformin in overweight patients with type 2 diabetes mellitus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 427px; height: 299px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Kaplan-Meier plots of any diabetes-related death in 753 overweight patients with type 2 diabetes mellitus in the United Kingdom Prospective Diabetes Study who were randomly assigned to either intensive therapy with metformin or to conventional treatment with diet; drugs were added if there were hyperglycemic symptoms or if the fasting blood glucose concentration was greater than 270 mg/dL (15 mmol/L). Another 951 overweight patients received intensive therapy with a sulfonylurea or insulin and are included in the analysis. Metformin was associated with a 42 percent reduction in any diabetes-related endpoint compared to conventional therapy (P = 0.02).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from UK Prospective Diabetes Study (UKPDS) Group, Lancet 1998; 352:854.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_5_19536=[""].join("\n");
var outline_f19_5_19536=null;
var title_f19_5_19537="Scabies infant scalp";
var content_f19_5_19537=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F72616&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F72616&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scabies, infant",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The rash of scabies may be more diffuse in infants, spreading to the trunk and scalp in addition to the extremities.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fleisher, GR, Ludwig, S, Baskin, MN. Atlas of Pediatric Emergency Medicine, Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright &copy;2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_5_19537=[""].join("\n");
var outline_f19_5_19537=null;
var title_f19_5_19538="Patient information: Early menopause (primary ovarian insufficiency) (The Basics)";
var content_f19_5_19538=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15606\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/50/3876\">",
"         How pregnancy happens",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?36/4/36930\">",
"         Patient information: Absent or irregular periods (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/16/11523\">",
"         Patient information: Infertility in women (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?11/63/12276\">",
"         Patient information: Early menopause (primary ovarian insufficiency) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Early menopause (primary ovarian insufficiency) (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/early-menopause-primary-ovarian-insufficiency-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H194440333\">",
"      <span class=\"h1\">",
"       What is early menopause?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Menopause is the time in a woman&rsquo;s life when she naturally stops having periods. Menopause usually occurs between the ages of 45 and 55. But in some women, menopause comes early &mdash; before the age of 40.",
"     </p>",
"     <p>",
"      Some women with this condition keep having periods every once in a while. They might even be able to get pregnant. Instead of calling it &ldquo;early menopause,&rdquo; doctors prefer to call it &ldquo;primary ovarian insufficiency&rdquo; (POI). You might also hear the term &ldquo;premature ovarian failure&rdquo; (POF).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H194440340\">",
"      <span class=\"h1\">",
"       What causes early menopause?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Early menopause happens when something causes the ovaries to stop working well. Normally, the ovaries release an egg about once a month. This is called &ldquo;ovulation,&rdquo; and it makes pregnancy possible (",
"      <a class=\"graphic graphic_figure graphicRef73238 \" href=\"UTD.htm?3/50/3876\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      In women with early menopause, the ovaries start running out of eggs. As a result, they might:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Release eggs less often than normal",
"       </li>",
"       <li>",
"        Stop releasing eggs completely",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H194440347\">",
"      <span class=\"h1\">",
"       Why did my ovaries stop working?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most of the time, doctors don&rsquo;t know what causes early menopause. In some women, causes include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Problems with their genes",
"       </li>",
"       <li>",
"        Cancer treatments",
"       </li>",
"       <li>",
"        Autoimmune diseases, in which the body attacks its own ovaries",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H194440354\">",
"      <span class=\"h1\">",
"       What are the symptoms of early menopause?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The first thing most women notice is missed periods, or periods that are lighter than normal. Other symptoms you might have are:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Hot flashes, which feel like a wave of heat that starts in your chest and face and then moves through your body",
"       </li>",
"       <li>",
"        Extreme sweating at night",
"       </li>",
"       <li>",
"        Dryness in your vagina",
"       </li>",
"       <li>",
"        Pain during sex",
"       </li>",
"       <li>",
"        Trouble sleeping",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H194440361\">",
"      <span class=\"h1\">",
"       What other symptoms should I watch for?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Certain symptoms can be clues about what is causing your condition. Make sure to tell your doctor if you:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Feel weak or very tired all the time",
"       </li>",
"       <li>",
"        Have lost weight without trying",
"       </li>",
"       <li>",
"        Have pain in your belly",
"       </li>",
"       <li>",
"        Crave salt",
"       </li>",
"       <li>",
"        Notice your skin getting darker, even though you have not been out in the sun",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H194440368\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;See your doctor or nurse if you are younger than 40 and your periods have been irregular for at least three months.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H194440375\">",
"      <span class=\"h1\">",
"       Are there tests I should have?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor or nurse will decide which tests you should have based on your age, other symptoms, and individual situation. Common tests include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        A pregnancy test",
"       </li>",
"       <li>",
"        Blood tests &ndash; These measure hormone levels. They can show why your periods are irregular.",
"       </li>",
"       <li>",
"        Genetic tests &ndash; If your hormone tests show that you do have early menopause, you will probably have other blood tests that can show if something is wrong with your chromosomes. (Chromosomes are structures in cells that contain thousands of genes.)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H194440382\">",
"      <span class=\"h1\">",
"       How is early menopause treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;That depends on what is causing your condition. The most common way to treat early menopause is with hormones, such as estrogen. These replace what the ovaries are not making anymore. Hormones will reduce your symptoms, especially hot flashes and night sweats. They will also help protect your bones and maybe your heart. Women usually take hormones until at least age 50.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H194440389\">",
"      <span class=\"h1\">",
"       What if I want to get pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There might still be hope. About 10 percent of women with early menopause are able to have a baby on their own. When women can&rsquo;t get pregnant on their own, they can still get pregnant with new technologies. These methods use eggs that come from another woman.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H194440396\">",
"      <span class=\"h1\">",
"       What will my life be like?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Learning that you have early menopause can be very emotional. You might feel anxiety, sadness, or grief. Some women worry that they will grow old very fast and die young. This is not true. Tell your doctor about these feelings. It takes time to cope. Therapy and support groups can help. You should also tell your doctor if you want to get pregnant. There might still be options.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H194440403\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/4/36930?source=see_link\">",
"       Patient information: Absent or irregular periods (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/16/11523?source=see_link\">",
"       Patient information: Infertility in women (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?11/63/12276?source=see_link\">",
"       Patient information: Early menopause (primary ovarian insufficiency) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?19/5/19538?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15606 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-1F43DE5731-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_5_19538=[""].join("\n");
var outline_f19_5_19538=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H194440333\">",
"      What is early menopause?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H194440340\">",
"      What causes early menopause?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H194440347\">",
"      Why did my ovaries stop working?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H194440354\">",
"      What are the symptoms of early menopause?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H194440361\">",
"      What other symptoms should I watch for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H194440368\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H194440375\">",
"      Are there tests I should have?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H194440382\">",
"      How is early menopause treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H194440389\">",
"      What if I want to get pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H194440396\">",
"      What will my life be like?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H194440403\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15606\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/50/3876\">",
"      How pregnancy happens",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/4/36930?source=related_link\">",
"      Patient information: Absent or irregular periods (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?11/63/12276?source=related_link\">",
"      Patient information: Early menopause (primary ovarian insufficiency) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/16/11523?source=related_link\">",
"      Patient information: Infertility in women (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_5_19539="Tromethamine: Pediatric drug information";
var content_f19_5_19539=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Tromethamine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?42/29/43475?source=see_link\">",
"    see \"Tromethamine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?6/23/6515?source=see_link\">",
"    see \"Tromethamine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F232038\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      THAM&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1062803\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Alkalinizing Agent, Parenteral",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11445210\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.: Dose depends on severity and progression of acidosis: Manufacturer's recommendation: 1 mL/kg for each pH unit below 7.4; additional doses to be determined by changes in PaO",
"     <sub>",
"      2",
"     </sub>",
"     , pH, and pCO",
"     <sub>",
"      2",
"     </sub>",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1062799\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?42/29/43475?source=see_link\">",
"      see \"Tromethamine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.: Dose depends on severity and progression of acidosis: Infants, Children, and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Empiric dosage based upon base deficit: Tromethamine mL of 0.3 M solution = body weight (kg) x base deficit (mEq/L) x 1.1*; maximum: 500 mg/kg/dose = 13.9 mL/kg/dose using 0.3 M solution",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     *Factor of 1.1 accounts for an approximate reduction of 10% in buffering capacity due to the presence of sufficient acetic acid to lower the pH of the 0.3 M solution to approximately 8.6",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolic acidosis with cardiac arrest: Tromethamine mL of 0.3 M solution: 3.5-6 mL/kg/dose (126-216 mg/kg/dose); maximum: 500 mg/kg/dose = 13.9 mL/kg/dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolic acidosis with cardiac arrest: Direct instillation to ventricle: Adults: Tromethamine 0.3 M solution: 2-6 g (62-185 mL); do not inject into cardiac muscle",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excess acidity of acid citrate dextrose priming blood: Tromethamine mL of 0.3 M solution: 15-77 mL added to each 500 mL of ACD blood used for priming the pump-oxygenator",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Acidosis during cardiac bypass surgery: Tromethamine mL of 0.3 M solution: 9 mL/kg (324 mg/kg/dose); maximum: 1000 mL (36 g) as single dose dose in severe cases and not to exceed 500 mg/kg over a period of 1 hour (eg, for 70 kg patient, not to exceed 35 g/hour)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F232027\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     THAM&reg;: 18 g (500 mL) [0.3 molar]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F232014\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1062806\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: Maximum concentration: 0.3 molar; infuse slowly over at least 1 hour or 3-16 mL/kg/hour up to 33-40 mL/kg/day; administer into a central venous line and avoid administration into low-lying umbilical venous lines",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F4298172\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at room temperature; protect from freezing",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1062805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Correction of metabolic acidosis associated with cardiac bypass surgery or cardiac arrest; to correct excess acidity of stored blood that is preserved with acid citrate dextrose (ACD); to prime the pump-oxygenator during cardiac bypass surgery; indicated in severe metabolic acidosis in patients in whom sodium or carbon dioxide elimination is restricted [eg, infants needing alkalinization after receiving maximum sodium bicarbonate (8-10 mEq/kg/24 hours)]",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F3123324\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Tromethamine may be confused with TrophAmine&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F232055\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Hypervolemia, venospasm",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hyperkalemia, hypoglycemia (usually doses &gt;500 mg/kg administered over &lt;1 hour)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Hepatic necrosis (resulted during delivery via umbilical venous catheter)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Necrosis with extravasation, phlebitis, tissue irritation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Apnea, pulmonary edema, respiratory depression",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1062809\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to tromethamine or any component; uremia or anuria; chronic respiratory acidosis (neonates); salicylate intoxication (neonates)",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1062798\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reduce dose and monitor pH and serum potassium carefully in renal impairment.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1062797\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid infusion via low-lying umbilical venous catheters (particularly with concentrations &ge;1.2 M) due to associated risk of hepatocellular necrosis; severe local tissue necrosis and sloughing may occur if solution extravasates; administer via central line or large vein slowly. Due to tromethamine's greater osmotic effects, use of sodium bicarbonate for the treatment of acidotic neonates and infants with RDS may be preferred; may cause prolonged hypoglycemia in neonates or with rapid I.V. infusion and overdosage. Monitor pH carefully as large doses may increase blood pH greater than normal which may result in depressed respiration.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300183\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6223545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Alkalinizing Agents may decrease the excretion of Amphetamines.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Flecainide: Tromethamine may increase the serum concentration of Flecainide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNINE: Alkalinizing Agents may increase the serum concentration of QuiNINE.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F232023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F3341462\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal studies have not been conducted. There are no adequate and well-controlled studies in pregnant women. Use only if potential benefit outweighs possible risk to the fetus.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1062802\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum electrolytes, arterial blood gases, serum pH, blood sugar, ECG monitoring, renal function tests",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1062796\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acts as a proton acceptor, which combines with hydrogen ions to form bicarbonate and buffer to correct acidosis; buffers both metabolic and respiratory acids, limiting carbon dioxide generation; also acts as an osmotic diuretic",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1062808\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     30% of dose is not ionized; rapidly eliminated by kidneys",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1062810\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     1 mM = 120 mg = 3.3 mL = 1 mEq of THAM&reg;",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12868 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-1.234.2.38-35693F307E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_5_19539=[""].join("\n");
var outline_f19_5_19539=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232038\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062803\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11445210\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062799\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232027\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232014\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062806\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4298172\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062805\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3123324\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232055\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062809\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062798\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062797\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300183\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6223545\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232023\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3341462\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062802\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062796\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062808\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062810\">",
"      Additional Information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12868\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12868|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?42/29/43475?source=related_link\">",
"      Tromethamine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?6/23/6515?source=related_link\">",
"      Tromethamine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_5_19540="Treatment of seizures in children";
var content_f19_5_19540=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Treatment of seizures in children (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?19/5/19540/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19540/contributors\" id=\"au1329\">",
"       Angus Wilfong, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?19/5/19540/contributors\">",
"       Section Editors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19540/contributors\" id=\"se1864\">",
"       Douglas R Nordli, Jr, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19540/contributors\" id=\"se6945\">",
"       Timothy A Pedley, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?19/5/19540/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19540/contributors\" id=\"de8764\">",
"       April F Eichler, MD, MPH",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?19/5/19540?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      SEIZURES OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     This article discusses common medications and treatments used to treat children with seizures.",
"    </p>",
"    <p>",
"     An article about the various types of seizures and the methods used to diagnose seizures is also available. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/26/419?source=see_link\">",
"      \"Patient information: Seizures in children (Beyond the Basics)\"",
"     </a>",
"     .) A discussion of febrile seizures and treatment is also available (see",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/35/39473?source=see_link\">",
"      \"Patient information: Febrile seizures (Beyond the Basics)\"",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      WHEN TO TREAT SEIZURES",
"     </span>",
"    </p>",
"    <p>",
"     Seizures are treated if they recur or appear likely to recur. Not all children will require treatment for seizures, especially if the child only has one seizure and the EEG and MRI (or other imaging test) are normal.",
"    </p>",
"    <p>",
"     Even when treatment is necessary, the long-term impact of seizures is small for most children, especially if there are no underlying abnormalities in the brain. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37386?source=see_link\">",
"      \"Overview of the treatment of seizures and epileptic syndromes in children\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      GENERAL INFORMATION ABOUT MEDICATIONS",
"     </span>",
"    </p>",
"    <p>",
"     Medications used to prevent seizure are called antiepileptic drugs (AEDs).",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Most medications are started at a low dose and slowly increased until seizures no longer occur.",
"      </li>",
"      <li>",
"       The dose of the medication may be adjusted as the child grows and weight increases or as new medications are added for other problems (eg, asthma).",
"      </li>",
"      <li>",
"       A second AED may be added or substituted if the first drug was only partially effective in stopping seizures, or if there were significant side effects with the first drug.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Interactions with other medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;Many AEDs can interact with other medications; parents should be sure that their child's healthcare providers and pharmacist are aware of all prescription and nonprescription medications taken by the child.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Monitoring during treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;Occasional blood testing is recommended with some drugs to monitor the level of the drug in the body. Testing may be done on a regular basis and when the dose changes.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Allergic reaction",
"     </span>",
"     &nbsp;&mdash;&nbsp;All drugs have the potential to cause an allergic reaction. The first sign of a drug allergy is often a rash; parents who notice this should call their healthcare provider immediately. Rashes can be caused by many different things, including some common viruses, and the provider will evaluate the situation to decide whether or not the rash is related to the AED. Do not stop giving the antiepileptic medication unless the child's doctor says so because some medications should not be stopped suddenly.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Risk of suicide",
"     </span>",
"     &nbsp;&mdash;&nbsp;An expert review suggested that antiepileptic drugs can slightly increase the risk of suicidal thoughts in children over the age of five [",
"     <a class=\"abstract\" href=\"UTD.htm?19/5/19540/abstract/1\">",
"      1",
"     </a>",
"     ]. In considering whether or not to use AEDs to treat seizures, the parent(s) and physician must balance the small increased risk of suicidal thoughts against the risk of continued seizures if the child is not adequately treated. Any mention of suicidal thoughts or feelings should be taken seriously and reported to the child's physician. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/6/13413?source=see_link&amp;anchor=H5#H5\">",
"      \"Patient information: Depression in adolescents (Beyond the Basics)\", section on 'Preventing suicide'",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Dealing with side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;AEDs often have side effects, some of which can be bothersome and interfere with a child's ability to function (",
"     <a class=\"graphic graphic_table graphicRef61234 \" href=\"UTD.htm?41/42/42668\">",
"      table 1",
"     </a>",
"     ). &nbsp;Side effects can sometimes be managed by lowering the medication's dose or changing the dosing schedule.",
"    </p>",
"    <p>",
"     Parents should not assume that a side effect is caused by medication; it is possible that the child's seizure disorder or another condition is responsible. Parents should discuss any concerns about side effects with their child's healthcare provider, and should never stop their child's AED without first discussing it with their child's provider.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Stopping antiepileptic drugs",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most children who are treated with AEDs continue taking them until there have been no seizures for two years. After two years of being seizure-free, the chance of having another seizure is reduced to 30 to 40 percent. This is true for all types of seizures, although children with other neurologic problems (eg, cerebral palsy) have a slightly higher risk of having another seizure after the AED is stopped.",
"    </p>",
"    <p>",
"     AEDs should be tapered slowly rather than stopped suddenly. This may mean that the dose is reduced on a weekly basis over several months. Parents should discuss the tapering schedule with the child's healthcare provider.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Specific antiepileptic drugs",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are a number of anti-seizure medications available. A table that briefly describes these medications is available here (",
"     <a class=\"graphic graphic_table graphicRef61234 \" href=\"UTD.htm?41/42/42668\">",
"      table 1",
"     </a>",
"     ). (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=see_link\">",
"      \"Pharmacology of antiepileptic drugs\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      OTHER TREATMENTS",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Dietary treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;A special diet, known as the ketogenic diet, has been used as a treatment for children with some types of seizures that do not respond to AEDs. The diet consists of high fat, relatively low carbohydrate and adequate protein. The diet does not usually \"cure\" the seizures, but it lowers the likelihood of seizures by at least 50 percent in approximately 40 percent of patients, particularly those between one and 10 years of age.",
"    </p>",
"    <p>",
"     Parents should not attempt to start their child on a ketogenic diet on their own; it should be supervised by a well-trained dietitian in an Epilepsy Center with experience managing the diet. The diet is usually started in a hospital setting, although some experts are able to manage patients at home. The child must be closely monitored to ensure he or she is growing and getting all the necessary nutrients. The diet is often continued for at least two years in children who improve significantly.",
"    </p>",
"    <p>",
"     The restriction on eating carbohydrates may be difficult for some children, especially those who are reluctant to try new foods. Parents, teachers, relatives, and friends need to understand that even one bite or taste of a restricted food can lead to a seizure. The diet may significantly change experiences like birthday parties and holidays, which frequently include high carbohydrate foods. Talking to other parents of children who have used the diet may be helpful in deciding whether to attempt it.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2208683\">",
"     <span class=\"h2\">",
"      Vagus nerve stimulation (VNS)",
"     </span>",
"     &nbsp;&mdash;&nbsp;The vagus nerves are a pair of large nerves located in the neck. Stimulating the left vagus nerve intermittently with electrical pulses can reduce the frequency of seizures in some people. This requires surgically implanting a small device or pacemaker, called a stimulator, under the skin in the left upper chest, which is attached to a wire secured around the nerve in the neck.",
"    </p>",
"    <p>",
"     Often, many months of VNS are needed before benefit is seen. Studies show that VNS reduces seizure frequency by about 50 percent in 30 to 40 percent of individuals. VNS is approved for children over age 12 years, although it has been used in younger children. Some patients are able to significantly shorten or abort seizures by use of the VNS magnet at the onset of a seizure.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Brain surgery",
"     </span>",
"     &nbsp;&mdash;&nbsp;Children whose seizures do not respond to medications may be candidates for brain surgery. Surgical treatments may be considered for children who have persistent, frequent seizures that are not controlled after a trial of at least two to three AEDs.",
"    </p>",
"    <p>",
"     Most epilepsy surgeries involve removal of the area of the brain causing the seizures. This area may be as small as the tip of a finger (focal cortical resection or topectomy) or as large as an entire lobe of the brain (lobectomy) or even the entire half of the brain (hemispherectomy).",
"    </p>",
"    <p>",
"     The area causing seizures is often found to be a scar (gliosis), an area of abnormal brain growth (dysplasias or hamartomas), or rarely, a tumor (neoplasias). Many of these abnormalities can be seen on MRI scans, but not all. Some children will require other specialized tests in order to localize the exact spot where the seizures are arising. The risk and benefits of epilepsy surgery must be discussed in detail with an epilepsy team, including a neurosurgeon",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     neurologist prior to proceeding.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h1\">",
"      CARE DURING SEIZURES",
"     </span>",
"    </p>",
"    <p>",
"     If you witness your child's seizure, it is important to prevent the child from harming him or herself.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Place the child on their side to keep the throat clear and allow secretions (saliva or vomit) to drain. Do not try to stop the child's movements or convulsions. Do not put anything in the child's mouth, and do not try to hold the tongue. It is not possible to swallow the tongue, although some children may bite their tongue during a seizure, which can cause bleeding. If this happens, it usually does not cause serious harm.",
"      </li>",
"      <li>",
"       Keep an eye on a clock or watch. Seizures that last for more than five minutes require immediate treatment.",
"      </li>",
"      <li>",
"       Move the child away from potential hazards, such as a stove, furniture, stairs, or traffic.",
"      </li>",
"      <li>",
"       Stay with the child until the seizure ends. Allow the child to sleep after the seizure if",
"       <span class=\"nowrap\">",
"        he/she",
"       </span>",
"       is tired. Explain what happened and reassure the child that they are safe when they awaken.",
"      </li>",
"      <li>",
"       Discuss a post-seizure plan of care with your child's healthcare provider to determine if and when to call the doctor or go to the emergency room and when to give additional anti-seizure medicine after a seizure.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      When to call for help",
"     </span>",
"     &nbsp;&mdash;&nbsp;Call for an ambulance in the following situations:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       If the seizure lasts for more than five minutes, one person should stay with the child while another person calls for emergency medical assistance, available by dialing 911 in the United States and Canada",
"      </li>",
"      <li>",
"       If the child is seriously injured during the seizure (eg, falls and hits head)",
"      </li>",
"      <li>",
"       If the child is having difficulty breathing",
"       <span class=\"nowrap\">",
"        and/or",
"       </span>",
"       the skin is blue after the seizure",
"      </li>",
"      <li>",
"       If another seizure occurs immediately or if the child cannot be aroused after the seizure",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Status epilepticus",
"     </span>",
"     &nbsp;&mdash;&nbsp;Status epilepticus is the name for a prolonged seizure (greater than 10 minutes) or clusters of seizures in which the child does not awaken between seizures. Status epilepticus requires emergency medical attention to stop seizures and prevent them from recurring. You should not attempt to drive a child with status epilepticus to the hospital; an ambulance should be called.",
"    </p>",
"    <p>",
"     If your child has a history of status epilepticus, you should develop a plan for future episodes with your child's healthcare provider; this may include having emergency treatment available at home. Home treatment usually involves giving one dose of diazepam gel (Diastat&reg;) into the rectum if a child's seizure lasts more than five minutes. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/50/30505?source=see_link\">",
"      \"Management of status epilepticus in children\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h1\">",
"      LIVING WITH SEIZURES",
"     </span>",
"    </p>",
"    <p>",
"     Children with epilepsy often need to make lifestyle changes to minimize the frequency of seizures and possible dangers associated with seizures. However, you must balance your concerns about your child's health so that the child can have as full and independent a life as possible.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Reducing and avoiding harm",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are many things that parents of a child with epilepsy need to know about decreasing the risk of harm due to seizures and seizure treatment. A few tips are listed here.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Parents should teach their child to avoid biking, skating, and skateboarding on streets with heavy traffic. All children need to wear protective gear, including a helmet, during these activities.",
"      </li>",
"      <li>",
"       Activities at heights (eg, climbing a tree or rope) should be avoided to prevent serious falls if the child has a seizure while climbing.",
"      </li>",
"      <li>",
"       Always supervise the child around water, including bathtubs, at the beach, and near wading pools. Showers may be unsupervised, but swimming should be closely supervised at all times by someone who is aware of their condition. If seizures are poorly controlled, a life jacket should be worn when they are in the water.",
"      </li>",
"      <li>",
"       Parents should talk to their child's teachers and other parents about their child's condition and what to do in case a seizure occurs.",
"      </li>",
"      <li>",
"       Children with epilepsy should wear a medical identification bracelet or necklace at all times. If a seizure occurs and the child is unable to explain their condition, this will help responders give the proper care as quickly as possible. The identification device should include the child's condition, a list of known allergies, as well as the name and phone number of an emergency contact. One device, Medic Alert&reg; (",
"       <a class=\"external\" href=\"file://www.medicalert.org/\">",
"        www.medicalert.org",
"       </a>",
"       ), provides a toll-free number that emergency medical workers can call to find out a person's medical history, list of medications, family emergency contact numbers, and healthcare provider names and numbers.",
"      </li>",
"      <li>",
"       Encourage the child to sleep well and take medications on time.",
"      </li>",
"      <li>",
"       Driving restrictions for people with seizures vary from state to state and country to country. Some people with seizures are not allowed to drive at all, while others can drive with restrictions (eg, unless a seizure has occurred recently or medication type or dose is changing).",
"      </li>",
"      <li>",
"       Teens with epilepsy need counseling about the effects of seizures and seizure medications on sexual activity. All medications have the potential to cause birth defects if taken during pregnancy, although some may be riskier than others. Also, birth control pills may not be effective in preventing pregnancy when used with some AEDs.",
"      </li>",
"      <li>",
"       Parents of teens should also discuss the increased risk of seizures due to drinking alcohol or using recreational drugs. Alcohol and drugs (prescription, over-the-counter, and recreational) can interact with AEDs, making them less effective and increasing the risk of seizure. Also, the effects of alcohol and the side effects of AEDs can be enhanced when combined.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      School and seizures",
"     </span>",
"     &nbsp;&mdash;&nbsp;Children with epilepsy are often fearful of having a seizure while at school. Seizures can be an embarrassing and frightening event, but advance planning can help a child to feel more confident. Parents should be sure that their child's teacher, school nurse, and other faculty are aware of the child's condition, need for treatment, and what to do in case the child has a seizure (see",
"     <a class=\"local\" href=\"#H22\">",
"      'Where to get more information'",
"     </a>",
"     below). Local epilepsy groups often have information that parents can give to school personnel that describes what epilepsy is and how it is treated. Meeting to discuss an individual child's needs is often helpful.",
"    </p>",
"    <p>",
"     Children with epilepsy sometimes have difficulty keeping up academically with peers as a result of missing school for appointments or tests. While intelligence is not usually affected by epilepsy, seizures and the side effects of anti-seizure medications can affect a child's ability to perform well on tests and remember detailed information. The child's neurologist or other healthcare provider can be helpful in providing guidance to parents and children about difficulties with school performance.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H22\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your child's healthcare provider is the best source of information for questions and concerns related to your child's medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3498656171\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H181962416\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/56/28546?source=see_link\">",
"      Patient information: Seizures (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/20/11586?source=see_link\">",
"      Patient information: Febrile seizures (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H181962454\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/26/419?source=see_link\">",
"      Patient information: Seizures in children (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/35/39473?source=see_link\">",
"      Patient information: Febrile seizures (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/6/13413?source=see_link\">",
"      Patient information: Depression in adolescents (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/4/14409?source=see_link\">",
"      Clinical and laboratory diagnosis of seizures in infants and children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/28/18888?source=see_link\">",
"      Clinical features and complications of status epilepticus in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/2/1063?source=see_link\">",
"      Clinical features and diagnosis of infantile spasms",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/11/6328?source=see_link\">",
"      Clinical features and electrodiagnosis of neonatal seizures",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33769?source=see_link\">",
"      Epilepsy syndromes in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/23/41335?source=see_link\">",
"      Etiology and prognosis of neonatal seizures",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/9/3226?source=see_link\">",
"      Febrile seizures",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/28/30154?source=see_link\">",
"      Management and prognosis of infantile spasms",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/50/30505?source=see_link\">",
"      Management of status epilepticus in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/60/35783?source=see_link\">",
"      Neonatal epileptic syndromes",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21912?source=see_link\">",
"      Overview of the classification, etiology, and clinical features of pediatric seizures and epilepsy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=see_link\">",
"      Pharmacology of antiepileptic drugs",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/0/13?source=see_link\">",
"      Treatment of neonatal seizures",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37386?source=see_link\">",
"      Overview of the treatment of seizures and epileptic syndromes in children",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The Epilepsy Foundation",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.epilepsyfoundation.org/\">",
"      www.epilepsyfoundation.org/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Neurological Disorders and Stroke",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.ninds.nih.gov/disorders/epilepsy/detail_epilepsy.htm\">",
"      www.ninds.nih.gov/disorders/epilepsy/detail_epilepsy.htm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/epilepsy.html\">",
"      www.nlm.nih.gov/medlineplus/epilepsy.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Epilepsy Therapy Development Project",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.epilepsy.com/\">",
"      www.epilepsy.com",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       International League Against Epilepsy and the International Bureau for Epilepsy",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.epilepsy.org/\">",
"      www.epilepsy.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?19/5/19540/abstract/2-6\">",
"      2-6",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 12, 2011.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?19/5/19540?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     www.fda.gov/cder/drug/InfoSheets/HCP/antiepilepticsHCP.htm; accessed January 31, 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19540/abstract/2\">",
"      Sillanp&auml;&auml; M, Schmidt D. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain 2006; 129:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19540/abstract/3\">",
"      American Academy of Pediatrics. Behavioral and cognitive effects of anticonvulsant therapy. Committee on Drugs. Pediatrics 1985; 76:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19540/abstract/4\">",
"      Hirtz D, Berg A, Bettis D, et al. Practice parameter: treatment of the child with a first unprovoked seizure: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2003; 60:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19540/abstract/5\">",
"      Sillanp&auml;&auml; M, Schmidt D. Prognosis of seizure recurrence after stopping antiepileptic drugs in seizure-free patients: A long-term population-based study of childhood-onset epilepsy. Epilepsy Behav 2006; 8:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19540/abstract/6\">",
"      Vining EP, Freeman JM, Ballaban-Gil K, et al. A multicenter study of the efficacy of the ketogenic diet. Arch Neurol 1998; 55:1433.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f19_5_19540=[""].join("\n");
var outline_f19_5_19540=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           SEIZURES OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           WHEN TO TREAT SEIZURES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           GENERAL INFORMATION ABOUT MEDICATIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           OTHER TREATMENTS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H16\">",
"           CARE DURING SEIZURES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H19\">",
"           LIVING WITH SEIZURES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H22\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?41/42/42668\" title=\"table 1\">",
"           Anti seizure medications PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f19_5_19541="Mefenamic acid: Patient drug information";
var content_f19_5_19541=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Mefenamic acid: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/63/41976?source=see_link\">",
"     see \"Mefenamic acid: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F192138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ponstel&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F192139\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Mefenamic&reg;;",
"     </li>",
"     <li>",
"      Dom-Mefenamic Acid;",
"     </li>",
"     <li>",
"      Mefenamic-250;",
"     </li>",
"     <li>",
"      Nu-Mefenamic;",
"     </li>",
"     <li>",
"      PMS-Mefenamic Acid;",
"     </li>",
"     <li>",
"      Ponstan&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10029894\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700782",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of very bad and sometimes deadly heart and blood vessel side effects like heart attack and stroke. The risk may be greater if you have heart disease or risks for heart disease. The risk may be greater with long-term use. Do not use this drug right before or after bypass heart surgery.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700792",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of ulcers or bleeding from the stomach or bowel. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10029896\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain, swelling, and fever.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease painful period (menstrual) cycles.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10029895\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702455",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to mefenamic acid or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: GI (gastrointestinal) bleeding, kidney disease, or ulcer disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701061",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are more than 24 weeks pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029900\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696862",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take colestipol or cholestyramine within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029901\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697889",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain or heartburn.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10029903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699050",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling or pain of hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Black, tarry, or bloody stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698609",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blood in the urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10029898\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695904",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with food to stop an upset stomach.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10029899\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10029904\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029905\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10833 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-60.18.131.125-8B92F8E3C2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_5_19541=[""].join("\n");
var outline_f19_5_19541=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192138\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192139\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029894\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029896\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029895\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029900\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029901\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029903\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029898\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029899\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029904\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029905\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?40/63/41976?source=related_link\">",
"      Mefenamic acid: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_5_19542="Herniated disc PI";
var content_f19_5_19542=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F64922&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F64922&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 577px\">",
"   <div class=\"ttl\">",
"    Herniation and pain in disc injury",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 557px; height: 430px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Anatomical Chart Co. Copyright &copy; 2009.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_5_19542=[""].join("\n");
var outline_f19_5_19542=null;
var title_f19_5_19543="EP study tracings post RF ablation WPW";
var content_f19_5_19543=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F78363&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F78363&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 612px\">",
"   <div class=\"ttl\">",
"    Intracardiac and surface ECG recordings during electrophysiologic study post-radiofrequency ablation of accessory pathway in Wolff-Parkinson-White",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 592px; height: 422px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Shown are five surface leads (I, AVF, V1, V3, and V6) and intracardiac recording from the high right atrium (HRA), lateral mitral annulus (HBE1-2 and HBE3-4), coronary sinus proximal to distal (CS9-10, 7-8, 5-6, 3-4, 1-2), and right ventricular apex (RVA3-4). The tip of the mapping catheter is positioned at the site along the mitral annulus recording the earliest ventricular activity (HBE1-2), ie, the location of the accessory pathway. Within a few beats after the application of radiofrequency energy (RF on) the delta wave on the ECG disappeared (arrow) and the PR interval normalized. Prior to ablation, he recordings from the CS catheter show continuous atrial (A) and ventricular (V) electrograms; after ablation there is a normal interval between A and V.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_5_19543=[""].join("\n");
var outline_f19_5_19543=null;
var title_f19_5_19544="Treatment and prognosis of coma in children";
var content_f19_5_19544=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment and prognosis of coma in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/5/19544/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19544/contributors\">",
"     Linda Thompson, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19544/contributors\">",
"     Eric Williams, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/5/19544/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19544/contributors\">",
"     Marc C Patterson, MD, FRACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/5/19544/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19544/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/5/19544/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coma is an alteration of consciousness in which a person appears to be asleep, cannot be aroused, and shows no awareness of the environment [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/1\">",
"     1",
"    </a>",
"    ]. Coma is therefore the most profound degree to which the two components of consciousness, arousal and awareness, can be diminished. Less profound states of impaired consciousness (stupor, lethargy, obtundation) preserve one or more of these components to some degree.",
"   </p>",
"   <p>",
"    This topic will discuss issues related to the acute management of a child presenting with altered arousal. The differential diagnosis and evaluation of stupor and coma is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/30/28136?source=see_link\">",
"     \"Evaluation of stupor and coma in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early treatment of coma is generally supportive until a definitive diagnosis is made. An important goal of early treatment is to limit brain injury. Treatments for dangerous etiologies (eg, hypoglycemia, increased intracranial pressure, bacterial meningitis) are often initiated empirically, especially if there are suggestive clinical features.",
"   </p>",
"   <p>",
"    Although discussed separately, the assessment and management of children in coma are performed jointly in practice (",
"    <a class=\"graphic graphic_table graphicRef62416 \" href=\"UTD.htm?4/22/4461\">",
"     table 1",
"    </a>",
"    ). The primacy of ABC's (airway, breathing, circulation) applies to coma as to other medical emergencies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Airway",
"    </span>",
"    &nbsp;&mdash;&nbsp;Establishing a secure airway and providing adequate ventilation may be lifesaving and also may limit neurologic injury. Establishing a secure airway in a patient with coma may be attained by repositioning the child to open the airway, but often requires intubation to ensure adequate ventilation and to prevent aspiration of secretions or gastric contents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=see_link\">",
"     \"Emergent endotracheal intubation in children\"",
"    </a>",
"    .) Patients with GCS &lt;8 (",
"    <a class=\"graphic graphic_table graphicRef59662 \" href=\"UTD.htm?2/58/2989\">",
"     table 2",
"    </a>",
"    ) are usually unable to adequately protect their airway and should be intubated. If trauma is suspected, the cervical spine should be stabilized with a collar while securing the airway. Approaches to minimize the impact of intubation on potentially elevated intracranial pressure should be considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=see_link\">",
"     \"Elevated intracranial pressure in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oxygen saturation should be measured and supplemental oxygen provided. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/24/27014?source=see_link\">",
"     \"Continuous oxygen delivery systems for infants, children, and adults\"",
"    </a>",
"    .) Adequacy of ventilation should be assessed by examination and arterial blood gases. Moderate hyperventilation (target PaCO2 30 to 35 mm Hg) to produce arterial constriction and lower intracranial pressure (ICP) should only be initiated for patients with increased ICP. Extreme hyperventilation has been associated with brain ischemia; the risks of aggressive hyperventilation (PaCO2 &lt;30 mmHg) are only justified in patients with transtentorial herniation [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=see_link\">",
"     \"Elevated intracranial pressure in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Circulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depressed level of consciousness may be an early indicator of poor end-organ perfusion in a patient with shock. When cerebral blood flow (CBF) falls to below half normal, oxygen delivery is insufficient for normal oxidative metabolism, patients lose consciousness, and EEG activity is suppressed. Further falls in CBF cause irreversible neuronal injury unless prompt intervention restores circulation [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hypotension has been associated with poor neurologic outcome following traumatic brain injury (TBI) and meningitis in children [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. Effective circulation through intravenous fluid administration (normal saline or lactated Ringers) and inotropes, if necessary, is essential to deliver oxygen and metabolic substrates to the brain and remove toxic metabolites.",
"   </p>",
"   <p>",
"    For patients with hypertensive encephalopathy, the blood pressure should be lowered slowly to avoid superimposing an ischemic insult. Intravenous medications are preferred to oral agents for closer control of blood pressure. The goal of therapy is to lower the diastolic blood pressure to 100 to 110 mmHg (or by a maximum of 25 percent) within two to six hours [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41398?source=see_link\">",
"     \"Malignant hypertension and hypertensive encephalopathy in adults\"",
"    </a>",
"    .) Hypertensive encephalopathy has an excellent prognosis for recovery if ischemia can be avoided [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Glucose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fingerstick blood sugar and a serum glucose should be checked immediately in the evaluation of a comatose child. Glucose (2.5",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    of 10 percent dextrose solution) should be administered even before test results are known. If hypoglycemia is revealed, then ongoing monitoring and treatment will be needed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/0/8201?source=see_link\">",
"     \"Approach to hypoglycemia in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Intracranial pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;When increased intracranial pressure (ICP) is suspected based on CT findings, papilledema, split sutures, or a herniation syndrome, emergent treatment is recommended. Increased ICP is assumed when there is coma after head injury.",
"   </p>",
"   <p>",
"    Early interventions to reduce intracranial pressure include treating fever, elevating the head of the bed to 30 degrees above horizontal, moderate hyperventilation (target PaCO2 30 to 35 mmHg) and administering",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/60/43975?source=see_link\">",
"     mannitol",
"    </a>",
"    (0.25 to 1",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    IV). Neurosurgery should be consulted. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=see_link&amp;anchor=H20#H20\">",
"     \"Elevated intracranial pressure in children\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Seizures",
"    </span>",
"    &nbsp;&mdash;&nbsp;If seizures have occurred,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/19/33082?source=see_link\">",
"     phenytoin",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/45/23258?source=see_link\">",
"     fosphenytoin",
"    </a>",
"    (15 to 20",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    phenytoin equivalent IV) should be administered. Recurrent seizures or status epilepticus may increase ICP and may be associated with secondary brain injury and worse neurologic outcome. Prolonged seizures have been associated with adverse outcomes in meningitis, encephalitis, and other CNS infections [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/10-14\">",
"     10-14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nonconvulsive status epilepticus should be considered as a diagnosis even when there are no obvious seizure movements. Nonconvulsive seizures can cause coma and also complicate other etiologies of coma, including infection and metabolic disease. If nonconvulsive seizures are suspected and an electroencephalogram (EEG) is not available, a therapeutic trial of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/19/33082?source=see_link\">",
"     phenytoin",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/22/25959?source=see_link\">",
"     lorazepam",
"    </a>",
"    (1 to 2 mg IV) is reasonable. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/50/30505?source=see_link\">",
"     \"Management of status epilepticus in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Empiric antibiotic and antiviral therapy are recommended if bacterial meningitis (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    100",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in one or two divided doses, maximum dose 4 g per day, plus",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    60",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in four divided doses) or viral encephalitis (",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/38/34400?source=see_link\">",
"     acyclovir",
"    </a>",
"    30 to 60",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day, in three divided doses) are among the suspected entities [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. Blood cultures should be obtained prior to starting antibiotics but initiation of therapy should NOT await lumbar puncture. Therapy should be continued until these conditions have been excluded (",
"    <a class=\"graphic graphic_algorithm graphicRef74865 \" href=\"UTD.htm?34/44/35521\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link&amp;anchor=H13#H13\">",
"     \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Empiric therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35640?source=see_link&amp;anchor=H8#H8\">",
"     \"Viral meningitis: Management, prognosis, and prevention in children\", section on 'Empiric therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/21/10586?source=see_link&amp;anchor=H3#H3\">",
"     \"Viral meningitis: Clinical features and diagnosis in children\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Temperature control",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperthermia (&gt;38.5 degrees C) can contribute to brain damage in cases of ischemia. Fever also increases cerebral metabolism and blood flow, thereby contributing to elevated ICP [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/17\">",
"     17",
"    </a>",
"    ]. Fever should be lowered with antipyretics",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cooling blankets immediately. Shivering, which can contribute to elevated ICP, should be avoided.",
"   </p>",
"   <p>",
"    While hypothermia to 32 to 36 degrees has been suggested as a second-tier therapy for refractory increased ICP in children with traumatic brain injury [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/18,19\">",
"     18,19",
"    </a>",
"    ], it is currently not recommended for the treatment of severe traumatic brain injury in children outside of clinical trials. A prospective, randomized multicenter trial of 225 children with severe brain injury caused by blunt trauma found no benefit and possibly worse outcomes in children who were externally cooled to 32 to 33&ordm;C (89.6 to 91.4&deg;F) for 24 hours within 8 hours of injury [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=see_link&amp;anchor=H30#H30\">",
"     \"Elevated intracranial pressure in children\", section on 'Hypothermia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In some adults with cardiac arrest, hypothermia of 32 to 34 degrees C is currently recommended to improve neurologic outcomes. In children, evidence is limited [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/21\">",
"     21",
"    </a>",
"    ]. The use of therapeutic hypothermia (brain temperature 32 to 34&deg;C) may be appropriate for children with out-of-hospital arrest and persistent coma or those with ventricular fibrillation or pulseless ventricular tachycardia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/16/20746?source=see_link&amp;anchor=H35#H35\">",
"     \"Guidelines for pediatric advanced life support\", section on 'Early postresuscitation management'",
"    </a>",
"    .) Multicenter trials are underway to confirm the benefit of hypothermia in this clinical setting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Acid-base and electrolyte imbalance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrolyte imbalance may cause or be a complication of coma, and may increase the risk of neurologic injury. Iatrogenic causes of electrolyte derangement may result from resuscitation of patients with hypotonic or large volumes of hypertonic solutions. Resuscitation of patients with cardiovascular compromise should use isotonic solutions only (normal saline or lactated Ringers). Any electrolyte abnormalities should be corrected and monitored. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22506?source=see_link&amp;anchor=H18#H18\">",
"     \"Acute toxic-metabolic encephalopathy in children\", section on 'Fluid and electrolyte disturbances'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Antidotes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antidote use is recommended only in the setting of known or strongly suspected drug overdose [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/22\">",
"     22",
"    </a>",
"    ].",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"     Naloxone",
"    </a>",
"    (0.1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV in patients up to 20 kg or &le;5 years; maximum 2 mg) is a relatively safe and effective treatment and should be considered when the history suggests possible opiate ingestion.",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/58/38821?source=see_link\">",
"     Flumazenil",
"    </a>",
"    is an antidote for benzodiazepine overdose, but will render benzodiazepines ineffective in the event of a seizure, so it should also be used with caution.",
"   </p>",
"   <p>",
"    The management of toxic ingestions is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22474?source=see_link\">",
"     \"Approach to the child with occult toxic exposure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37913?source=see_link\">",
"     \"Decontamination of poisoned children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22874?source=see_link\">",
"     \"Opioid intoxication in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Agitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Agitation may increase ICP, interfere with respiratory support, and increase the risk of injury. Significant sedation, however, may obscure the neurologic exam, may contribute to hypotension and hypoventilation, and should be administered only when the benefits of relieving agitation outweigh the need for close neurologic monitoring by exam.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coma is a transient state, usually lasting no more than two to four weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/23\">",
"     23",
"    </a>",
"    ]. Children recover, die, or evolve into a persistent vegetative or minimally conscious state. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/30/28136?source=see_link&amp;anchor=H4#H4\">",
"     \"Evaluation of stupor and coma in children\", section on 'Coma sequelae'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A vegetative state is considered permanent, with little chance of improvement, if it lasts longer than 12 months after traumatic injury or longer than three months after nontraumatic injury. There are fewer studies regarding minimally conscious patients, but the prognosis is probably less dire. Accurate differentiation of minimally conscious patients from vegetative patients requires repeated assessments by an experienced multidisciplinary team [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/23\">",
"     23",
"    </a>",
"    ]. Functional MRI and PET studies hold promise for better classification of these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prognosis in coma is largely specific to the etiology. In a study of 278 previously healthy children in England, mortality ranged from 84 percent in victims of drowning to 3.4 percent in victims of intoxication (accidental and intentional). Infection (predominantly Neisseria meningitis) had a mortality of 60 percent, while metabolic causes showed a 27 percent mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prognosis for coma recovery in children has been most studied for hypoxic-ischemic encephalopathy (HIE) and traumatic brain injury (TBI). Studies of outcome in these conditions are not clearly applicable to other etiologies. Similarly, studies in adults are not necessarily generalizable to children. While several factors have been shown to be associated with prognosis, none have sufficient predictive power for clinical decision making.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Examination findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Glasgow Coma Scale (GCS) and its modification for young children, the Pediatric Coma Scale (PCS) (",
"    <a class=\"graphic graphic_table graphicRef59662 \" href=\"UTD.htm?2/58/2989\">",
"     table 2",
"    </a>",
"    ), grade coma severity according to three categories of responsiveness: eye opening, motor, and verbal responses [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/26-29\">",
"     26-29",
"    </a>",
"    ]. GCS has been associated with prognosis in a number of conditions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 57 children with HIE, a GCS &lt;5 and absent spontaneous breathing at 24 hours, each had a positive predictive value of 100 percent for severe disability or death [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/30\">",
"       30",
"      </a>",
"      ]. However, these exam findings did not capture all children who later progressed to severe disability or death, with a sensitivity of about 50 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In patients with HIE after near drowning, a low admission GCS may be less predictive of poor outcome [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/31\">",
"       31",
"      </a>",
"      ]. This may be due to a neuroprotective affect of cold-water immersion. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/11/26809?source=see_link\">",
"       \"Drowning (submersion injuries)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lower GCS has also been correlated to increased mortality and worse functional outcome in children after TBI [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/32-38\">",
"       32-38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      At least one study has linked low GCS to death and disability in childhood viral encephalitis [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Other clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence and severity of certain early complications has been linked to worse outcome (mortality, poorer functional recovery), especially hypotension in TBI patients and prolonged seizures in children with CNS infections [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/5-7,10-14,39,40\">",
"     5-7,10-14,39,40",
"    </a>",
"    ]. In HIE, a longer duration of hypotension",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    anoxia is associated with poorer outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In some, but not all studies, young age, less than two years, has been associated with worse prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/37,41-43\">",
"     37,41-43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Electroencephalogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;EEG has been studied as a predictor of outcome in coma of certain etiologies. Limiting factors include its sensitivity to electrical noise, common in an emergency room or intensive care unit. Sedative drugs cause EEG abnormalities and make interpretation difficult, particularly for prognosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/13/27863?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical neurophysiology\", section on 'Electroencephalogram'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Studies using EEG for prognosis in comatose children are limited. Serial EEGs appear to be more useful than a single study [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/31,44\">",
"     31,44",
"    </a>",
"    ]. In a meta-analysis including patients older than 10 years of age with HIE, EEG findings of an isoelectric baseline or a burst suppression pattern during the first week after coma were 100 percent specific for poor outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/45\">",
"     45",
"    </a>",
"    ]. This finding, however, is not predictive of a poor outcome in other toxic metabolic encephalopathies. Other EEG patterns, (eg, periodic epileptiform discharges, nonreactive rhythms) have been associated with poor outcome, but have poor sensitivity and specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/31,46\">",
"     31,46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Evoked potentials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evoked potentials (EPs) are measured responses in electrical signals of the brain after a sensory stimulus. Compared with EEG, EPs are less affected by sedative medication and are insensitive to electrical noise. The test is technically more demanding to perform, however [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/47\">",
"     47",
"    </a>",
"    ]. Also, patients with focal brain lesions, subdural hemorrhage, or craniotomy may have an absent (false positive) EP response; data should be interpreted with caution in these patients. EP should be performed more than 24 hours after the onset of coma and reconfirmed 24 hours after the initial examination in order to maximize specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Somatosensory-evoked potentials (SEP) have high specificity and are more useful than EEG in predicting poor outcome in both children and adults in coma, especially due to HIE [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/31,39,45,49\">",
"     31,39,45,49",
"    </a>",
"    ]. As an example, in one study of 57 children with HIE, SEPs, when bilaterally absent at 24 hours, had a positive predictive value for poor outcome of 100 percent and a sensitivity of 63 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    False positive SEP results may be more problematic in other conditions. In one series of 53 children with coma from a variety of etiologies and bilaterally absent SEPs, the overall prognosis was very poor; 38 died and 11 survived with persistent vegetative state or severe neurologic deficits [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/40\">",
"     40",
"    </a>",
"    ]. However four, all with TBI, did survive with mild to moderate neurologic deficits. A systematic review of SEPs for prognosis in coma in patients of all ages, published before this report, found an overall false positive rate of &lt;0.5 percent; however, they noted that most of the false positives were children and cases of TBI [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/48\">",
"     48",
"    </a>",
"    ]. Another systematic review included an independent analysis of 10 studies done in children in coma. They found an overall false positive rate of seven percent for absent SEPs in children who awakened from coma [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While associated with poor outcome, absent visual EP and brainstem auditory-evoked potentials do not have adequate predictive ability for outcome in childhood coma [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/49,51,52\">",
"     49,51,52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;MRI can be helpful in the diagnosis of coma etiology. In some coma etiologies (eg, HIE, TBI) MRI often shows a greater extent of injury than can be appreciated on CT; this can be helpful in making qualitative assessments regarding prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/34,53\">",
"     34,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one study of 40 children with HIE, MRIs were scored based on findings of brain edema, herniation, or structural changes in \"watershed areas\" or basal ganglia [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/54\">",
"     54",
"    </a>",
"    ]. A high score had a sensitivity of 96 percent and specificity of 50 percent for moderate to severe disability. The presence and extent of brain edema, brainstem injury, and diffuse axonal injury on MRI has also been associated with poorer prognosis in patients with TBI [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/33,37,55-57\">",
"     33,37,55-57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other neuroimaging modalities, MR spectroscopy, functional MRI, positron emission tomography are not useful in the evaluation of coma prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/58\">",
"     58",
"    </a>",
"    ]. Studies, awaiting validation, suggest that these tools may help discriminate between persistent vegetative state, minimally conscious state and other states of impaired consciousness [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Serum biomarkers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevated neuron specific enolase (NSE) levels have been associated with poor outcome in adults after HIE. Elevated levels have also been associated with severity of brain injury in children with TBI and other conditions (eg, encephalitis, Reye's syndrome) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/60\">",
"     60",
"    </a>",
"    ]. One study in 86 children with traumatic brain injury found that NSE &gt;21.2",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    obtained within 24 hours of injury was 86 percent sensitive and 74 percent specific for poor neurologic outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19544/abstract/61\">",
"     61",
"    </a>",
"    ]. Further studies are needed to validate these findings and extend them to prognosis in other causes of pediatric coma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/1/37905?source=see_link\">",
"       \"Patient information: Coma (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stupor and coma are alterations in arousal; these are neurologic emergencies.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evaluation and early therapeutic interventions should proceed promptly, even simultaneously. A protocol for urgent evaluation and management is recommended (",
"      <a class=\"graphic graphic_table graphicRef62416 \" href=\"UTD.htm?4/22/4461\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The prognosis for neurologic recovery depends in large part on etiology with good prognosis for uncomplicated drug intoxications, to a poor prognosis for hypoxic ischemic encephalopathy. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Examination findings, clinical course, electrophysiologic tests, and MRI all provide information that is helpful in gauging neurologic prognosis. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      However, uniformly reliable tools that accurately predict outcome in most clinical situations are lacking. In cases of hypoxic ischemic encephalopathy, which is not associated with cold water drowning, a Glasgow Coma Score &lt;5 and bilaterally absent somatosensory evoked potentials appear to have the best established predictive ability for poor neurologic outcome. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Examination findings'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'Evoked potentials'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/1\">",
"      Kennealy JA, McLennan JE, Loudon RG, McLaurin RL. Hyperventilation-induced cerebral hypoxia. Am Rev Respir Dis 1980; 122:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/2\">",
"      Skippen P, Seear M, Poskitt K, et al. Effect of hyperventilation on regional cerebral blood flow in head-injured children. Crit Care Med 1997; 25:1402.",
"     </a>",
"    </li>",
"    <li>",
"     Stubgen JP, Plum F. Coma. In: Textbook of Critical Care Medicine, 5th, Fink MP, Abraham E, Vincent JL, Kochanek PM.  (Eds), Elsevier Saunders, Philadelphia 2005. p.295.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/4\">",
"      Markus HS. Cerebral perfusion and stroke. J Neurol Neurosurg Psychiatry 2004; 75:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/5\">",
"      Coates BM, Vavilala MS, Mack CD, et al. Influence of definition and location of hypotension on outcome following severe pediatric traumatic brain injury. Crit Care Med 2005; 33:2645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/6\">",
"      Odetola FO, Bratton SL. Characteristics and immediate outcome of childhood meningitis treated in the pediatric intensive care unit. Intensive Care Med 2005; 31:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/7\">",
"      Chambers IR, Kirkham FJ. What is the optimal cerebral perfusion pressure in children suffering from traumatic coma? Neurosurg Focus 2003; 15:E3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/8\">",
"      Williams O, Brust JC. Hypertensive Encephalopathy. Curr Treat Options Cardiovasc Med 2004; 6:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/9\">",
"      Wright RR, Mathews KD. Hypertensive encephalopathy in childhood. J Child Neurol 1996; 11:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/10\">",
"      Grimwood K, Nolan TM, Bond L, et al. Risk factors for adverse outcomes of bacterial meningitis. J Paediatr Child Health 1996; 32:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/11\">",
"      Bhutto E, Naim M, Ehtesham M, et al. Prognostic indicators of childhood acute viral encephalitis. J Pak Med Assoc 1999; 49:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/12\">",
"      Kirkham, FJ, Wairui, C, Newton, CR. Clinical and electroencephalographic seizures in coma: relationship to outcome. Arch Dis Child 2000; 82 (suppl 1):A59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/13\">",
"      Idro R, Carter JA, Fegan G, et al. Risk factors for persisting neurological and cognitive impairments following cerebral malaria. Arch Dis Child 2006; 91:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/14\">",
"      Kramer U, Shorer Z, Ben-Zeev B, et al. Severe refractory status epilepticus owing to presumed encephalitis. J Child Neurol 2005; 20:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/15\">",
"      Whitley RJ, Kimberlin DW, Roizman B. Herpes simplex viruses. Clin Infect Dis 1998; 26:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/16\">",
"      Arditi M, Mason EO Jr, Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998; 102:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/17\">",
"      Chesnut RM. Medical management of severe head injury: present and future. New Horiz 1995; 3:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/18\">",
"      Adelson PD, Bratton SL, Carney NA, et al. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents. Chapter 17. Critical pathway for the treatment of established intracranial hypertension in pediatric traumatic brain injury. Pediatr Crit Care Med 2003; 4:S65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/19\">",
"      Yamamoto T, Mori K, Maeda M. Assessment of prognostic factors in severe traumatic brain injury patients treated by mild therapeutic cerebral hypothermia therapy. Neurol Res 2002; 24:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/20\">",
"      Hutchison JS, Ward RE, Lacroix J, et al. Hypothermia therapy after traumatic brain injury in children. N Engl J Med 2008; 358:2447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/21\">",
"      Kleinman ME, Chameides L, Schexnayder SM, et al. Part 14: pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/22\">",
"      Hoffman RS, Goldfrank LR. The poisoned patient with altered consciousness. Controversies in the use of a 'coma cocktail'. JAMA 1995; 274:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/23\">",
"      Ashwal S. Medical aspects of the minimally conscious state in children. Brain Dev 2003; 25:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/24\">",
"      Laureys S. Functional neuroimaging in the vegetative state. NeuroRehabilitation 2004; 19:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/25\">",
"      Wong CP, Forsyth RJ, Kelly TP, Eyre JA. Incidence, aetiology, and outcome of non-traumatic coma: a population based study. Arch Dis Child 2001; 84:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/26\">",
"      Zeman A. Consciousness. Brain 2001; 124:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/27\">",
"      Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974; 2:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/28\">",
"      Simpson D, Reilly P. Pediatric coma scale. Lancet 1982; 2:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/29\">",
"      Hahn YS, Chyung C, Barthel MJ, et al. Head injuries in children under 36 months of age. Demography and outcome. Childs Nerv Syst 1988; 4:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/30\">",
"      Mandel R, Martinot A, Delepoulle F, et al. Prediction of outcome after hypoxic-ischemic encephalopathy: a prospective clinical and electrophysiologic study. J Pediatr 2002; 141:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/31\">",
"      Jacinto SJ, Gieron-Korthals M, Ferreira JA. Predicting outcome in hypoxic-ischemic brain injury. Pediatr Clin North Am 2001; 48:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/32\">",
"      Avesani R, Salvi L, Rigoli G, Gambini MG. Reintegration after severe brain injury: a retrospective study. Brain Inj 2005; 19:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/33\">",
"      Ciurea AV, Coman T, Ro��u L, et al. Severe brain injuries in children. Acta Neurochir Suppl 2005; 93:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/34\">",
"      Bonnier C, Nassogne MC, Saint-Martin C, et al. Neuroimaging of intraparenchymal lesions predicts outcome in shaken baby syndrome. Pediatrics 2003; 112:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/35\">",
"      Chiaretti A, Piastra M, Pulitan&ograve; S, et al. Prognostic factors and outcome of children with severe head injury: an 8-year experience. Childs Nerv Syst 2002; 18:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/36\">",
"      Chiaretti A, De Benedictis R, Della Corte F, et al. The impact of initial management on the outcome of children with severe head injury. Childs Nerv Syst 2002; 18:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/37\">",
"      Prasad MR, Ewing-Cobbs L, Swank PR, Kramer L. Predictors of outcome following traumatic brain injury in young children. Pediatr Neurosurg 2002; 36:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/38\">",
"      White JR, Farukhi Z, Bull C, et al. Predictors of outcome in severely head-injured children. Crit Care Med 2001; 29:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/39\">",
"      Chen R, Bolton CF, Young B. Prediction of outcome in patients with anoxic coma: a clinical and electrophysiologic study. Crit Care Med 1996; 24:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/40\">",
"      Wohlrab G, Boltshauser E, Schmitt B. Neurological outcome in comatose children with bilateral loss of cortical somatosensory evoked potentials. Neuropediatrics 2001; 32:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/41\">",
"      Bansal A, Singhi SC, Singhi PD, et al. Non traumatic coma. Indian J Pediatr 2005; 72:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/42\">",
"      Suresh HS, Praharaj SS, Indira Devi B, et al. Prognosis in children with head injury: an analysis of 340 patients. Neurol India 2003; 51:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/43\">",
"      Pfenninger J, Bachmann D, Wagner BP. Survivors with bad outcome after hypoxic-ischaemic encephalopathy: full-term neonates compare unfavourably with children. Swiss Med Wkly 2001; 131:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/44\">",
"      Pressler RM, Boylan GB, Morton M, et al. Early serial EEG in hypoxic ischaemic encephalopathy. Clin Neurophysiol 2001; 112:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/45\">",
"      Zandbergen EG, de Haan RJ, Stoutenbeek CP, et al. Systematic review of early prediction of poor outcome in anoxic-ischaemic coma. Lancet 1998; 352:1808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/46\">",
"      RamachandranNair R, Sharma R, Weiss SK, et al. A reappraisal of rhythmic coma patterns in children. Can J Neurol Sci 2005; 32:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/47\">",
"      Tr&uuml;bel HK, Novotny E, Lister G. Outcome of coma in children. Curr Opin Pediatr 2003; 15:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/48\">",
"      Carter BG, Butt W. Review of the use of somatosensory evoked potentials in the prediction of outcome after severe brain injury. Crit Care Med 2001; 29:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/49\">",
"      Frank LM, Furgiuele TL, Etheridge JE Jr. Prediction of chronic vegetative state in children using evoked potentials. Neurology 1985; 35:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/50\">",
"      Robinson LR, Micklesen PJ, Tirschwell DL, Lew HL. Predictive value of somatosensory evoked potentials for awakening from coma. Crit Care Med 2003; 31:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/51\">",
"      Shewmon DA. Coma prognosis in children. Part I: definitional and methodological challenges. J Clin Neurophysiol 2000; 17:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/52\">",
"      Mewasingh LD, Christophe C, Fonteyne C, et al. Predictive value of electrophysiology in children with hypoxic coma. Pediatr Neurol 2003; 28:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/53\">",
"      Ghahreman A, Bhasin V, Chaseling R, et al. Nonaccidental head injuries in children: a Sydney experience. J Neurosurg 2005; 103:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/54\">",
"      Christophe C, Fonteyne C, Ziereisen F, et al. Value of MR imaging of the brain in children with hypoxic coma. AJNR Am J Neuroradiol 2002; 23:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/55\">",
"      Tong KA, Ashwal S, Holshouser BA, et al. Diffuse axonal injury in children: clinical correlation with hemorrhagic lesions. Ann Neurol 2004; 56:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/56\">",
"      Kemp AM, Stoodley N, Cobley C, et al. Apnoea and brain swelling in non-accidental head injury. Arch Dis Child 2003; 88:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/57\">",
"      Woischneck D, Klein S, Reissberg S, et al. Prognosis of brain stem lesion in children with head injury. Childs Nerv Syst 2003; 19:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/58\">",
"      Bernat JL. Chronic disorders of consciousness. Lancet 2006; 367:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/59\">",
"      Laureys S, Owen AM, Schiff ND. Brain function in coma, vegetative state, and related disorders. Lancet Neurol 2004; 3:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/60\">",
"      Nara T, Nozaki H, Nakae Y, et al. Neuron-specific enolase in comatose children. Am J Dis Child 1988; 142:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19544/abstract/61\">",
"      Bandyopadhyay S, Hennes H, Gorelick MH, et al. Serum neuron-specific enolase as a predictor of short-term outcome in children with closed traumatic brain injury. Acad Emerg Med 2005; 12:732.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6164 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-519069B3B6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_5_19544=[""].join("\n");
var outline_f19_5_19544=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Airway",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Breathing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Circulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Glucose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Intracranial pressure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Seizures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Temperature control",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Acid-base and electrolyte imbalance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Antidotes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Agitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Examination findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Other clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Electroencephalogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Evoked potentials",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Serum biomarkers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6164\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6164|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?34/44/35521\" title=\"algorithm 1\">",
"      Management of suspected meningitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6164|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/22/4461\" title=\"table 1\">",
"      Initial coma eval and Rx childr",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/58/2989\" title=\"table 2\">",
"      Glasgow and pediatric coma scales",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22506?source=related_link\">",
"      Acute toxic-metabolic encephalopathy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/0/8201?source=related_link\">",
"      Approach to hypoglycemia in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22474?source=related_link\">",
"      Approach to the child with occult toxic exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/13/27863?source=related_link\">",
"      Clinical neurophysiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/24/27014?source=related_link\">",
"      Continuous oxygen delivery systems for infants, children, and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37913?source=related_link\">",
"      Decontamination of poisoned children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/11/26809?source=related_link\">",
"      Drowning (submersion injuries)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=related_link\">",
"      Elevated intracranial pressure in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=related_link\">",
"      Emergent endotracheal intubation in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/30/28136?source=related_link\">",
"      Evaluation of stupor and coma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/16/20746?source=related_link\">",
"      Guidelines for pediatric advanced life support",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41398?source=related_link\">",
"      Malignant hypertension and hypertensive encephalopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/50/30505?source=related_link\">",
"      Management of status epilepticus in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22874?source=related_link\">",
"      Opioid intoxication in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/1/37905?source=related_link\">",
"      Patient information: Coma (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=related_link\">",
"      Treatment and prognosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/21/10586?source=related_link\">",
"      Viral meningitis: Clinical features and diagnosis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35640?source=related_link\">",
"      Viral meningitis: Management, prognosis, and prevention in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_5_19545="Initial evaluation and management of blunt abdominal trauma in adults";
var content_f19_5_19545=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Initial evaluation and management of blunt abdominal trauma in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/5/19545/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19545/contributors\">",
"     Michael A Puskarich, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/5/19545/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19545/contributors\">",
"     Robert S Hockberger, MD, FACEP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19545/contributors\">",
"     Maria E Moreira, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/5/19545/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19545/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/5/19545/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blunt abdominal trauma is regularly encountered in the emergency department. The lack of historical data and the presence of distracting injuries or altered mental status, from head injury or intoxication, can make these injuries difficult to diagnose and manage. Victims of blunt trauma often have both abdominal and extraabdominal injuries, further complicating care.",
"   </p>",
"   <p>",
"    The initial evaluation and management of patients with blunt abdominal trauma are reviewed here. Discussions of penetrating abdominal trauma, the general management of the acutely injured adult, and ultrasound evaluation in patients with abdominal or thoracic trauma are found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12776?source=see_link\">",
"     \"Initial evaluation and management of abdominal stab wounds in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/54/3943?source=see_link\">",
"     \"Initial evaluation and management of abdominal gunshot wounds in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/11/35002?source=see_link\">",
"     \"Initial management of trauma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/30/7658?source=see_link\">",
"     \"Emergency ultrasound in adults with abdominal and thoracic trauma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blunt abdominal trauma (BAT) most often results from a motor vehicle collision (MVC), and such incidents, combined with pedestrian versus automobile collisions, account for over 75 percent of cases. Blows to the abdomen and falls are responsible for 15 and 6 to 9 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/1\">",
"     1",
"    </a>",
"    ]. Occult BAT may occur with child abuse and domestic violence. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=see_link\">",
"     \"Physical abuse in children: Diagnostic evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prevalence of intraabdominal injury among patients presenting to the emergency department with BAT is approximately 13 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/2\">",
"     2",
"    </a>",
"    ]. When injury does occur from BAT, the spleen is the most commonly injured organ. In over 60 percent of cases, the spleen is the only damaged intraperitoneal structure [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/1\">",
"     1",
"    </a>",
"    ]. The liver and kidney can also be injured [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. Less commonly, hollow viscus injury may occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MECHANISM OF INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several pathophysiologic mechanisms can occur in patients with blunt abdominal trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. A sudden and pronounced rise in intraabdominal pressure created by outward forces can rupture a hollow viscus. Passengers wearing a lap-belt without a shoulder attachment can sustain injury from such a mechanism when the belt forcefully compresses the abdomen.",
"   </p>",
"   <p>",
"    Blunt forces exerted against the anterior abdominal wall can compress abdominal viscera against the posterior thoracic cage or vertebral column, crushing tissue. Solid organs (eg, spleen and liver) are particularly susceptible to laceration or fracture by this mechanism. Elderly and alcoholic patients generally have lax abdominal walls and are more likely to sustain such injuries. Delayed splenic rupture can occur. Retroperitoneal structures, such as the duodenum or pancreas, may be injured.",
"   </p>",
"   <p>",
"    Shearing forces created by sudden deceleration can cause lacerations of both solid and hollow organs at their points of attachment to the peritoneum. They may also create tears at vascular pedicles or cause stretch injuries to the intima and media of arteries, resulting in infarction of the susceptible organ. The kidney is most susceptible to such stretch injury.",
"   </p>",
"   <p>",
"    Fractured ribs or pelvic bones can lacerate intraabdominal tissue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;With blunt trauma, specifically those resulting from a vehicular crash, clinicians should ask about the following historical features:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fatality at the scene",
"     </li>",
"     <li>",
"      Vehicle type and velocity",
"     </li>",
"     <li>",
"      Whether the vehicle rolled over",
"     </li>",
"     <li>",
"      Patient's location within the vehicle",
"     </li>",
"     <li>",
"      Extent of intrusion into the passenger compartment",
"     </li>",
"     <li>",
"      Extent of damage to the vehicle",
"     </li>",
"     <li>",
"      Steering wheel deformity",
"     </li>",
"     <li>",
"      Whether seat belts were used and, if so, what type",
"     </li>",
"     <li>",
"      Whether front or side air bags were deployed",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Unrestrained victims are at higher risk of injury than those who are restrained [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/4\">",
"     4",
"    </a>",
"    ]. Paradoxically, steering wheel deformity may be an independent predictor of abdominal injury in front seat passengers, but not drivers [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The magnitude of injury to pedestrians varies with the speed and size of the striking vehicle. Pedestrians often sustain a triad of injuries to the leg, torso, and cranium; injury to any of these sites should prompt careful evaluation of the others [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Historical data are important, but mechanism alone cannot reliably predict the need for emergent laparotomy and must be coupled with other information such as prehospital vital signs, physical exam findings, diagnostic tests, and underlying medical conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PRIMARY EVALUATION AND MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial resuscitation and management of the trauma patient is based upon protocols from Advanced Trauma Life Support (ATLS&reg;). Primary assessment (ie, the primary survey) follows the ABCDE pattern: Airway, Breathing, Circulation, Disability (Neurologic status), Exposure. Details related to initial management of blunt abdominal trauma (BAT) are discussed below. A basic algorithm for management of BAT is provided (",
"    <a class=\"graphic graphic_algorithm graphicRef82663 \" href=\"UTD.htm?20/63/21503\">",
"     algorithm 1",
"    </a>",
"    ); initial evaluation of the trauma patient is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/11/35002?source=see_link\">",
"     \"Initial management of trauma in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Initial assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blunt abdominal trauma (BAT) can manifest a wide range of presentations, from a patient with normal vital signs and minor complaints to an obtunded patient in severe shock. The initial presentation may be benign despite the presence of significant intraabdominal injury. If evidence of",
"    <strong>",
"     extra",
"    </strong>",
"    abdominal injury exists, the emergency clinician must assess for",
"    <strong>",
"     intra",
"    </strong>",
"    abdominal injury, even in hemodynamically stable patients without abdominal complaints. In the hemodynamically unstable patient, concurrent resuscitation and assessment are paramount.",
"   </p>",
"   <p>",
"    Although the presence of physical findings makes intraperitoneal injury more likely, the accuracy of the physical examination in BAT is only 55 to 65 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/9\">",
"     9",
"    </a>",
"    ]. The absence of physical findings does",
"    <strong>",
"     NOT",
"    </strong>",
"    preclude serious pathology, and no sign is exclusively diagnostic of a specific injury [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/2,10,11\">",
"     2,10,11",
"    </a>",
"    ]. Extensive observation and the focused use of specific diagnostic imaging tests help prevent missed injuries.",
"   </p>",
"   <p>",
"    The presence of an altered sensorium or painful extraabdominal injuries in victims of blunt trauma should raise the specter of abdominal injury, even in the absence of suggestive symptoms or signs [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/2\">",
"     2",
"    </a>",
"    ]. Up to 10 percent of patients with apparently isolated head injury may have concomitant intraabdominal injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/12\">",
"     12",
"    </a>",
"    ], and, according to one prospective observational study, 7 percent of blunt trauma patients with distracting extraabdominal injuries have an abdominal injury despite the absence of abdominal pain or tenderness [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In alert patients free of distracting injuries, the most reliable symptoms and signs of BAT are pain, tenderness, and peritoneal findings, particularly when risk factors for abdominal injury are present. Patients with visceral injury present with local or general abdominal tenderness in up to 90 percent of cases. These signs are not specific, however, and may also be found with isolated thoracoabdominal wall contusions or lower rib fractures. More importantly, the absence of tenderness in an awake, stable patient indicates injury is highly unlikely. Nevertheless, intraabdominal injury can occur in conscious patients without tenderness [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/2,10,14-16\">",
"     2,10,14-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hypotension following BAT most often results from hemorrhage from a solid abdominal organ or intraabdominal vascular injury. Although clinicians must look for extraabdominal sources of bleeding (eg, scalp laceration, thoracic injury, or long bone fracture), an extraabdominal source of hemorrhage never obviates the need to evaluate the peritoneal cavity. Head injury alone cannot explain shock except in rare cases of profound intracranial trauma or in infants who may have significant intracranial bleeding or cephalohematoma [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Abdominal wall ecchymosis, abdominal distention, and decreased bowel sounds may herald intraabdominal injury. The proverbial \"seat belt sign\" (ecchymosis over the abdominal wall in the distribution of the seat belt) indicates intraabdominal injury in up to one-third of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/2,18\">",
"     2,18",
"    </a>",
"    ]. Abdominal distention, resulting from peritoneal irritation producing an ileus, pneumoperitoneum, or gastric dilation, can indicate significant injury. Clinicians should never wait for such signs of hemoperitoneum, as the blood volume required to create distention exceeds that of the entire vasculature. Decreased bowel sounds can result from chemical peritonitis caused by hemorrhage or from a ruptured hollow viscus. Bowel sounds heard in the chest suggest the presence of diaphragmatic rupture.",
"   </p>",
"   <p>",
"    A rectal examination rarely reveals blood or subcutaneous emphysema, but the presence of either correlates with abdominal injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/19\">",
"     19",
"    </a>",
"    ]. The evaluation of rectal tone is an important part of determining the patient's spinal cord integrity, particularly if the patient is to be paralyzed as part of a rapid sequence intubation. Palpation of a high-riding prostate suggests urethral injury.",
"   </p>",
"   <p>",
"    According to a systematic review of 12 studies involving 10,757 patients, the physical examination findings associated most closely with a clinically significant intraabdominal injury following BAT include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Seat belt sign (likelihood ratio (LR) range 5.6 to 9.9)",
"     </li>",
"     <li>",
"      Rebound tenderness (uncommon but substantially increases risk when present; LR 6.5, 95% CI 1.8-24)",
"     </li>",
"     <li>",
"      Hypotension (defined as SBP &lt;90 mmHg; LR 5.2, 95% CI 3.5-7.5)",
"     </li>",
"     <li>",
"      Abdominal distension (LR 3.8, 95% CI 1.9-7.6)",
"     </li>",
"     <li>",
"      Abdominal guarding (LR 3.7, 95% CI 2.3-5.9)",
"     </li>",
"     <li>",
"      Concomitant femur fracture (LR 2.9, 95% CI 2.1-4.1)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Of note, although abdominal pain and abdominal tenderness did increase the likelihood of intraabdominal injury among patients with BAT, both were less predictive than the signs described above. While the absence of the aforementioned signs and symptoms statistically decrease the risk of intraabdominal injury (LR 0.52-0.96), their absence, alone or in combination, is insufficient to rule-out intra-abdominal injury. This systematic review included only studies with a clear reference standard (eg, CT, DPL, laparotomy) and all were performed at major academic trauma centers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Diagnostic tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hematology and chemistry laboratory tests are of limited use in the management of the acutely traumatized patient. Clinicians should consider them adjuncts to diagnosis and not substitutes for clinical assessment in blunt abdominal trauma (BAT). The appropriate use of laboratory tests in the initial evaluation of trauma is reviewed separately; the use of tests of particular relevance to blunt abdominal trauma is discussed here. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/11/35002?source=see_link&amp;anchor=H11715830#H11715830\">",
"     \"Initial management of trauma in adults\", section on 'Laboratory tests'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hematocrit &ndash; The hematocrit can be useful as a baseline value in BAT patients. It must be interpreted in light of the clinical context, including the extent of hemorrhage, time since the injury, and the amount of exogenous fluid administration. As an example, the clinician should not be reassured by a normal hematocrit in the acute trauma victim with hypotension. The hematocrit is most helpful when measured serially to assess ongoing hemorrhage.",
"     </li>",
"     <li>",
"      Leukocyte count &ndash; In acute BAT management, the white blood cell (WBC) count is nonspecific and of little value [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/20\">",
"       20",
"      </a>",
"      ]. The positive and negative predictive value of, respectively, an elevated or normal WBC is poor. Epinephrine release from trauma can cause demargination and may elevate the WBC to 12,000 to",
"      <span class=\"nowrap\">",
"       20,000/mm3",
"      </span>",
"      with a moderate left shift. Solid or hollow viscus injury can cause comparable elevations [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Pancreatic enzymes &ndash; Serum amylase and lipase levels have poor negative and positive predictive value. Normal serum amylase or lipase levels cannot exclude significant pancreatic injury. Elevated levels may suggest pancreatic injury, but may be caused by nonpancreatic abdominal injury, and alone are nondiagnostic. If pancreatic injury is suspected, further confirmatory studies (eg, CT scan) are needed [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Liver function tests &ndash; Liver injury may elevate serum transaminase levels, but such elevations cannot distinguish minor contusions from severe injury [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/23\">",
"       23",
"      </a>",
"      ]. Patients with comorbidities such as alcohol-induced liver disease may have abnormal transaminase levels at baseline.",
"     </li>",
"     <li>",
"      Urinalysis &ndash; Gross hematuria suggests serious renal injury and requires further investigation. Visual inspection alone can miss microscopic hematuria, which can be associated with significant injury. Therefore it is prudent to perform microscopic or dipstick urinalysis in all victims of BAT [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/24\">",
"       24",
"      </a>",
"      ]. The presence of both abdominal tenderness and microscopic hematuria has been found to be 64 percent sensitive and 94 percent specific in predicting intraabdominal injury by abdominal CT [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Additional tests &ndash; It is reasonable to obtain a pregnancy test in women of childbearing age with BAT. Clinical circumstance may suggest the need for further testing.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Radiologic studies",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiologic studies can provide important information to guide the care of patients with blunt abdominal trauma (BAT), but are not without risk. The traumatized patient must be stabilized before most abdominal radiographic studies can be performed, bedside ultrasound being a notable exception. Clinicians must pay careful attention to potential spinal cord injuries and guard against further injury during positioning and transfer for radiographic studies.",
"   </p>",
"   <p>",
"    The uncooperative patient may interfere with the performance of radiologic studies, limiting study quality, while putting themselves at risk for cervical spine injury. Clinicians must evaluate the patient to determine the likely cause for their uncooperativeness (eg, hypoxia, traumatic brain injury). Combative patients may require sedation.",
"   </p>",
"   <p>",
"    A clinician familiar with trauma care must accompany any patient who has the potential to deteriorate precipitously. Placing a patient in the radiology department unattended for even a brief period can have disastrous consequences. In addition to patients with likely intraabdominal injury, radiographic studies of the abdomen are indicated in stable patients when the physical examination and laboratory tests are inconclusive and the information will guide therapy.",
"   </p>",
"   <p>",
"    While chest and anteroposterior pelvis x-rays can be invaluable in blunt trauma, plain abdominal films are of limited use in assessing BAT and have largely been replaced by computed tomography (CT) and ultrasound (US). Should plain x-rays be taken, identification of rib, pelvic, vertebral body, or transverse spinous process fractures raise concern for injury to adjacent viscera.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Speed and image resolution have improved dramatically with the advent of multidetector helical computed tomography (CT) scanners, increasing their importance and utility for the imaging of patients with blunt abdominal trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/26\">",
"     26",
"    </a>",
"    ]. However, their use remains largely restricted to hemodynamically stable patients.",
"   </p>",
"   <p>",
"    Hemodynamically stable patients with blunt trauma who meet the criteria listed below are unlikely to have sustained an intraabdominal injury, and their management is unlikely to change based upon the results of an abdominal CT scan [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Glasgow coma scale &ge;14",
"     </li>",
"     <li>",
"      No hypotension (SBP &lt;90 mmHg)",
"     </li>",
"     <li>",
"      No abdominal or costal margin tenderness",
"     </li>",
"     <li>",
"      No abnormalities on chest radiograph",
"     </li>",
"     <li>",
"      No femur or pelvic fracture",
"     </li>",
"     <li>",
"      Hematocrit &ge;30 percent",
"     </li>",
"     <li>",
"      No hematuria (&lt;25 red blood",
"      <span class=\"nowrap\">",
"       cells/high",
"      </span>",
"      powered field)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    CT scanning's benefits include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Noninvasive",
"     </li>",
"     <li>",
"      Better defines organ injury and potential for nonoperative management of splenic and liver injuries [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/29,30\">",
"       29,30",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Detects not only the presence but the source and amount of hemoperitoneum",
"     </li>",
"     <li>",
"      Active bleeding often detectable",
"     </li>",
"     <li>",
"      Retroperitoneum and vertebral column can be assessed in conjunction with the peritoneum",
"     </li>",
"     <li>",
"      Additional imaging can be performed when needed (eg, head, cervical spine, chest, pelvis).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    CT scanning's disadvantages include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Suboptimal sensitivity for pancreatic, diaphragmatic, bowel, and mesentery injury [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/31-34\">",
"       31-34",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      IV contrast is needed; oral contrast is",
"      <strong>",
"       NOT",
"      </strong>",
"      needed as it rarely adds to diagnostic accuracy and may delay imaging [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/35,36\">",
"       35,36",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Relatively high cost",
"     </li>",
"     <li>",
"      Can be unobtainable or harmful to obtain in unstable patients [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/37\">",
"       37",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Radiation exposure (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=see_link\">",
"       \"Radiation-related risks of imaging studies\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bedside ultrasound (US) is an integral component of trauma management used primarily to detect free intraperitoneal blood after blunt trauma. The trauma US examination focuses on dependent intraperitoneal sites where blood is most likely to accumulate: the hepatorenal space (ie, Morrison's pouch), the splenorenal recess, and the inferior portion of the intraperitoneal cavity (including pouch of Douglas). These studies, when combined with evaluation of the pericardium (which must not be neglected in the setting of BAT), are often referred to as the FAST exam (Focused Assessment with Sonography for Trauma). The use of the FAST exam in the management of patients with abdominal trauma is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/30/7658?source=see_link\">",
"     \"Emergency ultrasound in adults with abdominal and thoracic trauma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Limitations of ultrasound in the setting of blunt abdominal trauma include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Injury to solid parenchyma, the retroperitoneum, or the diaphragm is not well seen",
"     </li>",
"     <li>",
"      Uncooperative patients, obesity, bowel gas, and subcutaneous air interfere with image quality",
"     </li>",
"     <li>",
"      Less sensitive than peritoneal lavage for hemoperitoneum",
"     </li>",
"     <li>",
"      Blood cannot be distinguished from ascites or urine",
"     </li>",
"     <li>",
"      Subcapsular injuries cannot be detected",
"     </li>",
"     <li>",
"      Insensitive for detecting bowel injury",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unstable patients with BAT and pelvic fracture may benefit from angiography. While a time-consuming procedure, angiography can be used to embolize bleeding pelvic vessels, to manage hemorrhage from solid viscera (usually the spleen), and to assess vascular pedicle injuries of the kidneys [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Diagnostic peritoneal lavage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic peritoneal lavage (DPL) has played a major role in the management of blunt abdominal trauma (BAT) since its introduction by Root and his colleagues in 1964 [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/38\">",
"     38",
"    </a>",
"    ]. However, its role has steadily declined in parallel with the advances made in ultrasound and multidetector helical CT. DPL accurately determines the presence of intraperitoneal hemorrhage in hemodynamically unstable patients and remains an invaluable diagnostic tool in such cases, particularly when ultrasound is unavailable or the results of the FAST examination are equivocal [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Ultrasound'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    DPL is most useful in patients with an unreliable examination who are at high risk for hollow viscus injury (HVI) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/39\">",
"     39",
"    </a>",
"    ], particularly when computed tomography (CT) or ultrasound (US) detects minimal fluid, and the patient manifests fever, peritonitis, or both. This circumstance usually occurs 6 to 12 hours following a HVI.",
"   </p>",
"   <p>",
"    Traditionally DPL was performed in two steps, but the latter is rarely used today as it is time consuming and faster, more accurate diagnostic tools such as CT and US are available. In the initial step, the clinician attempts to aspirate free intraperitoneal blood (ie, diagnostic peritoneal tap (DPT) or diagnostic peritoneal aspirate (DPA)). If 10 mL or more of blood is aspirated, the procedure stops because intraperitoneal injury is likely. If the DPT detects no blood, the clinician performs a lavage of the peritoneal cavity with normal saline and the effluent is sent for laboratory evaluation. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'DPL interpretation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    An obvious need for laparotomy is the only absolute contraindication to",
"    <span class=\"nowrap\">",
"     DPL/DPT.",
"    </span>",
"    Prior abdominal surgery, abdominal infections, coagulopathy, obesity, and second or third-trimester pregnancy are all relative contraindications [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Advantages of DPL include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Triage of hemodynamically unstable multisystem trauma patient by revealing or excluding intraperitoneal hemorrhage",
"     </li>",
"     <li>",
"      Detection of small amounts of intraperitoneal blood in stable trauma patient with minor injury that might be missed",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <span class=\"nowrap\">",
"     Disadvantages/complications",
"    </span>",
"    of DPL include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Local or systemic infection (occurs in less than 0.3 percent of cases) [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/41\">",
"       41",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Intraperitoneal injury",
"     </li>",
"     <li>",
"      False positive results from insertion through an abdominal wall hematoma or inadequate hemostasis",
"     </li>",
"     <li>",
"      Unnecessary laparotomy: may occur if hemoperitoneum is detected in a hemodynamically stable patient",
"     </li>",
"     <li>",
"      Potential failure to recover lavage fluid due to:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Inadvertent placement of the catheter into the preperitoneal space",
"     </li>",
"     <li>",
"      Compartmentalization of fluid by adhesions",
"     </li>",
"     <li>",
"      Obstruction of fluid outflow (eg, by omentum)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fluid pooling in the intrathoracic cavity due to diaphragmatic injury [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/40\">",
"       40",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     DPL interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gross inspection of DPL effluent is neither adequate nor reliable. Little correlation between fluid color and cell count has been found. In blunt trauma, the aspiration of 10 mL or more of blood has a positive predictive value of greater than 90 percent for intraperitoneal injury [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If lavage is performed, the fluid is sent to the laboratory for a red blood cell (RBC) count. In blunt trauma, an RBC count greater than",
"    <span class=\"nowrap\">",
"     100,000/mm3",
"    </span>",
"    is considered positive and specific for intraabdominal injury [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/40\">",
"     40",
"    </a>",
"    ]. While a positive aspirate or cell count connotes injury, particularly to solid viscera or vascular structures, it does not equate with an absolute need for laparotomy. Hemodynamically stable patients may have injuries amenable to management with angiography.",
"   </p>",
"   <p>",
"    In patients with pelvic fractures, clinicians must be alert to the possibility of a falsely positive DPL [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/42\">",
"     42",
"    </a>",
"    ]. Retroperitoneal injury can lead to blood in the peritoneum via tears in the posterior peritoneum, egress of RBCs across the peritoneum into the peritoneal cavity, and dissection of a retroperitoneal hematoma along the anterior abdominal wall.",
"   </p>",
"   <p>",
"    Nevertheless, a positive peritoneal aspirate in the setting of pelvic fracture indicates active intraperitoneal hemorrhage in more than 85 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. A negative aspirate in an unstable patient with a pelvic fracture suggests retroperitoneal hemorrhage, and angiography with possible embolization should ensue.",
"   </p>",
"   <p>",
"    Elevation of the white blood cell count lags three to six hours behind initial injury and therefore is unhelpful in initial DPL interpretation [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/44\">",
"     44",
"    </a>",
"    ]. Elevations in DPL amylase are nonspecific and insensitive for pancreatic injury [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUBSEQUENT MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with blunt abdominal trauma (BAT) require expeditious evaluation to determine the need for operative care. After providing initial resuscitation and management based upon protocols from Advanced Trauma Life Support (ATLS&reg;), emergency clinicians determine the need for laparotomy using some combination of physical examination, ultrasound (US), computed tomography (CT), and diagnostic peritoneal tap",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lavage",
"    <span class=\"nowrap\">",
"     (DPT/DPL).",
"    </span>",
"    In some instances, such as patients with a severe pelvic fracture, angiography may be necessary to control hemorrhage and stabilize the patient [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/46\">",
"     46",
"    </a>",
"    ]. A basic algorithm for management of BAT is provided (",
"    <a class=\"graphic graphic_algorithm graphicRef82663 \" href=\"UTD.htm?20/63/21503\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Hemodynamically unstable",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the unstable trauma patient, management hinges on determining the presence or absence of intraperitoneal hemorrhage. The emergency clinician performs a focused abdominal ultrasound (US) exam or diagnostic peritoneal tap (DPT) to make this determination. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Ultrasound'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H13\">",
"     'Diagnostic peritoneal lavage'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Although many retrospective and several prospective studies support the use of US as a trauma screening tool, some researchers question reliance upon ultrasound in trauma management. They emphasize the wide range in sensitivity and possibly inadequate negative predictive value found in studies of ultrasound to detect intraperitoneal injury. Nevertheless, most trauma centers incorporate the Focused Assessment with Sonography for Trauma (ie, FAST) exam into the evaluation of the unstable trauma patient, although variation exists in the way this is done. Most centers perform the FAST exam immediately following the primary survey or, when there are multiple clinicians working in parallel, concomitant with the primary survey, essentially as part of C (ie, Circulation) in the ABC's. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Ultrasound'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    We suggest a FAST examination be performed in all BAT patients, if US is available. If the FAST exam is limited (eg, poor image quality) and the patient is unstable, a DPT is performed. If US or DPT reveals hemoperitoneum, emergent laparotomy is performed. Hemoperitoneum in the clinically unstable patient without other apparent injury mandates laparotomy. For patients without hemoperitoneum by US or DPT, clinicians perform further investigation looking for sites of hemorrhage. When managing an unstable trauma patient with a major pelvic fracture, clinicians should note that US cannot distinguish between hemoperitoneum and uroperitoneum. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Pelvic fracture'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A chest x-ray can reveal significant bleeding into the thoracic cavity and should be performed as part of the initial patient evaluation. An anterior-posterior pelvic radiograph may demonstrate a pelvic fracture requiring immediate stabilization and possible angiography for control of retroperitoneal hemorrhage. As part of the secondary survey, clinicians should assess long bones for fractures, hemorrhage from which can be significant. Lacerations, especially those of the scalp, should be closed with a whip-stitch or scalp clips (eg, Raney clips) to achieve rapid hemostasis. If the patient can be stabilized, further evaluation of the intraabdominal cavity with CT may be warranted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Hemodynamically stable",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical assessment of an alert, non-intoxicated BAT patient that depends solely on abdominal examination findings is reasonably accurate but not infallible [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/13\">",
"     13",
"    </a>",
"    ]. One prospective observational study of such patients, with no signs of external trauma and a normal abdominal exam, found clinically significant abnormalities in 7.1 percent based on CT findings [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/14\">",
"     14",
"    </a>",
"    ]. Significance in this study was defined as any alteration in treatment that resulted directly from the abdominal CT.",
"   </p>",
"   <p>",
"    US and CT are often used in the evaluation of stable BAT patients. If the initial US does not detect intraperitoneal hemorrhage, serial physical examination, US, or CT is performed. Serial physical examination is reserved for patients whose examination is deemed reliable (ie, those with a normal sensorium and no distracting injury). A prospective observational study of 547 patients found a second ultrasound (ie, FAST) examination performed within 24 hours of admission significantly increased both the test's sensitivity and negative predictive value for intraabdominal injury [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/47\">",
"     47",
"    </a>",
"    ]. Given increasing concerns regarding the adverse effects of the radiation from CT scans, many trauma centers are making increased use of serial examinations and standardized clinical assessments [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=see_link\">",
"     \"Radiation-related risks of imaging studies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the initial US detects intraperitoneal blood, the patient undergoes abdominal CT scan to delineate intraperitoneal injuries and quantify the hemoperitoneum. The clinician may choose either admission with nonoperative management or immediate laparotomy depending on the injuries detected and the patient's clinical status. Abdominal CT may also be needed for patients who are hemodynamically stable, but whose sensorium or reliability is altered by closed head injury, drug or alcohol intoxication, or significant distracting injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Clinical indications for laparotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immediate laparotomy after injury from a blunt mechanism is rarely based solely on clinical parameters. Potential indications include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Unexplained signs of blood loss or hypotension in a patient who cannot be stabilized and in whom intraabdominal injury is strongly suspected",
"     </li>",
"     <li>",
"      Clear and persistent signs of peritoneal irritation",
"     </li>",
"     <li>",
"      Radiologic evidence of pneumoperitoneum consistent with a viscus rupture",
"     </li>",
"     <li>",
"      Evidence of a diaphragmatic rupture",
"     </li>",
"     <li>",
"      Persistent, significant GI bleeding seen in nasogastric drainage or vomitus",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Establishing the need for urgent celiotomy on clinical grounds is particularly problematic in the patient with multiple blunt injuries. Numerous extraabdominal sources of hemorrhage may exist. Head injury or intoxication often coexist with abdominal trauma, further impairing the reliability of examination findings. Laparotomy may imperil the patient when more crucial diagnostic and therapeutic steps are delayed. Where confusion exists, we strongly prefer that corroborative diagnostic tests be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Special considerations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Pelvic fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with a pelvic fracture and evidence of ongoing bleeding (ie, hemodynamic instability), the presence or absence of hemoperitoneum determines management. Detection of free fluid by ultrasound (US) or gross intraperitoneal blood by deep peritoneal tap (DPT) accurately predicts active intraperitoneal hemorrhage and the need for emergent laparotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. The absence of intraperitoneal blood as determined by US or DPT suggests major retroperitoneal hemorrhage, assuming there is no extraabdominal source of bleeding. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/7/22650?source=see_link\">",
"     \"Pelvic trauma: Initial evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is an important exception when intraperitoneal fluid detected by US does not represent hemorrhage. Major pelvic fracture can be associated with intraperitoneal bladder rupture. In such cases, the free intraperitoneal fluid found on US is uroperitoneum rather than hemoperitoneum. Intraperitoneal bladder rupture requires surgical repair but not emergently.",
"   </p>",
"   <p>",
"    Patients with a major pelvic fracture are at risk for life-threatening retroperitoneal hemorrhage. As such, some clinicians perform a DPT in the hemodynamically unstable patient with major pelvic fracture and a positive US in order to distinguish hemoperitoneum, which requires exigent laparotomy, from uroperitoneum, and to help decide whether to perform diagnostic and potentially therapeutic pelvic angiography as the next step. Urgent laparotomy for bladder repair is performed thereafter.",
"   </p>",
"   <p>",
"    After carefully examining the perineum and rectum, clinicians should place a pelvic stabilization device (prefabricated pelvic binder, or a bed sheet tied tightly around the pelvis) on any potentially unstable pelvic fracture that may be contributing to hemodynamic instability (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73047 \" href=\"UTD.htm?13/32/13824\">",
"     image 1",
"    </a>",
"    ). External fixation devices are generally placed in the operating room because placement can be difficult and time-consuming and may interfere with other components of resuscitation.",
"   </p>",
"   <p>",
"    Following stabilization with pelvic angiography and embolization, abdominal CT may be used to look further for intraperitoneal injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Multiple system injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians cannot approach the management of the abdominal trauma patient with more than one life-threatening injury dogmatically. At major trauma centers, it is not uncommon to confront intraperitoneal hemorrhage in a patient with apparent closed head injury and suspected blunt aortic disruption. Traditionally, laparotomy to control intraperitoneal hemorrhage takes precedence over operative management of head or chest trauma. However, these situations are complex, and decision-making is influenced by numerous dynamic variables. In general, a patient with known hemoperitoneum who cannot be stabilized must first undergo laparotomy for life-saving hemostasis before other injuries are addressed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Closed head injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, BAT patients with coincident severe closed head injury but without lateralizing signs do not have intracranial lesions that require craniotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/48\">",
"     48",
"    </a>",
"    ]. When lateralizing features appear, the clinician must choose between a CT scan of the head before laparotomy or preemptive burr holes at laparotomy. This judgement depends primarily on the patient's response to resuscitative measures and the availability of CT [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/2/35882?source=see_link\">",
"     \"Management of acute severe traumatic brain injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Blunt aortic disruption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific features of the plain chest x-ray (eg, wide mediastinum) have reasonable sensitivity and moderate specificity for detecting thoracic aortic injury. None is sufficient to corroborate or refute this life-threatening diagnosis. For patients who survive transport to the ED, blunt aortic injuries follow a well-known decay curve prior to rupture, although for any particular patient rupture may be a matter of minutes to days. Any patient with hemodynamic instability from known intraperitoneal injury requires laparotomy first and helical CT angiography of the chest immediately thereafter. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=see_link&amp;anchor=H14#H14\">",
"     \"Initial evaluation and management of blunt thoracic trauma in adults\", section on 'Aortic injury'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Transfers",
"    </span>",
"    &nbsp;&mdash;&nbsp;A trauma patient at a small rural hospital may need a laparotomy for hemorrhage control before being transferred to a trauma center for definitive care [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19545/abstract/50\">",
"     50",
"    </a>",
"    ]. Consultation with the trauma center should begin as soon as it is apparent the patient has sustained injuries beyond the management capacity of the hospital.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emergency clinicians managing blunt trauma must maintain a high degree of clinical suspicion for intraabdominal injury, particularly in patients with suggestive mechanisms, signs of external trauma, or an altered sensorium due to head injury or intoxication. Prompt resuscitation of the unstable patient with blunt abdominal trauma (BAT) must coincide with physical examination and diagnostic testing aimed at determining the presence or absence of hemoperitoneum and organ injury. A basic algorithm for the management of blunt abdominal trauma is provided (",
"    <a class=\"graphic graphic_algorithm graphicRef82663 \" href=\"UTD.htm?20/63/21503\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      BAT most often results in injury to the spleen, which in over 60 percent of cases is the only damaged intraperitoneal structure. Delayed splenic rupture can occur. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Mechanism of injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Noteworthy historical features include (see",
"      <a class=\"local\" href=\"#H4\">",
"       'History'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Fatality at the scene",
"     </li>",
"     <li>",
"      Vehicle type and velocity",
"     </li>",
"     <li>",
"      Whether the vehicle rolled over",
"     </li>",
"     <li>",
"      Patient's location within the vehicle",
"     </li>",
"     <li>",
"      Extent of intrusion into the passenger compartment",
"     </li>",
"     <li>",
"      Extent of damage to the vehicle",
"     </li>",
"     <li>",
"      Steering wheel deformity",
"     </li>",
"     <li>",
"      Whether seat belts were used and if so, what type",
"     </li>",
"     <li>",
"      Whether front or side air bags were deployed",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pedestrians often sustain a triad of injuries to the leg, torso, and cranium; injury to any of these sites should prompt careful evaluation of the others. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical presentation of BAT varies widely, from minor complaints to shock. The accuracy of physical examination is limited. Clinicians must look for intraabdominal injury in patients with an altered sensorium or extraabdominal injuries. If the patient is awake, alert, and hemodynamically stable, and is free of abdominal pain or tenderness, intraabdominal injury is highly unlikely. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Initial assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hematology and chemistry laboratory tests are of limited use in the management of the acutely traumatized patient. Order a blood type and screen for any victim of significant trauma. Notify the blood bank directly (ie, by telephone or in person) of the need for transfusion should a trauma victim present with life-threatening bleeding. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnostic tests'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/55/29562?source=see_link\">",
"       \"Initial evaluation and management of shock in adult trauma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The traumatized patient must be stabilized before most abdominal radiographic studies (eg, computed tomography, or CT) can be performed. Clinicians must pay careful attention to potential spinal cord injuries and guard against injury during positioning. Patients must be closely monitored while in the radiology area. The indications, advantages, and disadvantages of the major modalities for imaging BAT are discussed above. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Radiologic studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the unstable trauma patient, management hinges on determining the presence or absence of intraperitoneal hemorrhage. The emergency clinician performs a focused abdominal ultrasound (US) exam or diagnostic peritoneal tap (DPT) to make this determination. Hemoperitoneum in the clinically unstable patient without other apparent injury mandates laparotomy. For patients without hemoperitoneum, clinicians search for extraabdominal sites of hemorrhage. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Diagnostic peritoneal lavage'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Subsequent management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prompt consultation with a trauma center is paramount for those patients with severe BAT presenting to a small emergency department without the capacity to manage such injuries.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5224776\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the untimely death of John Marx, MD, who passed away in July 2012. We wish to acknowledge Dr. Marx's dedication and his many contributions to UpToDate, in particular, his work as editor-in-chief for Emergency Medicine and as a section editor and author for Adult Trauma.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/1\">",
"      Davis JJ, Cohn I Jr, Nance FC. Diagnosis and management of blunt abdominal trauma. Ann Surg 1976; 183:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/2\">",
"      Nishijima DK, Simel DL, Wisner DH, Holmes JF. Does this adult patient have a blunt intra-abdominal injury? JAMA 2012; 307:1517.",
"     </a>",
"    </li>",
"    <li>",
"     Marx, JA, Isenhour, JL. Abdominal Trauma. In: Emergency Medicine Concepts and Clinical Practice, 6th ed, Marx, JA (Eds), Elsevier, 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/4\">",
"      Rivara FP, Koepsell TD, Grossman DC, Mock C. Effectiveness of automatic shoulder belt systems in motor vehicle crashes. JAMA 2000; 283:2826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/5\">",
"      Brasel KJ, Nirula R. What mechanism justifies abdominal evaluation in motor vehicle crashes? J Trauma 2005; 59:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/6\">",
"      Newgard CD, Lewis RJ, Kraus JF. Steering wheel deformity and serious thoracic or abdominal injury among drivers and passengers involved in motor vehicle crashes. Ann Emerg Med 2005; 45:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/7\">",
"      Demetriades D, Murray J, Martin M, et al. Pedestrians injured by automobiles: relationship of age to injury type and severity. J Am Coll Surg 2004; 199:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/8\">",
"      Roudsari BS, Mock CN, Kaufman R. An evaluation of the association between vehicle type and the source and severity of pedestrian injuries. Traffic Inj Prev 2005; 6:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/9\">",
"      Brown CK, Dunn KA, Wilson K. Diagnostic evaluation of patients with blunt abdominal trauma: a decision analysis. Acad Emerg Med 2000; 7:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/10\">",
"      Poletti PA, Mirvis SE, Shanmuganathan K, et al. Blunt abdominal trauma patients: can organ injury be excluded without performing computed tomography? J Trauma 2004; 57:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/11\">",
"      Beck D, Marley R, Salvator A, Muakkassa F. Prospective study of the clinical predictors of a positive abdominal computed tomography in blunt trauma patients. J Trauma 2004; 57:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/12\">",
"      Schurink GW, Bode PJ, van Luijt PA, van Vugt AB. The value of physical examination in the diagnosis of patients with blunt abdominal trauma: a retrospective study. Injury 1997; 28:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/13\">",
"      Ferrera PC, Verdile VP, Bartfield JM, et al. Injuries distracting from intraabdominal injuries after blunt trauma. Am J Emerg Med 1998; 16:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/14\">",
"      Salim A, Sangthong B, Martin M, et al. Whole body imaging in blunt multisystem trauma patients without obvious signs of injury: results of a prospective study. Arch Surg 2006; 141:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/15\">",
"      Rodriguez A, DuPriest RW Jr, Shatney CH. Recognition of intra-abdominal injury in blunt trauma victims. A prospective study comparing physical examination with peritoneal lavage. Am Surg 1982; 48:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/16\">",
"      Livingston DH, Lavery RF, Passannante MR, et al. Admission or observation is not necessary after a negative abdominal computed tomographic scan in patients with suspected blunt abdominal trauma: results of a prospective, multi-institutional trial. J Trauma 1998; 44:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/17\">",
"      Mahoney EJ, Biffl WL, Harrington DT, Cioffi WG. Isolated brain injury as a cause of hypotension in the blunt trauma patient. J Trauma 2003; 55:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/18\">",
"      Velmahos GC, Tatevossian R, Demetriades D. The \"seat belt mark\" sign: a call for increased vigilance among physicians treating victims of motor vehicle accidents. Am Surg 1999; 65:181.",
"     </a>",
"    </li>",
"    <li>",
"     Sullivan, DM. Myths in Trauma Management. In: Trauma Management: An emergency medicine approach, Ferrera, PC, Marx, J, Colucciello, SA, et al (Eds), Mosby, St. Louis 2001. p.706.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/20\">",
"      Asimos AW, Gibbs MA, Marx JA, et al. Value of point-of-care blood testing in emergent trauma management. J Trauma 2000; 48:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/21\">",
"      Schn&uuml;riger B, Inaba K, Barmparas G, et al. Serial white blood cell counts in trauma: do they predict a hollow viscus injury? J Trauma 2010; 69:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/22\">",
"      Takishima T, Sugimoto K, Hirata M, et al. Serum amylase level on admission in the diagnosis of blunt injury to the pancreas: its significance and limitations. Ann Surg 1997; 226:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/23\">",
"      Holmes JF, Sokolove PE, Brant WE, et al. Identification of children with intra-abdominal injuries after blunt trauma. Ann Emerg Med 2002; 39:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/24\">",
"      Knudson MM, McAninch JW, Gomez R, et al. Hematuria as a predictor of abdominal injury after blunt trauma. Am J Surg 1992; 164:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/25\">",
"      Richards JR, Derlet RW. Computed tomography for blunt abdominal trauma in the ED: a prospective study. Am J Emerg Med 1998; 16:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/26\">",
"      Soto JA, Anderson SW. Multidetector CT of blunt abdominal trauma. Radiology 2012; 265:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/27\">",
"      Holmes JF, Wisner DH, McGahan JP, et al. Clinical prediction rules for identifying adults at very low risk for intra-abdominal injuries after blunt trauma. Ann Emerg Med 2009; 54:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/28\">",
"      Deunk J, Brink M, Dekker HM, et al. Predictors for the selection of patients for abdominal CT after blunt trauma: a proposal for a diagnostic algorithm. Ann Surg 2010; 251:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/29\">",
"      Haan JM, Biffl W, Knudson MM, et al. Splenic embolization revisited: a multicenter review. J Trauma 2004; 56:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/30\">",
"      Mele TS, Stewart K, Marokus B, O'Keefe GE. Evaluation of a diagnostic protocol using screening diagnostic peritoneal lavage with selective use of abdominal computed tomography in blunt abdominal trauma. J Trauma 1999; 46:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/31\">",
"      Williams MD, Watts D, Fakhry S. Colon injury after blunt abdominal trauma: results of the EAST Multi-Institutional Hollow Viscus Injury Study. J Trauma 2003; 55:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/32\">",
"      Mitsuhide K, Junichi S, Atsushi N, et al. Computed tomographic scanning and selective laparoscopy in the diagnosis of blunt bowel injury: a prospective study. J Trauma 2005; 58:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/33\">",
"      Ekeh AP, Saxe J, Walusimbi M, et al. Diagnosis of blunt intestinal and mesenteric injury in the era of multidetector CT technology--are results better? J Trauma 2008; 65:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/34\">",
"      Phelan HA, Velmahos GC, Jurkovich GJ, et al. An evaluation of multidetector computed tomography in detecting pancreatic injury: results of a multicenter AAST study. J Trauma 2009; 66:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/35\">",
"      Allen TL, Mueller MT, Bonk RT, et al. Computed tomographic scanning without oral contrast solution for blunt bowel and mesenteric injuries in abdominal trauma. J Trauma 2004; 56:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/36\">",
"      Stafford RE, McGonigal MD, Weigelt JA, Johnson TJ. Oral contrast solution and computed tomography for blunt abdominal trauma: a randomized study. Arch Surg 1999; 134:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/37\">",
"      Neal MD, Peitzman AB, Forsythe RM, et al. Over reliance on computed tomography imaging in patients with severe abdominal injury: is the delay worth the risk? J Trauma 2011; 70:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/38\">",
"      ROOT HD, HAUSER CW, MCKINLEY CR, et al. DIAGNOSTIC PERITONEAL LAVAGE. Surgery 1965; 57:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/39\">",
"      Cha JY, Kashuk JL, Sarin EL, et al. Diagnostic peritoneal lavage remains a valuable adjunct to modern imaging techniques. J Trauma 2009; 67:330.",
"     </a>",
"    </li>",
"    <li>",
"     Marx, JA. Peritoneal procedures. In: Clinical procedures in emergency medicine, 3rd ed, Hedges, JR, Roberts, JR (Eds), WB Saunders, Philadelphia 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/41\">",
"      Henneman PL, Marx JA, Moore EE, et al. Diagnostic peritoneal lavage: accuracy in predicting necessary laparotomy following blunt and penetrating trauma. J Trauma 1990; 30:1345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/42\">",
"      Radlauer, M, Marx, JA, Moore, EE. Peritoneal aspiration in patients with pelvic fractures. J Emerg Med 1993; 11:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/43\">",
"      Mendez C, Gubler KD, Maier RV. Diagnostic accuracy of peritoneal lavage in patients with pelvic fractures. Arch Surg 1994; 129:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/44\">",
"      Otomo Y, Henmi H, Mashiko K, et al. New diagnostic peritoneal lavage criteria for diagnosis of intestinal injury. J Trauma 1998; 44:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/45\">",
"      Marx JA, Bar-Or D, Moore EE, Tercier JA. Utility of lavage alkaline phosphatase in detection of isolated small intestinal injury. Ann Emerg Med 1985; 14:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/46\">",
"      Branney SW, Moore EE, Cantrill SV, et al. Ultrasound based key clinical pathway reduces the use of hospital resources for the evaluation of blunt abdominal trauma. J Trauma 1997; 42:1086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/47\">",
"      Blackbourne LH, Soffer D, McKenney M, et al. Secondary ultrasound examination increases the sensitivity of the FAST exam in blunt trauma. J Trauma 2004; 57:934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/48\">",
"      Thomason M, Messick J, Rutledge R, et al. Head CT scanning versus urgent exploration in the hypotensive blunt trauma patient. J Trauma 1993; 34:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/49\">",
"      Winchell RJ, Hoyt DB, Simons RK. Use of computed tomography of the head in the hypotensive blunt-trauma patient. Ann Emerg Med 1995; 25:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19545/abstract/50\">",
"      Weinberg JA, McKinley K, Petersen SR, et al. Trauma laparotomy in a rural setting before transfer to a regional center: does it save lives? J Trauma 2003; 54:823.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 348 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-9F549ED38C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_5_19545=[""].join("\n");
var outline_f19_5_19545=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MECHANISM OF INJURY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PRIMARY EVALUATION AND MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Initial assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Radiologic studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Computed tomography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Diagnostic peritoneal lavage",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - DPL interpretation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUBSEQUENT MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Hemodynamically unstable",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Hemodynamically stable",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Clinical indications for laparotomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Special considerations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Pelvic fracture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Multiple system injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Closed head injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Blunt aortic disruption",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Transfers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5224776\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/348\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/348|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?20/63/21503\" title=\"algorithm 1\">",
"      BAT algorithm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/348|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/32/13824\" title=\"diagnostic image 1\">",
"      Open book fracture pubic symphysis diastasis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/30/7658?source=related_link\">",
"      Emergency ultrasound in adults with abdominal and thoracic trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/54/3943?source=related_link\">",
"      Initial evaluation and management of abdominal gunshot wounds in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12776?source=related_link\">",
"      Initial evaluation and management of abdominal stab wounds in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=related_link\">",
"      Initial evaluation and management of blunt thoracic trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/55/29562?source=related_link\">",
"      Initial evaluation and management of shock in adult trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/11/35002?source=related_link\">",
"      Initial management of trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/2/35882?source=related_link\">",
"      Management of acute severe traumatic brain injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/7/22650?source=related_link\">",
"      Pelvic trauma: Initial evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=related_link\">",
"      Physical abuse in children: Diagnostic evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=related_link\">",
"      Radiation-related risks of imaging studies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_5_19546="Definition, etiology, and evaluation of precocious puberty";
var content_f19_5_19546=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Definition, etiology, and evaluation of precocious puberty",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/5/19546/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19546/contributors\">",
"     Paul Saenger, MD, MACE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/5/19546/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19546/contributors\">",
"     Peter J Snyder, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19546/contributors\">",
"     William F Crowley, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19546/contributors\">",
"     Mitchell Geffner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/5/19546/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19546/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/5/19546/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/5/19546/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 5, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Precocious puberty is the onset of pubertal development at an earlier age than is expected based upon established normal standards. The cause of precocious puberty may range from a variant of normal development (eg, premature adrenarche or isolated premature thelarche) to pathologic conditions with significant risk of morbidity and even death (eg, malignant germ-cell tumor and astrocytoma).",
"   </p>",
"   <p>",
"    The clinician faced with a child who presents with early sexual development should consider the following questions.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Is the child too young to have reached the pubertal milestone in question? To answer this question, the clinician needs to know the normal ages for pubertal milestones and the line between normal and abnormal development.",
"     </li>",
"     <li>",
"      What is causing the early sexual development? To answer this question, the physician ascertains whether the sexual development is attributable to androgen or estrogen excess, and whether the source of excess sex hormone is centrally mediated through the hypothalamic-pituitary-gonadal axis, or from an autonomous peripheral origin, or has an exogenous basis.",
"     </li>",
"     <li>",
"      Is therapy indicated, and, if so, what therapy?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The definition of precocious puberty and its causes and evaluation will be reviewed here. The treatment of precocious puberty is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4889?source=see_link\">",
"     \"Treatment of precocious puberty\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NORMAL PUBERTAL DEVELOPMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hypothalamic-pituitary-gonadal axis is biologically active in infancy with peak activity between six and eight weeks of age. This state yields sex steroid levels comparable with those seen in early-to-mid puberty, but without peripheral effects. Known as the &ldquo;mini-puberty of infancy,&rdquo; its biological relevance is unknown.",
"   </p>",
"   <p>",
"    The neonatal stage is followed by a long period of pre-puberty, which is a state of active suppression of the hypothalamic-pituitary-gonadal axis. Children enter puberty when the suppression is released, which permits re-activation of the hypothalamic-pituitary-gonadal axis. The physiologic and genetic mechanisms that affect timing of pubertal maturation are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/25/1434?source=see_link&amp;anchor=H8#H8\">",
"     \"Normal puberty\", section on 'Physiology of pubertal maturation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In 1969 and 1970, Marshall and Tanner defined the standards of normal pubertal development in children and adolescents, known as sexual maturity ratings or &ldquo;Tanner stages&rdquo; (",
"    <a class=\"graphic graphic_table graphicRef55329 \" href=\"UTD.htm?8/1/8220\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. These studies reported that the first sign of puberty in English girls was breast development at an average age of 11 years (thelarche), followed by pubic hair growth (pubarche) and menarche. In English boys, the first sign was testicular enlargement at an average age of 11.5 years followed by penile growth and pubic hair growth (",
"    <a class=\"graphic graphic_table graphicRef76651 \" href=\"UTD.htm?39/57/40859\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/25/1434?source=see_link\">",
"     \"Normal puberty\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Since these reports by Marshall and Tanner, several studies in the United States suggest that children, especially overweight children, are entering puberty at a younger age than previously [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/3-7\">",
"     3-7",
"    </a>",
"    ]. In addition, there are racial differences with puberty occurring earlier in African-American children compared with non-Hispanic white and Hispanic children. These data and the proposed explanations for the trends are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/25/1434?source=see_link&amp;anchor=H13#H13\">",
"     \"Normal puberty\", section on 'Earlier onset of puberty'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Precocious puberty is usually defined as the onset of secondary sexual development before the age of eight years in girls and nine years in boys [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/8\">",
"     8",
"    </a>",
"    ]. These limits are chosen to be 2.5 to 3 standard deviations (SD) below the mean age of onset of puberty. In most populations, attainment of pubertal milestones is normally distributed, with a standard deviation of approximately one year, and the mean age of onset of puberty is about 10.5 years of age in girls and 11.5 years in boys (",
"    <a class=\"graphic graphic_figure graphicRef52047 graphicRef72046 \" href=\"UTD.htm?26/57/27543\">",
"     figure 1A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/1-6,8\">",
"     1-6,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Threshold for evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 1999, the Lawson Wilkins Pediatric Endocrine Society (LWPES) recommended that evaluation for a pathologic cause of precocious puberty be reserved for white girls who have breast",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pubic hair development before seven years of age and black girls who have these findings before six years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/9\">",
"     9",
"    </a>",
"    ]. This recommendation was based on a study describing the first signs of pubertal development among approximately 18,000 girls in the United States and Puerto Rico, which occurred at a younger age than had been previously reported (",
"    <a class=\"graphic graphic_figure graphicRef72226 \" href=\"UTD.htm?19/24/19855\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/7\">",
"     7",
"    </a>",
"    ]. The study did not distinguish between girls with isolated thelarche or adrenarche from those with true precocious puberty. This same study did not show that menarche was occurring any earlier (ie, approximately 12.5 years) than had been thought since the 1940s [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This recommendation has been controversial because of concerns that lowering the age threshold for evaluation of precocious puberty will result in failure to identify some children with pathologic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. As an example, a retrospective review of 223 girls referred to a tertiary center for evaluation of pubertal development before eight years of age found that utilization of the LWPES guidelines would have resulted in failure to identify a substantial number of patients with treatable disease [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/12\">",
"     12",
"    </a>",
"    ]. Twelve percent of these girls were ultimately diagnosed with an endocrinopathy that was amenable to early intervention, including congenital adrenal hyperplasia, McCune-Albright syndrome, pituitary adenoma, and neurofibromatosis.",
"   </p>",
"   <p>",
"    We believe careful evaluation is warranted in children presenting with signs of secondary sexual development younger than the age of eight years in girls or nine years in boys. The level of concern and extent of evaluation should increase with decreasing age at presentation. In girls who are between the ages of seven and eight and boys who are between the ages of eight and nine, a comprehensive history and physical examination may be sufficient initially if this examination does not raise any additional concerns. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Evaluation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Precocious puberty can be classified based upon the underlying pathologic process.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Gonadotropin-dependent precocious puberty",
"      </strong>",
"      &ndash; Gonadotropin-dependent precocious puberty (GDPP, also known as central precocious puberty or true precocious puberty), is caused by early maturation of the hypothalamic-pituitary-gonadal axis. GDPP is characterized by sequential maturation of breasts and pubic hair in girls, and of testicular enlargement and pubic hair in boys. In these patients, the sexual characteristics are appropriate for the child's gender (isosexual). GDPP is idiopathic in more than 80 percent of cases, and almost all idiopathic cases occur in girls (",
"      <a class=\"graphic graphic_table graphicRef52565 \" href=\"UTD.htm?41/47/42747\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Causes of gonadotropin dependent precocious puberty (GDPP)'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       Gonadotropin-independent precocious puberty",
"      </strong>",
"      &ndash; Gonadotropin-independent precocious puberty (GIPP, also known as peripheral precocious puberty or pseudo-precocious puberty) is caused by excess secretion of sex hormones (estrogens or androgens) derived either from the gonads or adrenal glands, exogenous sources of sex steroids, or ectopic production of gonadotropin from a germ cell tumor (eg, human chorionic gonadotropin, hCG) (",
"      <a class=\"graphic graphic_table graphicRef59268 \" href=\"UTD.htm?38/57/39837\">",
"       table 4",
"      </a>",
"      ). This form of puberty may be appropriate for the child&rsquo;s gender (isosexual) or inappropriate, with virilization of girls and feminization of boys (contrasexual). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Causes of gonadotropin independent precocious puberty (GIPP)'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       Incomplete precocious puberty",
"      </strong>",
"      &ndash; Incomplete precocious puberty is defined as isolated breast development in girls (premature thelarche) or isolated male hormone-mediated sexual characteristics, such as pubic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      axillary, acne, and apocrine odor, in boys or girls that results from increased adrenal androgen production (premature adrenarche) (",
"      <a class=\"graphic graphic_table graphicRef72054 \" href=\"UTD.htm?41/53/42843\">",
"       table 5",
"      </a>",
"      ). Both of these disorders can be a variant of normal puberty. However, these children should be monitored because some progress to precocious puberty. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Types of incomplete precocious puberty'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The traditional definition of precocious puberty as onset of any pubertal development before age eight in girls and nine in boys yields markedly different rates depending on the population studied:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a population-based study, breast",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pubic hair development was present at age eight in 48 percent of African-American girls and 15 percent of White girls [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/7\">",
"       7",
"      </a>",
"      ]. At seven years of age, the proportions were 27 percent and 7 percent, respectively.",
"     </li>",
"     <li>",
"      In a population-based study that reviewed data from Danish national registries from 1993 to 2001, the incidence of precocious puberty was 20 per 10,000 girls and less than 5 per 10,000 boys [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/13\">",
"       13",
"      </a>",
"      ]. The diagnostic age limit utilized in this study was eight years for girls and nine for boys. About half the patients had GDPP and the remaining cases were results of isolated premature thelarche or adrenarche, or early normal pubertal development. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/62/21481?source=see_link\">",
"       \"Premature adrenarche\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because precocious puberty is statistically defined as 2.5 to 3.0 SDs below the average age of onset of puberty in healthy children, one would expect that the prevalence rate should be 0.6 percent, or 1 in 160 children, which is considerably lower than the rate in the US study cited above and considerably higher than the Danish study. These observations suggest that the current definition of precocious puberty is problematic, at least in girls, and that selection of children for evaluation should depend on clinical features and perhaps on the rate of progression of observed pubertal changes in the population, which may be related to",
"    <span class=\"nowrap\">",
"     race/ethnic",
"    </span>",
"    factors and obesity rates [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Definition'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H4\">",
"     'Threshold for evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    There is a strong female predominance of precocious puberty [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/15\">",
"     15",
"    </a>",
"    ]. As an example, in a retrospective review from a tertiary care center the female to male ratio was 23:1 [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/16\">",
"     16",
"    </a>",
"    ]. About half of the 197 girls and one quarter of the boys had GDPP. An etiology was found in all 16 boys and only in 6 girls (3 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CAUSES OF GONADOTROPIN DEPENDENT PRECOCIOUS PUBERTY (GDPP)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gonadotropin-dependent precocious puberty (central precocious puberty) is caused by early maturation of hypothalamic-pituitary-gonadal axis. As described above, GDPP affects 10 to 20 times more girls than boys [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. Although the onset is early, the pattern and timing of pubertal events usually progresses in the normal sequence. These children have accelerated linear growth for age, advanced bone age, and pubertal levels of follicle stimulating hormone (FSH) and luteinizing hormone (LH) and of estradiol in girls and testosterone in boys.",
"   </p>",
"   <p>",
"    GDPP is typically treated with a gonadotropin releasing hormone (GnRH) agonist, which produces a prepubertal hormonal state and stops the progression of secondary sexual development, accelerated growth, and bone age advancement. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4889?source=see_link&amp;anchor=H23808992#H23808992\">",
"     \"Treatment of precocious puberty\", section on 'Treatment for GDPP'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23810893\">",
"    <span class=\"h2\">",
"     Idiopathic",
"    </span>",
"    &nbsp;&mdash;&nbsp;GDPP is idiopathic in more than 80 percent of cases, and almost all idiopathic cases occur in girls [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. As a result, this idiopathic category is responsible for the striking female predominance of GDPP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23810924\">",
"    <span class=\"h2\">",
"     CNS lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although GDPP is usually idiopathic, some cases are caused by lesions of the central nervous system (CNS) (",
"    <a class=\"graphic graphic_table graphicRef52565 \" href=\"UTD.htm?41/47/42747\">",
"     table 3",
"    </a>",
"    ). This association mandates that a contrast-enhanced magnetic resonance imaging (MRI) be performed even in the absence of any neurologic abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Imaging and laboratory tests'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Any type of intracranial disturbance can cause precocious puberty including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hamartomas &ndash; Hamartomas of the tuber cinereum are benign tumors that are the most frequent type of CNS tumor to cause precocious puberty in very young children. One speculative explanation is the presence of GnRH neurons that act as ectopic hypothalamic GnRH pulse generator [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/20\">",
"       20",
"      </a>",
"      ]. In most cases, the mechanism is unknown. Some hamartomas may produce transforming growth factor alpha (TGF alpha), which is thought to mediate release of GnRH [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other CNS tumors &ndash; Other CNS tumors associated with precocious puberty include astrocytoma [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/21\">",
"       21",
"      </a>",
"      ], ependymoma, pinealomas, and optic and hypothalamic gliomas. Sexual precocity in patients with neurofibromatosis is usually, but not always, associated with an optic glioma [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/22\">",
"       22",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/56/13192?source=see_link\">",
"       \"Clinical manifestations and diagnosis of central nervous system tumors in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      CNS irradiation &ndash; Precocious puberty caused by CNS irradiation also is commonly associated with growth hormone (GH) deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/23\">",
"       23",
"      </a>",
"      ]. GH reserve should be tested and, if deficient, treated with GH, combined with GnRH agonist therapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7401?source=see_link&amp;anchor=H3#H3\">",
"       \"Pubertal development and gonadal function in survivors of childhood cancer\", section on 'Precocious or rapid puberty'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/55/31607?source=see_link\">",
"       \"Growth failure after childhood cancer: Role of growth hormone deficiency\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other CNS lesions &ndash; Precocious puberty has been associated with hydrocephalus, cysts, trauma, CNS inflammatory disease, and congenital mid-line defects, such as optic nerve hypoplasia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/47/6906?source=see_link&amp;anchor=H5#H5\">",
"       \"Congenital anomalies and acquired abnormalities of the optic nerve\", section on 'Hypoplasia'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3989359\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;GPR54 is a G protein-coupled receptor that acts as a ligand for kisspeptin. The action of the kisspeptin-GPR54 signaling complex is essential for gonadotropin-releasing hormone physiology and for initiation of puberty [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/24\">",
"     24",
"    </a>",
"    ]. Gain-of-function mutations in GPR54 are a newly described and apparently rare form of GDPP [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/25\">",
"     25",
"    </a>",
"    ]. Conversely, loss-of function mutations in GPR54 can cause hypogonadotropic hypogonadism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2170?source=see_link&amp;anchor=H372820004#H372820004\">",
"     \"Congenital gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)\", section on 'Kisspeptin 1 receptor gene (KISS1R, formerly GPR54)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3989366\">",
"    <span class=\"h2\">",
"     Previous excess sex steroid exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children who have been exposed to high serum levels of sex steroid (eg, those with poorly controlled congenital adrenal hyperplasia and McCune Albright Syndrome) may sometimes develop superimposed GDPP, either from the priming effect of the GIPP-derived sex steroid on the hypothalamus or from sudden lowering of the sex steroid levels following improvement in the control of the GIPP [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3989453\">",
"     'McCune-Albright syndrome'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3989383\">",
"    <span class=\"h2\">",
"     Primary hypothyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with severe, long-standing primary hypothyroidism occasionally present with precocious puberty. In girls, findings include early breast development, galactorrhea, and recurrent menstrual bleeding; and in boys, premature testicular enlargement [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. Historically this has been referred to as the \"overlap\" or Van Wyk-Grumbach syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/32\">",
"     32",
"    </a>",
"    ]. The signs of pubertal development regress with thyroxine therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/22/21865?source=see_link\">",
"     \"Acquired hypothyroidism in childhood and adolescence\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A few patients have had high serum FSH or LH concentrations as the underlying pathology. Another proposed mechanism is stimulation of the FSH receptor by high serum thyrotropin (TSH) concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/33\">",
"     33",
"    </a>",
"    ]. Activating mutations of the FSH receptor have been reported in women with spontaneous ovarian hyperstimulation during pregnancy; the receptors were highly sensitive to stimulation by hCG, and in vitro, by TSH. It was hypothesized that similar mutations would be seen in children with severe primary hypothyroidism and gonadal hyperstimulation, but in two studies of 12 children with the disorder, none had an FSH receptor mutation [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/34,35\">",
"     34,35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CAUSES OF GONADOTROPIN INDEPENDENT PRECOCIOUS PUBERTY (GIPP)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gonadotropin-independent precocious puberty (also known as peripheral precocious puberty or pseudo-precocious puberty) is caused by excess secretion of sex hormones (estrogens or androgens) derived either from the gonads or adrenal glands or from exogenous sources (",
"    <a class=\"graphic graphic_table graphicRef59268 \" href=\"UTD.htm?38/57/39837\">",
"     table 4",
"    </a>",
"    ). Further characterization is based upon whether the sexual characteristics are appropriate for the child's gender (isosexual) or inappropriate, with virilization of girls and feminization of boys (contrasexual). FSH and LH levels are suppressed (in the prepubertal range) and do not increase with GnRH stimulation.",
"   </p>",
"   <p>",
"    Treatment for GIPP depends on the cause. GnRH agonist therapy is ineffective, in contrast to patients with GDPP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4889?source=see_link&amp;anchor=H23809049#H23809049\">",
"     \"Treatment of precocious puberty\", section on 'Treatment for GIPP'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the following discussion, the causes of GIPP are described based upon gender.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Girls",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3989390\">",
"    <span class=\"h3\">",
"     Ovarian cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;A large functioning follicular cyst of the ovaries is the most common cause of GIPP in girls [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/36\">",
"     36",
"    </a>",
"    ]. Affected patients often present after an episode of vaginal bleeding. These cysts may appear and regress spontaneously, so conservative management is usually appropriate. Large cysts may predispose to ovarian torsion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3989404\">",
"    <span class=\"h3\">",
"     Ovarian tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ovarian tumors are a rare cause of GIPP in girls. Granulosa cell tumors can cause isosexual GIPP;",
"    <span class=\"nowrap\">",
"     Sertoli/Leydig",
"    </span>",
"    cell tumors (arrhenoblastoma), pure Leydig cell tumors, and gonadoblastoma may make androgens and cause contrasexual GIPP [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/37-39\">",
"     37-39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Boys",
"    </span>",
"    &nbsp;&mdash;&nbsp;In boys, causes of isosexual GIPP include:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3989411\">",
"    <span class=\"h3\">",
"     Leydig cell tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leydig cell tumor should be considered in any boy with asymmetric testicular enlargement. Even if a distinct mass cannot be palpated and none is evident on ultrasonography, the larger testis should be biopsied if it enlarges during follow-up. These testosterone-secreting tumors are almost always benign, and are readily cured by surgical removal [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/40\">",
"     40",
"    </a>",
"    ]. Radical orchiectomy is the recommended procedure; however, successful treatment by direct enucleation of the tumor with sparing of the testis has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3989418\">",
"    <span class=\"h3\">",
"     Human chorionic gonadotropin (hCG) secreting germ cell tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Germ-cell tumors secrete hCG, which activates LH receptors on the Leydig cells. This results in increased testosterone secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/42\">",
"     42",
"    </a>",
"    ]. The increase in testicular size correlates poorly with the serum testosterone concentration because most of the testis is made up of tubular elements whose maturation depends upon FSH.",
"   </p>",
"   <p>",
"    These tumors occur in the gonads, brain (usually in the pineal region), liver, retroperitoneum, and posterior mediastinum, reflecting sites of embryonic germ cells before their coalescence in the gonadal ridge [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/42\">",
"     42",
"    </a>",
"    ]. The histology of hCG-secreting tumors ranges from dysgerminoma, which respond readily to therapy, to the more malignant embryonal cell carcinoma and choriocarcinoma. All males with mediastinal germinomas should be karyotyped because these tumors are frequently associated with Klinefelter syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/47/41720?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and staging of testicular germ cell tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/43/4794?source=see_link&amp;anchor=H18#H18\">",
"     \"Pathology of mediastinal tumors\", section on 'Germ cell tumors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3989425\">",
"    <span class=\"h3\">",
"     Familial male-limited precocious puberty",
"    </span>",
"    &nbsp;&mdash;&nbsp;This rare disorder (also known as familial GIPP or testotoxicosis) is caused by an activating mutation in the LH receptor gene, which results in premature Leydig cell maturation and testosterone secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/43\">",
"     43",
"    </a>",
"    ]. Although inherited as an autosomal dominant disorder, girls are not affected clinically because activation of both the FSH and LH receptors is required for estrogen biosynthesis, so the disorder is considered \"male-limited\" [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/44\">",
"     44",
"    </a>",
"    ]. Affected boys present at one to four years of age.",
"   </p>",
"   <p>",
"    Treatment of this disorder is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4889?source=see_link&amp;anchor=H23809063#H23809063\">",
"     \"Treatment of precocious puberty\", section on 'Familial male-limited precocious puberty'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Both girls and boys",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following causes of GIPP can occur in either girls or boys. Sexual changes either may be isosexual or contrasexual depending on the gender of the child and the type of sex hormone produced. Excess estrogen will cause feminization, while excess androgen will result in virilization.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3989432\">",
"    <span class=\"h3\">",
"     Exogenous estrogen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Feminization has been attributed to excess estrogen exposure from creams, ointments, and sprays (eg,",
"    <a class=\"external\" href=\"file://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm220185.htm\">",
"     estradiol transdermal spray",
"    </a>",
"    ), food contamination, and folk remedies such as lavender oil and tea tree oil [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. Caretakers using these topical estrogens to treat menopausal symptoms may inadvertently expose children to the hormones.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3989439\">",
"    <span class=\"h3\">",
"     Adrenal pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adrenal causes of excess androgen production include androgen-secreting tumors and enzymatic defects in adrenal steroid biosynthesis (congenital adrenal hyperplasia). Boys who have an adrenal cause for their precocity will not have testicular enlargement (&lt;4 mL testicular volume or &lt;2.5 cm in diameter). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19560?source=see_link\">",
"     \"Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Premature pubarche may be the presenting feature of an inherited disorder of adrenal steroid metabolism, including 11-beta hydroxylase deficiency, 3-beta hydroxysteroid dehydrogenase type 2 deficiency, hexose-6-phosphate dehydrogenase deficiency and PAPSS2 deficiency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/32/15878?source=see_link\">",
"     \"Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Adrenal estrogen-secreting tumors can lead to feminization. Rarely, adrenal tumors may produce androgen and estrogen, the latter because of intra-adrenal aromatization of androgen (or enough androgen that is peripherally aromatized to estrogen), causing both male and female pubertal changes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12826?source=see_link\">",
"     \"Clinical presentation and evaluation of adrenocortical tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3989446\">",
"    <span class=\"h3\">",
"     Pituitary gonadotropin-secreting tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;These tumors are extremely rare in children and are associated with elevated levels of FSH",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    LH [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/48,49\">",
"     48,49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3989453\">",
"    <span class=\"h3\">",
"     McCune-Albright syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;McCune-Albright Syndrome (MAS) is a rare disorder defined as the triad of peripheral precocious puberty, caf&eacute;-au-lait skin pigmentation (",
"    <a class=\"graphic graphic_picture graphicRef80844 \" href=\"UTD.htm?41/51/42815\">",
"     picture 1",
"    </a>",
"    ), and fibrous dysplasia of bone (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef81627 \" href=\"UTD.htm?39/19/40243\">",
"     image 1",
"    </a>",
"    ). MAS should be considered in girls with recurrent formation of follicular cysts and cyclic menses [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/50\">",
"     50",
"    </a>",
"    ]. The skin manifestations and bone lesions may increase over time. In girls presenting with vaginal bleeding, the ovarian enlargement has often been mistaken for an ovarian tumor, leading to unnecessary oophorectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/51\">",
"     51",
"    </a>",
"    ]. Girls presenting with premature vaginal bleeding should be carefully evaluated for features of McCune-Albright syndrome to avoid this potential mistake.",
"   </p>",
"   <p>",
"    Patients with MAS have a somatic (postzygotic) mutation of the alpha subunit of the G3 protein that activities adenylate cyclase [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/52-54\">",
"     52-54",
"    </a>",
"    ]. This mutation leads to continued stimulation of endocrine function (eg, precocious puberty, thyrotoxicosis, gigantism or acromegaly, Cushing syndrome, and hypophosphatemic rickets), in various combinations. Mutations can be found in other nonendocrine organs (liver and heart) resulting in cholestasis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hepatitis, intestinal polyps, and cardiac arrhythmias, respectively. A heightened risk of malignancy has also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/55\">",
"     55",
"    </a>",
"    ]. Germline mutations of this mutation would be lethal [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/52,54,56,57\">",
"     52,54,56,57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical phenotype varies markedly, depending on which tissues are affected by the mutation, but precocious puberty is the most commonly reported manifestation [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/58\">",
"     58",
"    </a>",
"    ]. As in other forms of GIPP, the sequence of pubertal progression may be abnormal, in that vaginal bleeding often precedes significant breast development [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/59\">",
"     59",
"    </a>",
"    ]. Prolonged exposure to elevated levels of sex steroids may cause accelerated growth, advanced skeletal maturation, and compromised adult height. Although the precocious puberty is typically GIPP, a secondary component of GDPP may develop, also because of prolonged exposure to sex steroids [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/60\">",
"     60",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3989366\">",
"     'Previous excess sex steroid exposure'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    McCune-Albright syndrome is more common in girls than in boys. Affected girls tend to overproduce estrogens, whereas affected boys overproduce androgens. Therefore, treatment also varies by gender and clinical phenotype. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4889?source=see_link&amp;anchor=H23809056#H23809056\">",
"     \"Treatment of precocious puberty\", section on 'McCune-Albright syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TYPES OF INCOMPLETE PRECOCIOUS PUBERTY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Incomplete precocious puberty is the early development of secondary sexual characteristics and usually is a variant of normal puberty (",
"    <a class=\"graphic graphic_table graphicRef72054 \" href=\"UTD.htm?41/53/42843\">",
"     table 5",
"    </a>",
"    ). Radiologic determination of bone age should be performed to confirm that epiphysial maturation is not unduly accelerated. If the bone age is normal or only marginally advanced, no other tests are usually required. Nonetheless, monitoring of children with this condition is needed to ensure that they do not develop GDPP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21089789\">",
"    <span class=\"h2\">",
"     Premature thelarche",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cases of premature thelarche are idiopathic and present around two years of age (but may start at birth) and either remit spontaneously or are very slowly progressive. Most of these girls have no other signs of pubertal development and their growth rate is normal. Their serum estradiol concentrations are typically in the prepubertal range. The cause is not known. Premature thelarche can progress to true isosexual precocious puberty in 14 to 20 percent of these children [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/61,62\">",
"     61,62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Key features of premature thelarche are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Isolated breast development, either unilateral or bilateral",
"     </li>",
"     <li>",
"      Absence of other secondary sexual characteristics",
"     </li>",
"     <li>",
"      Normal linear growth",
"     </li>",
"     <li>",
"      Normal bone age",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Premature thelarche occurs in two peaks: one during the first two years of life and the other at six to eight years of age. It may be more common in Black or Hispanic children, particularly if they are overweight [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/63-65\">",
"     63-65",
"    </a>",
"    ]. In most instances, no cause can be found. Soy-based infant formulas have been implicated, although the evidence is weak and the consequence may be only a slower waning of breast tissue during infancy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/66-68\">",
"     66-68",
"    </a>",
"    ]. Use of lavender oil, tea tree oil, or hair care products that contain placental extract has also been implicated in some cases of premature thelarche [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Generally premature thelarche requires only sympathetic reassurance. However, to identify any patient with progressive puberty, the patient should be followed regularly at six month intervals. The patient should be examined for signs of additional pubertal development, and growth data should be plotted; an accelerated height velocity would suggest progressive puberty and requires further evaluation. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Evaluation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Consultation with a pediatric endocrinologist is warranted if any of the following is present [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/69\">",
"     69",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Progressive secondary sexual development",
"     </li>",
"     <li>",
"      Increasing growth velocity",
"     </li>",
"     <li>",
"      Accelerated bone maturation",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11748219\">",
"    <span class=\"h3\">",
"     Neonates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast hypertrophy can occur in female and male neonates. It is caused by stimulation from maternal hormones and usually resolves spontaneously within a few weeks or months. While in most cases, neonatal thelarche disappears over the first months of life, failure to do so almost never has any pathologic significance. Breast development at birth in both sexes is sometimes quite prominent and may also be associated with galactorrhea (\"witch's milk\"), which resolves spontaneously [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/70\">",
"     70",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/49/42776?source=see_link&amp;anchor=H4#H4\">",
"     \"Overview of breast masses in children and adolescents\", section on 'Neonates and infants'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21089796\">",
"    <span class=\"h2\">",
"     Premature adrenarche",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature adrenarche is characterized by the appearance of pubic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    axillary hair prior to the age of eight years in girls and nine years in boys. It is more common in girls, Black females, and individuals with obesity and insulin resistance. Premature adrenarche is considered a variant of normal development but is a risk factor for polycystic ovary disease in girls. Follow up of all children with premature adrenarche is, therefore, recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/71\">",
"     71",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/62/21481?source=see_link\">",
"     \"Premature adrenarche\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/13/39130?source=see_link\">",
"     \"Clinical features and diagnosis of polycystic ovary syndrome in adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of premature adrenarche is best supported by documentation that the child's serum dehydroepiandrosterone sulfate (DHEA-sulfate) concentration is appropriate for pubic hair stage and that levels of 17-hydroxyprogesterone and testosterone (to access for pathologic sources of excess androgen, such as congenital adrenal hyperplasia), are in age-appropriate normal ranges.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Guiding principles",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation for precocious puberty focuses on answering the following questions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Who should be evaluated? &ndash; We believe careful evaluation is warranted in children presenting with signs of secondary sexual development younger than the age of eight (girls) or nine (boys) years. The concern and extent of evaluation should increase with decreasing age at presentation. In girls who are between the ages of seven and eight and boys who are between the ages of eight and nine, a comprehensive history and physical examination may be sufficient if this examination does not raise any additional concerns.",
"     </li>",
"     <li>",
"      Is the cause of precocity central or peripheral? &ndash; The sequence and pace of pubertal development in children with gonadotropin-dependent precocious puberty (GDPP, central precocious puberty) recapitulates normal pubertal development but at an earlier age (",
"      <a class=\"graphic graphic_figure graphicRef52047 graphicRef72046 \" href=\"UTD.htm?26/57/27543\">",
"       figure 1A-B",
"      </a>",
"      ). By contrast, individuals with gonadotropin-independent precocious puberty (GIPP) have a peripheral source of gonadal hormones and are more likely to display deviations from the normal sequence and pace of puberty. As an example, a girl who progresses to menstrual bleeding within one year of the onset of breast development is more likely to have ovarian disease (a cause of GIPP) than GDPP [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/72,73\">",
"       72,73",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      How quickly is the puberty progressing? &ndash; The pace of pubertal development reflects the degree and duration of sex steroid action. A rapid rate of linear growth and skeletal maturation (measured as bone age) suggests either GDPP or GIPP due to ovarian or testicular disease with high concentrations of sex steroids (",
"      <a class=\"graphic graphic_table graphicRef72017 \" href=\"UTD.htm?40/24/41356\">",
"       table 6",
"      </a>",
"      ). Pubertal progression would be considered slow if there is no change in stage of breast, pubic hair, or genital development during six or more months of observation. Height velocity is considered accelerated if it is more than 6 cm per year. By contrast, a child with premature adrenarche or with GIPP and low concentrations of sex steroids will have little or no acceleration of growth or bone age (",
"      <a class=\"graphic graphic_figure graphicRef60956 \" href=\"UTD.htm?34/52/35663\">",
"       figure 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Is the precocity because of excess estrogen or androgen? &ndash; Are the secondary sexual characteristics virilizing or feminizing? In girls, isolated virilization excludes a central etiology; in boys, feminization excludes both a central and most testicular etiologies. A rare ovarian cause of virilization is ovarian arrhenoblastoma (Sertoli-Leydig cell tumor) [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/74\">",
"       74",
"      </a>",
"      ]; a rare testicular cause of feminization is a feminizing Sertoli cell tumor, which may be associated with Peutz-Jeghers syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/75\">",
"       75",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Initial evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of a patient suspected to have precocious puberty begins with a history and physical examination, followed by radiographic measurement of bone age to determine whether there is a corresponding increase in epiphysial maturation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Medical history &ndash; The history focuses on when the initial pubertal changes were first noted for the patient, as well as the timing of pubertal onset in his or her parents and siblings. In addition, other questions are directed toward evidence of linear growth acceleration, the presence of headaches, seizures or abdominal pain (indicative of either CNS or ovarian process) and previous history of CNS disease or trauma. The possibility of exposure to exogenous sex steroids (medicinal or cosmetic sources) or compounds with sex-steroid-like properties should always be explored [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/76\">",
"       76",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Physical examination &ndash; The physical examination includes measurements of height, weight, and calculation of height velocity",
"      <span class=\"nowrap\">",
"       (cm/yr).",
"      </span>",
"      Girls with precocious puberty compared with normal girls display an early growth acceleration pattern that can be a useful clue in early identification [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/77\">",
"       77",
"      </a>",
"      ]. The physical examination should include a funduscopic examination to evaluate for papilledema (which would suggest increased intracranial pressure), restricted visual fields (suggestive of a CNS mass), and a thorough dermatological exam to evaluate for cafe-au-lait spots (which would suggest neurofibromatosis or McCune-Albright syndrome).",
"     </li>",
"     <li>",
"      Pubertal staging &ndash; Secondary sexual development should be assessed as objectively as possible to determine the sexual maturity rating (Tanner stage) of pubertal development (",
"      <a class=\"graphic graphic_table graphicRef55329 \" href=\"UTD.htm?8/1/8220\">",
"       table 1",
"      </a>",
"      ). This means staging breast development in girls (",
"      <a class=\"graphic graphic_picture graphicRef72038 \" href=\"UTD.htm?10/43/10932\">",
"       picture 2",
"      </a>",
"      ), genital development in boys, and pubic hair development in both sexes (",
"      <a class=\"graphic graphic_picture graphicRef80005 graphicRef79782 \" href=\"UTD.htm?31/25/32152\">",
"       picture 3A-B",
"      </a>",
"      ). In girls, the diameter of glandular breast tissue (by direct palpation including compression to differentiate from adipose tissue) and the nipple-areolar complex should be assessed. In boys, measurements are made of the testicular volume (",
"      <a class=\"graphic graphic_figure graphicRef60225 \" href=\"UTD.htm?43/46/44781\">",
"       figure 4",
"      </a>",
"      ) and penile size (stretched length of the non-erect penis, measuring from the pubic bone to tip of glans, excluding the foreskin). Accurate measurements are critical to determine whether further radiologic or laboratory testing is necessary. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/25/1434?source=see_link&amp;anchor=H4#H4\">",
"       \"Normal puberty\", section on 'Sexual maturity rating (Tanner stages)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Bone age &ndash; Patients who have early secondary sexual findings confirmed by physical examination should be evaluated for skeletal maturation by radiographic assessment of bone age. Further evaluation is warranted if the bone age is older than chronological age (",
"      <a class=\"graphic graphic_table graphicRef61907 \" href=\"UTD.htm?17/49/18204\">",
"       table 7",
"      </a>",
"      ). If the patient has a normal bone age, he or she is unlikely to have GDPP. If the clinical findings are consistent with incomplete precocious puberty and the bone age is normal, follow-up rather than further evaluation usually is appropriate. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Types of incomplete precocious puberty'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Further evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the diagnosis of precocious puberty has been made, further evaluation is needed to determine the cause of precocious puberty, whether therapy is needed, and if so which treatment is appropriate.",
"   </p>",
"   <p>",
"    The first step is to measure basal LH levels and LH levels following administration of GnRH. The results are used to differentiate between GDPP and GIPP, which then guides additional testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Serum LH concentrations after GnRH agonist stimulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with GDPP can be distinguished from those with GIPP (and from normal prepubertal children) on the basis of measurements of serum LH concentrations, at baseline and after administration of exogenous gonadotropin-releasing hormone (GnRH) or GnRH agonist. Interpretation of basal levels is confounded by the secretory pattern of LH, which is pulsatile and predominantly nocturnal in early puberty. LH levels, either basally or after GnRH stimulation, are most easily interpreted if the ultrasensitive assays are employed.",
"   </p>",
"   <p>",
"    If basal levels of LH are markedly elevated (eg, more than 5",
"    <span class=\"nowrap\">",
"     mIU/mL",
"    </span>",
"    [where IU &ndash; International Units]) in a child with precocious puberty, then a diagnosis of GDPP can be made without proceeding to a GnRH stimulation test. However, patients with low or intermediate basal levels of LH should have a GnRH stimulation test to clarify the diagnosis.",
"   </p>",
"   <p>",
"    GnRH is currently not available in the United States; a GnRH agonist may be used instead. Levels of LH and sex steroids should be measured using ultrasensitive assays with detection limits adapted to the pediatric age group (ie, LH detection limits near 0.3",
"    <span class=\"nowrap\">",
"     mIU/mL).",
"    </span>",
"    In most laboratories, prepubertal levels of LH are below 0.1",
"    <span class=\"nowrap\">",
"     mIU/mL.",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In GDPP, basal levels of LH and FSH are often at pubertal levels and will increase with GnRH stimulation. Peak LH levels above 5 to 8",
"      <span class=\"nowrap\">",
"       mIU/mL",
"      </span>",
"      suggest GDPP.",
"     </li>",
"     <li>",
"      In GIPP, LH and FSH levels are low at baseline (prepubertal range) and will not increase with GnRH stimulation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several different protocols have been used for this test. Blood is sampled at baseline for LH, FSH, and either estradiol or testosterone. A single dose of the GnRH agonist",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"     leuprolide",
"    </a>",
"    acetate is then given at a dose of 20",
"    <span class=\"nowrap\">",
"     mcg/kg.",
"    </span>",
"    LH is measured as a single sample at 60 minutes (or, in some protocols, 30 minutes) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/78-80\">",
"     78-80",
"    </a>",
"    ]. Other protocols employ sampling every 30 minutes for up to two hours. Girls with nonprogressive precocious puberty tend to have a delayed rise in LH and lower",
"    <span class=\"nowrap\">",
"     LH/FSH",
"    </span>",
"    ratios than those with GDPP [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/78,81\">",
"     78,81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The optimal cutoff value of LH for identifying children with GDPP has not been established, and varies somewhat among assays. However, for most current LH assays a value of 3.3 to 5",
"    <span class=\"nowrap\">",
"     mIU/mL",
"    </span>",
"    defines the upper limit of normal for stimulated LH values in prepubertal children [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/78\">",
"     78",
"    </a>",
"    ]. In addition, measurement of the appropriate sex steroid 24 hours after the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"     leuprolide",
"    </a>",
"    injection often yields supportive information. Note that neither basal nor stimulated FSH levels are useful for distinguishing the prepubertal state from that of puberty but are measured to assure bioactivity of the injected leuprolide.",
"   </p>",
"   <p>",
"    The diagnostic value of a GnRH stimulation test was shown in a study comparing results of 100 normal prepubertal children with those of 10 children with GIPP and 58 children with GDPP. The mean basal serum LH concentration was &lt;0.6",
"    <span class=\"nowrap\">",
"     mIU/mL",
"    </span>",
"    (the sensitivity limit of the assay) in the first two groups, but was 1.6",
"    <span class=\"nowrap\">",
"     mIU/mL",
"    </span>",
"    in 58 children with GDPP [",
"    <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/82\">",
"     82",
"    </a>",
"    ]. The peak serum LH responses to GnRH in the three groups were 3.1",
"    <span class=\"nowrap\">",
"     mIU/mL,",
"    </span>",
"    1.5",
"    <span class=\"nowrap\">",
"     mIU/mL,",
"    </span>",
"    and 22",
"    <span class=\"nowrap\">",
"     mIU/mL,",
"    </span>",
"    respectively. The values for serum FSH overlapped much more in the three groups. The specificity and positive predictive value of high basal and GnRH-stimulated serum LH concentrations for the diagnosis of GDPP were 100 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Imaging and laboratory tests",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      GDPP &ndash; Patients with GDPP, as indicated by elevated basal or stimulated serum LH concentrations, require brain imaging to determine whether there is an identifiable CNS cause (",
"      <a class=\"graphic graphic_table graphicRef61907 \" href=\"UTD.htm?17/49/18204\">",
"       table 7",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/78\">",
"       78",
"      </a>",
"      ]. Contrast-enhanced magnetic resonance imaging (MRI) is necessary to detect hypothalamic and infundibular lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/83,84\">",
"       83,84",
"      </a>",
"      ]. However, there is no clear-cut evidence that pituitary microadenomas are associated with GDPP, so magnetic resonance imaging without contrast is probably sufficient in most cases [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/85\">",
"       85",
"      </a>",
"      ]. There is some controversy about whether imaging is required for certain low-risk groups, such as girls presenting after age six [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/83\">",
"       83",
"      </a>",
"      ]. One series found no CNS lesions among a group of girls with pubertal onset after age six and serum estradiol concentrations &lt;45",
"      <span class=\"nowrap\">",
"       pmol/L",
"      </span>",
"      (12",
"      <span class=\"nowrap\">",
"       pg/ml)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/18\">",
"       18",
"      </a>",
"      ], while a second series reported CNS abnormalities in over 15 percent of girls with onset of puberty between six and nine years of age [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/85\">",
"       85",
"      </a>",
"      ]. Therefore, there is currently insufficient information to confidently exclude this group of patients from imaging.",
"      <br/>",
"      <br/>",
"      In addition, estradiol and testosterone levels should be measured to establish the degree of biochemical pubertal advancement, thyroid function studies should be performed if there is any clinical evidence of hypothyroidism, and children who have received cranial radiation should be evaluated for the possibility of concomitant growth hormone deficiency. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Causes of gonadotropin dependent precocious puberty (GDPP)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      GIPP &ndash; In patients with GIPP, the following laboratory tests are used to identify the peripheral cause of precocious puberty: testosterone, estradiol, LH, FSH, cortisol (drawn in the afternoon, to screen for Cushing syndrome which occasionally causes hyperandrogenism), DHEA, DHEAS, and 17-hydroxyprogesterone. In boys, human chorionic gonadotropin (hCG) should be measured to evaluate for the possibility of an hCG-secreting tumor; if a tumor is found in the mediastinum, a karyotype should be performed to evaluate for Klinefelter syndrome because of its association with mediastinal germinoma [",
"      <a class=\"abstract\" href=\"UTD.htm?19/5/19546/abstract/42\">",
"       42",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      An abdominal and pelvic ultrasound should be performed to identify the presence of an ovarian cyst or tumor (",
"      <a class=\"graphic graphic_table graphicRef61907 \" href=\"UTD.htm?17/49/18204\">",
"       table 7",
"      </a>",
"      ). Pelvic ultrasound also may be used to monitor pubertal progress in girls; uterine volume changes above 2 mL suggest progressive puberty. Ultrasound examination of the testes is indicated in boys with GIPP to evaluate for the possibility of Leydig-cell tumor.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?30/58/31650?source=see_link\">",
"       \"Patient information: Early puberty (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Precocious puberty is defined as the onset of pubertal development more than 2.5 to 3 standard deviations (SD) earlier than the average age (",
"      <a class=\"graphic graphic_figure graphicRef52047 graphicRef72046 \" href=\"UTD.htm?26/57/27543\">",
"       figure 1A-B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because of the trend of earlier pubertal development, there is controversy about the lower age limit for normal pubertal development. We recommend careful evaluation in children presenting with signs of secondary sexual development younger than the age of eight years in girls or nine years in boys (",
"      <a class=\"graphic graphic_figure graphicRef72226 \" href=\"UTD.htm?19/24/19855\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Definition'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The etiology of precocious puberty is classified by the underlying pathogenesis into three categories: Gonadotropin dependent precocious puberty (GDPP, also known as central precocious puberty), gonadotropin independent precocious puberty (GIPP), and incomplete precocious puberty. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gonadotropin dependent precocious puberty (GDPP) is caused by an early activation of normal pubertal development mediated through central activation of the hypothalamic-pituitary-gonadal axis. Although more than 80 percent of these patients have idiopathic GDPP (a diagnosis of exclusion), others will have an underlying CNS lesion that may be amenable to treatment (",
"      <a class=\"graphic graphic_table graphicRef52565 \" href=\"UTD.htm?41/47/42747\">",
"       table 3",
"      </a>",
"      ). Thus all patients with GDPP should have brain imaging. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Causes of gonadotropin dependent precocious puberty (GDPP)'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Further evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gonadotropin independent precocious puberty (GIPP) is caused by peripheral secretion of sex hormones either from the gonads or adrenal glands, ectopic hCG production by a germ cell tumor, or by exogenous sources of sex steroids, and is independent from the hypothalamic-pituitary-gonadal axis (",
"      <a class=\"graphic graphic_table graphicRef59268 \" href=\"UTD.htm?38/57/39837\">",
"       table 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      GDPP can be distinguished from GIPP by measuring LH levels: (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Serum LH concentrations after GnRH agonist stimulation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In GDPP, basal LH levels are often elevated into the pubertal range and show a pubertal (heightened) response to GnRH stimulation.",
"     </li>",
"     <li>",
"      In GIPP, the LH level is low at baseline and fails to respond to GnRH stimulation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Incomplete precocious puberty consists of isolated breast development (premature thelarche) or isolated characteristics such as pubic hair development mediated by androgens produced in the adrenal glands (premature adrenarche) (",
"      <a class=\"graphic graphic_table graphicRef72054 \" href=\"UTD.htm?41/53/42843\">",
"       table 5",
"      </a>",
"      ). Either of these patterns usually is a variant of normal puberty and requires no intervention. However, a percentage of these patients will develop precocious puberty and close follow-up is recommended. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Types of incomplete precocious puberty'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/1\">",
"      Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/2\">",
"      Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/3\">",
"      Harlan WR, Harlan EA, Grillo GP. Secondary sex characteristics of girls 12 to 17 years of age: the U.S. Health Examination Survey. J Pediatr 1980; 96:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/4\">",
"      Harlan WR, Grillo GP, Cornoni-Huntley J, Leaverton PE. Secondary sex characteristics of boys 12 to 17 years of age: the U.S. Health Examination Survey. J Pediatr 1979; 95:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/5\">",
"      Tanner JM, Davies PS. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 1985; 107:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/6\">",
"      Sun SS, Schubert CM, Chumlea WC, et al. National estimates of the timing of sexual maturation and racial differences among US children. Pediatrics 2002; 110:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/7\">",
"      Herman-Giddens ME, Slora EJ, Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics 1997; 99:505.",
"     </a>",
"    </li>",
"    <li>",
"     Boepple PA, Crowley WF Jr. Precocious puberty. In: Reproductive Endocrinology, Surgery, and Technology, Adashi EY, Rock JA, Rosenwaks Z (Eds), Lippincott-Raven, Philadelphia 1996. Vol 1, p.989.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/9\">",
"      Kaplowitz PB, Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics 1999; 104:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/10\">",
"      Euling SY, Herman-Giddens ME, Lee PA, et al. Examination of US puberty-timing data from 1940 to 1994 for secular trends: panel findings. Pediatrics 2008; 121 Suppl 3:S172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/11\">",
"      Rosenfield RL, Bachrach LK, Chernausek SD, et al. Current age of onset of puberty. Pediatrics 2000; 106:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/12\">",
"      Midyett LK, Moore WV, Jacobson JD. Are pubertal changes in girls before age 8 benign? Pediatrics 2003; 111:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/13\">",
"      Teilmann G, Pedersen CB, Jensen TK, et al. Prevalence and incidence of precocious pubertal development in Denmark: an epidemiologic study based on national registries. Pediatrics 2005; 116:1323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/14\">",
"      Rosenfield RL, Lipton RB, Drum ML. Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index. Pediatrics 2009; 123:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/15\">",
"      Pescovitz OH, Comite F, Hench K, et al. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy. J Pediatr 1986; 108:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/16\">",
"      Bridges NA, Christopher JA, Hindmarsh PC, Brook CG. Sexual precocity: sex incidence and aetiology. Arch Dis Child 1994; 70:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/17\">",
"      Chemaitilly W, Trivin C, Adan L, et al. Central precocious puberty: clinical and laboratory features. Clin Endocrinol (Oxf) 2001; 54:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/18\">",
"      Chalumeau M, Chemaitilly W, Trivin C, et al. Central precocious puberty in girls: an evidence-based diagnosis tree to predict central nervous system abnormalities. Pediatrics 2002; 109:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/19\">",
"      Ng SM, Kumar Y, Cody D, et al. Cranial MRI scans are indicated in all girls with central precocious puberty. Arch Dis Child 2003; 88:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/20\">",
"      Mahachoklertwattana P, Kaplan SL, Grumbach MM. The luteinizing hormone-releasing hormone-secreting hypothalamic hamartoma is a congenital malformation: natural history. J Clin Endocrinol Metab 1993; 77:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/21\">",
"      Jung H, Carmel P, Schwartz MS, et al. Some hypothalamic hamartomas contain transforming growth factor alpha, a puberty-inducing growth factor, but not luteinizing hormone-releasing hormone neurons. J Clin Endocrinol Metab 1999; 84:4695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/22\">",
"      Listernick R, Charrow J, Gutmann DH. Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet 1999; 89:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/23\">",
"      Ogilvy-Stuart AL, Clayton PE, Shalet SM. Cranial irradiation and early puberty. J Clin Endocrinol Metab 1994; 78:1282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/24\">",
"      Seminara SB, Messager S, Chatzidaki EE, et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003; 349:1614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/25\">",
"      Teles MG, Bianco SD, Brito VN, et al. A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 2008; 358:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/26\">",
"      Pescovitz OH, Hench K, Green O, et al. Central precocious puberty complicating a virilizing adrenal tumor: treatment with a long-acting LHRH analog. J Pediatr 1985; 106:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/27\">",
"      Pescovitz OH, Cassorla F, Comite F, et al. LHRH analog treatment of central precocious puberty complicating congenital adrenal hyperplasia. Ann N Y Acad Sci 1985; 458:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/28\">",
"      Holland FJ, Kirsch SE, Selby R. Gonadotropin-independent precocious puberty (\"testotoxicosis\"): influence of maturational status on response to ketoconazole. J Clin Endocrinol Metab 1987; 64:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/29\">",
"      Van Wyk JJ, Grumbach MM. Syndrome of precocious menstruation and galactorrhea in juvenile hypothyroidism: an example of hormonal overlap in pituitary feedback. J Pediatr 1960; 57:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/30\">",
"      Castro-Maga&ntilde;a M, Angulo M, Ca&ntilde;as A, et al. Hypothalamic-pituitary gonadal axis in boys with primary hypothyroidism and macroorchidism. J Pediatr 1988; 112:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/31\">",
"      Cabrera SM, Dimeglio LA, Eugster EA. Incidence and characteristics of pseudoprecocious puberty because of severe primary hypothyroidism. J Pediatr 2013; 162:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/32\">",
"      Bhansali A, Kashyap A, Lodha S, et al. Isosexual precocity: uncommon presentation of a common disorder. Postgrad Med J 2000; 76:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/33\">",
"      Anasti JN, Flack MR, Froehlich J, et al. A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab 1995; 80:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/34\">",
"      Ryan GL, Feng X, d'Alva CB, et al. Evaluating the roles of follicle-stimulating hormone receptor polymorphisms in gonadal hyperstimulation associated with severe juvenile primary hypothyroidism. J Clin Endocrinol Metab 2007; 92:2312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/35\">",
"      Suarez EA, d'Alva CB, Campbell A, et al. Absence of mutation in the follicle-stimulating hormone receptor gene in severe primary hypothyroidism associated with gonadal hyperstimulation. J Pediatr Endocrinol Metab 2007; 20:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/36\">",
"      Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 47-1989. A six-year-old girl with sexual precocity. N Engl J Med 1989; 321:1463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/37\">",
"      Lack EE, Perez-Atayde AR, Murthy AS, et al. Granulosa theca cell tumors in premenarchal girls: a clinical and pathologic study of ten cases. Cancer 1981; 48:1846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/38\">",
"      Young RH, Dickersin GR, Scully RE. Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases. Am J Surg Pathol 1984; 8:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/39\">",
"      Arhan E, Cetinkaya E, Aycan Z, et al. A very rare cause of virilization in childhood: ovarian Leydig cell tumor. J Pediatr Endocrinol Metab 2008; 21:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/40\">",
"      Urban MD, Lee PA, Plotnick LP, Migeon CJ. The diagnosis of Leydig cell tumors in childhood. Am J Dis Child 1978; 132:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/41\">",
"      Henderson CG, Ahmed AA, Sesterhenn I, et al. Enucleation for prepubertal leydig cell tumor. J Urol 2006; 176:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/42\">",
"      Englund AT, Geffner ME, Nagel RA, et al. Pediatric germ cell and human chorionic gonadotropin-producing tumors. Clinical and laboratory features. Am J Dis Child 1991; 145:1294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/43\">",
"      Shenker A, Laue L, Kosugi S, et al. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993; 365:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/44\">",
"      Egli CA, Rosenthal SM, Grumbach MM, et al. Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: familial testotoxicosis. J Pediatr 1985; 106:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/45\">",
"      Henley DV, Lipson N, Korach KS, Bloch CA. Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med 2007; 356:479.",
"     </a>",
"    </li>",
"    <li>",
"     Food and Drug Administration safety communication, 7/29/10:  file://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm220185.htm (Accessed on October 06, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/47\">",
"      Phornphutkul C, Okubo T, Wu K, et al. Aromatase p450 expression in a feminizing adrenal adenoma presenting as isosexual precocious puberty. J Clin Endocrinol Metab 2001; 86:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/48\">",
"      Faggiano M, Criscuolo T, Perrone L, et al. Sexual precocity in a boy due to hypersecretion of LH and prolactin by a pituitary adenoma. Acta Endocrinol (Copenh) 1983; 102:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/49\">",
"      Ambrosi B, Bassetti M, Ferrario R, et al. Precocious puberty in a boy with a PRL-, LH- and FSH-secreting pituitary tumour: hormonal and immunocytochemical studies. Acta Endocrinol (Copenh) 1990; 122:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/50\">",
"      Frisch LS, Copeland KC, Boepple PA. Recurrent ovarian cysts in childhood: diagnosis of McCune-Albright syndrome by bone scan. Pediatrics 1992; 90:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/51\">",
"      Nabhan ZM, West KW, Eugster EA. Oophorectomy in McCune-Albright syndrome: a case of mistaken identity. J Pediatr Surg 2007; 42:1578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/52\">",
"      Weinstein LS, Shenker A, Gejman PV, et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991; 325:1688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/53\">",
"      Shenker A, Weinstein LS, Moran A, et al. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr 1993; 123:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/54\">",
"      Lumbroso S, Paris F, Sultan C, European Collaborative Study. Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a European Collaborative Study. J Clin Endocrinol Metab 2004; 89:2107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/55\">",
"      Chanson P, Salenave S, Orcel P. McCune-Albright syndrome in adulthood. Pediatr Endocrinol Rev 2007; 4 Suppl 4:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/56\">",
"      Schwindinger WF, Francomano CA, Levine MA. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A 1992; 89:5152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/57\">",
"      Grant DB, Martinez L. The McCune-Albright syndrome without typical skin pigmentation. Acta Paediatr Scand 1983; 72:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/58\">",
"      de Sanctis C, Lala R, Matarazzo P, et al. McCune-Albright syndrome: a longitudinal clinical study of 32 patients. J Pediatr Endocrinol Metab 1999; 12:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/59\">",
"      Haddad N, Eugster E. An update on the treatment of precocious puberty in McCune-Albright syndrome and testotoxicosis. J Pediatr Endocrinol Metab 2007; 20:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/60\">",
"      Schmidt H, Kiess W. Secondary central precocious puberty in a girl with McCune-Albright syndrome responds to treatment with GnRH analogue. J Pediatr Endocrinol Metab 1998; 11:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/61\">",
"      Pasquino AM, Pucarelli I, Passeri F, et al. Progression of premature thelarche to central precocious puberty. J Pediatr 1995; 126:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/62\">",
"      Zhu SY, Du ML, Huang TT. An analysis of predictive factors for the conversion from premature thelarche into complete central precocious puberty. J Pediatr Endocrinol Metab 2008; 21:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/63\">",
"      Herman-Giddens ME, Kaplowitz PB, Wasserman R. Navigating the recent articles on girls' puberty in Pediatrics: what do we know and where do we go from here? Pediatrics 2004; 113:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/64\">",
"      Freedman DS, Khan LK, Serdula MK, et al. Racial and ethnic differences in secular trends for childhood BMI, weight, and height. Obesity (Silver Spring) 2006; 14:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/65\">",
"      Biro FM, Galvez MP, Greenspan LC, et al. Pubertal assessment method and baseline characteristics in a mixed longitudinal study of girls. Pediatrics 2010; 126:e583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/66\">",
"      Zung A, Glaser T, Kerem Z, Zadik Z. Breast development in the first 2 years of life: an association with soy-based infant formulas. J Pediatr Gastroenterol Nutr 2008; 46:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/67\">",
"      Mendez MA, Anthony MS, Arab L. Soy-based formulae and infant growth and development: a review. J Nutr 2002; 132:2127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/68\">",
"      Freni-Titulaer LW, Cordero JF, Haddock L, et al. Premature thelarche in Puerto Rico. A search for environmental factors. Am J Dis Child 1986; 140:1263.",
"     </a>",
"    </li>",
"    <li>",
"     Hoffman P, Pescovitz OH. Premature thelarch. In: Saunders Manual of Pediatric Practice, Findberg L, Kleinman RE (Eds), WB Saunders, Philadelphia 2002. p.745.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/70\">",
"      Madlon-Kay DJ. 'Witch's milk'. Galactorrhea in the newborn. Am J Dis Child 1986; 140:252.",
"     </a>",
"    </li>",
"    <li>",
"     Saenger P. Premature adrenarche. In: Saunders Manual of Pediatric Practice, 2nd ed, Fineberg L, Kleinman R (Eds), WB Saunders, Philadelphia 2002. p.833.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/72\">",
"      Heller ME, Dewhurst J, Grant DB. Premature menarche without other evidence of precocious puberty. Arch Dis Child 1979; 54:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/73\">",
"      Hill NC, Oppenheimer LW, Morton KE. The aetiology of vaginal bleeding in children. A 20-year review. Br J Obstet Gynaecol 1989; 96:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/74\">",
"      Tavassoli FA, Norris HJ. Sertoli tumors of the ovary. A clinicopathologic study of 28 cases with ultrastructural observations. Cancer 1980; 46:2281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/75\">",
"      Alikasifoglu A, Gonc EN, Akcoren Z, et al. Feminizing Sertoli cell tumor associated with Peutz-Jeghers syndrome. J Pediatr Endocrinol Metab 2002; 15:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/76\">",
"      Franklin SL. Effects of unintentional exposure of children to compounded transdermal sex hormone therapy. Pediatr Endocrinol Rev 2011; 8:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/77\">",
"      Papadimitriou A, Beri D, Tsialla A, et al. Early growth acceleration in girls with idiopathic precocious puberty. J Pediatr 2006; 149:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/78\">",
"      Carel JC, Eugster EA, Rogol A, et al. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 2009; 123:e752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/79\">",
"      Houk CP, Kunselman AR, Lee PA. The diagnostic value of a brief GnRH analogue stimulation test in girls with central precocious puberty: a single 30-minute post-stimulation LH sample is adequate. J Pediatr Endocrinol Metab 2008; 21:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/80\">",
"      Kandemir N, Demirbilek H, &Ouml;z&ouml;n ZA, et al. GnRH stimulation test in precocious puberty: single sample is adequate for diagnosis and dose adjustment. J Clin Res Pediatr Endocrinol 2011; 3:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/81\">",
"      Chi CH, Durham E, Neely EK. Pharmacodynamics of aqueous leuprolide acetate stimulation testing in girls: correlation between clinical diagnosis and time of peak luteinizing hormone level. J Pediatr 2012; 161:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/82\">",
"      Brito VN, Batista MC, Borges MF, et al. Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab 1999; 84:3539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/83\">",
"      Carel JC, L&eacute;ger J. Clinical practice. Precocious puberty. N Engl J Med 2008; 358:2366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/84\">",
"      Bladowska J, Biel A, Zimny A, et al. Are T2-weighted images more useful than T1-weighted contrast-enhanced images in assessment of postoperative sella and parasellar region? Med Sci Monit 2011; 17:MT83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/5/19546/abstract/85\">",
"      Mogensen SS, Aksglaede L, Mouritsen A, et al. Pathological and incidental findings on brain MRI in a single-center study of 229 consecutive girls with early or precocious puberty. PLoS One 2012; 7:e29829.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5812 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-B32189B1BC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_5_19546=[""].join("\n");
var outline_f19_5_19546=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NORMAL PUBERTAL DEVELOPMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Threshold for evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Classification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CAUSES OF GONADOTROPIN DEPENDENT PRECOCIOUS PUBERTY (GDPP)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23810893\">",
"      Idiopathic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23810924\">",
"      CNS lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3989359\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3989366\">",
"      Previous excess sex steroid exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3989383\">",
"      Primary hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CAUSES OF GONADOTROPIN INDEPENDENT PRECOCIOUS PUBERTY (GIPP)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Girls",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3989390\">",
"      - Ovarian cysts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3989404\">",
"      - Ovarian tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Boys",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3989411\">",
"      - Leydig cell tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3989418\">",
"      - Human chorionic gonadotropin (hCG) secreting germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3989425\">",
"      - Familial male-limited precocious puberty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Both girls and boys",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3989432\">",
"      - Exogenous estrogen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3989439\">",
"      - Adrenal pathology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3989446\">",
"      - Pituitary gonadotropin-secreting tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3989453\">",
"      - McCune-Albright syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TYPES OF INCOMPLETE PRECOCIOUS PUBERTY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21089789\">",
"      Premature thelarche",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11748219\">",
"      - Neonates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21089796\">",
"      Premature adrenarche",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Guiding principles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Initial evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Further evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Serum LH concentrations after GnRH agonist stimulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Imaging and laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5812\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5812|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/19/40243\" title=\"diagnostic image 1\">",
"      Fibrous dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5812|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/38/29283\" title=\"figure 1A\">",
"      Pubertal events girls",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/1/44048\" title=\"figure 1B\">",
"      Pubertal events boys",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/24/19855\" title=\"figure 2\">",
"      Time of puberty onset",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/52/35663\" title=\"figure 3\">",
"      Growth precocious puberty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/46/44781\" title=\"figure 4\">",
"      Testicular volume and sexual maturity rating",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5812|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/51/42815\" title=\"picture 1\">",
"      Cafe au lait spots",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/43/10932\" title=\"picture 2\">",
"      Sexual maturity rating of breast development in girls",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/26/33187\" title=\"picture 3A\">",
"      Sexual maturity rating of pubic hair in boys",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/33/30227\" title=\"picture 3B\">",
"      Sexual maturity rating of pubic hair in girls",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5812|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/1/8220\" title=\"table 1\">",
"      Sexual maturity rating of secondary sexual characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/57/40859\" title=\"table 2\">",
"      Normal testicular size",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/47/42747\" title=\"table 3\">",
"      Evaluation of gonadotropin-dependent precocious puberty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/57/39837\" title=\"table 4\">",
"      Evaluation of gonadotropin-independent precocious puberty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/53/42843\" title=\"table 5\">",
"      Evaluation of incomplete precocious puberty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/24/41356\" title=\"table 6\">",
"      Nonprogressive versus progressive precocious puberty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/49/18204\" title=\"table 7\">",
"      Radiological evaluation of precocious puberty",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/22/21865?source=related_link\">",
"      Acquired hypothyroidism in childhood and adolescence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/13/39130?source=related_link\">",
"      Clinical features and diagnosis of polycystic ovary syndrome in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/56/13192?source=related_link\">",
"      Clinical manifestations and diagnosis of central nervous system tumors in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/47/41720?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12826?source=related_link\">",
"      Clinical presentation and evaluation of adrenocortical tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/32/15878?source=related_link\">",
"      Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/47/6906?source=related_link\">",
"      Congenital anomalies and acquired abnormalities of the optic nerve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2170?source=related_link\">",
"      Congenital gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19560?source=related_link\">",
"      Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/55/31607?source=related_link\">",
"      Growth failure after childhood cancer: Role of growth hormone deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/25/1434?source=related_link\">",
"      Normal puberty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/49/42776?source=related_link\">",
"      Overview of breast masses in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/43/4794?source=related_link\">",
"      Pathology of mediastinal tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/58/31650?source=related_link\">",
"      Patient information: Early puberty (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/62/21481?source=related_link\">",
"      Premature adrenarche",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7401?source=related_link\">",
"      Pubertal development and gonadal function in survivors of childhood cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4889?source=related_link\">",
"      Treatment of precocious puberty",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_5_19547="Biliary complic post LT";
var content_f19_5_19547=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F75116&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F75116&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Biliary complications after liver transplantation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Bile leaks and biloma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Strictures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anastomotic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nonanastomotic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Diffuse intrahepatic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Common bile duct filling defects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Stones",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sludge",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Casts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Sphincter of Oddi dysfunction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other complications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hemobilia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mucocele",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bactobilia",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Andres C&aacute;rdenas, MD, MMSc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_5_19547=[""].join("\n");
var outline_f19_5_19547=null;
var title_f19_5_19548="FEV1 and survival in COPD";
var content_f19_5_19548=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F61524&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F61524&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Survival rates in COPD according to percent predicted postbronchodilator FEV",
"    <sub>",
"     1",
"    </sub>",
"    (PB FEV",
"    <sub>",
"     1",
"    </sub>",
"    ) &le;65 years of age in patients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup width=\"30%\">",
"     </colgroup>",
"     <colgroup span=\"5\" width=\"14%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Initial PB FEV",
"        <sub>",
"         1",
"        </sub>",
"        <br/>",
"        (percent predicted)",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Number",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"4\">",
"        Culmulative survival rate",
"        <br/>",
"        (percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        At 2 years",
"       </td>",
"       <td class=\"subtitle2\">",
"        At 5 years",
"       </td>",
"       <td class=\"subtitle2\">",
"        At 10 years",
"       </td>",
"       <td class=\"subtitle2\">",
"        At 15 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &lt;20",
"       </td>",
"       <td>",
"        9",
"       </td>",
"       <td>",
"        44",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        20 to 29",
"       </td>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        65",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        30 to 39",
"       </td>",
"       <td>",
"        43",
"       </td>",
"       <td>",
"        83",
"       </td>",
"       <td>",
"        47",
"       </td>",
"       <td>",
"        21",
"       </td>",
"       <td>",
"        7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        40 to 49",
"       </td>",
"       <td>",
"        26",
"       </td>",
"       <td>",
"        92",
"       </td>",
"       <td>",
"        89",
"       </td>",
"       <td>",
"        39",
"       </td>",
"       <td>",
"        30",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        50 to 59",
"       </td>",
"       <td>",
"        21",
"       </td>",
"       <td>",
"        95",
"       </td>",
"       <td>",
"        95",
"       </td>",
"       <td>",
"        57",
"       </td>",
"       <td>",
"        32",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        60+",
"       </td>",
"       <td>",
"        9",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        89",
"       </td>",
"       <td>",
"        89",
"       </td>",
"       <td>",
"        67",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     FEV",
"     <sub>",
"      1",
"     </sub>",
"     : forced expiratory volume in one second; PB: postbronchodilator.",
"    </div>",
"    <div class=\"reference\">",
"     Reference: Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. Am Rev Respir Dis 1979; 119:895.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_5_19548=[""].join("\n");
var outline_f19_5_19548=null;
var title_f19_5_19549="Monitoring of MTF transsexual persons on cross-hormone therapy";
var content_f19_5_19549=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F67967%7EENDO%2F78811&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F67967%7EENDO%2F78811&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Monitoring of male-to-female transsexual persons on cross-hormone therapy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        1. Evaluate patient every two to three months in the first year and then&nbsp;one to two&nbsp;times per year afterward to monitor for appropriate signs of feminization and for development of adverse reactions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        2. Measure serum testosterone and estradiol every&nbsp;three months.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        a. Serum testosterone levels should be &lt;55 ng/dL.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        b. Serum estradiol should not exceed the peak physiological range for young healthy females, with ideal levels &lt;200 pg/mL.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        c. Doses of estrogen should be adjusted according to the serum levels of estradiol.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. For individuals on spironolactone, serum electrolytes (particularly potassium) should be monitored every&nbsp;two to three&nbsp;months initially in the first year.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4.",
"        <span style=\"font-family: calibri,sans-serif; font-size: 11pt;\">",
"         Routine cancer screening should be performed for colon and prostate cancer, as well as breast cancer (because of high dose estrogen)",
"        </span>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Consider BMD testing at baseline if risk factors for osteoporotic fracture are present (eg, previous fracture, family history, glucocorticoid use, prolonged hypogonadism). In individuals at low risk, screening for osteoporosis should be conducted at age 60 and in those who are not compliant with hormone therapy.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BMD: bone mineral density.",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, et al. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2009; 94:3132. Copyright &copy; 2009 The Endocrine Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Monitoring of female-to-male transsexual persons on cross-hormone therapy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        1. Evaluate patient every 2-3 months in the first year and then 1-2 times per year to monitor for appropriate signs of virilization and for development of adverse reactions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        2. Measure serum testosterone every 2-3 months until levels are in the normal physiological male range:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        a. For testosterone enanthate/cypionate injections, the testosterone level should be measured midway between injections. If the level is &gt;700 ng/dL or &lt;350 ng/dL, adjust dose accordingly.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        b. For parenteral testosterone undecanoate, testosterone should be measured just before the next injection.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        c. For transdermal testosterone, the testosterone level can be measured at any time after 1 wk.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        d. For oral testosterone undecanoate, the testosterone level should be measured 3-5 h after ingestion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        e. Note: During the first 3-9 months of testosterone treatment, total testosterone levels may be high, although free testosterone levels are normal, due to high SHBG levels in some biological women.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Measure estradiol levels during the first 6 months of testosterone treatment or until there has been no uterine bleeding for 6 months. Estradiol levels should be &lt;50 pg/mL.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Measure complete blood count and liver function tests at baseline and every 3 months for the first year and then 1-2 times a year. Monitor weight, blood pressure, lipids, fasting blood sugar (if family history of diabetes), and hemoglobin A1c (if diabetic) at regular visits.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Consider BMD testing at baseline if risk factors for osteoporotic fracture are present (eg, previous fracture, family history, glucocorticoid use, prolonged hypogonadism). In individuals at low risk, screening for osteoporosis should be conducted at age 60 and in those who are not compliant with hormone therapy.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6. If cervical tissue is present, an annual pap smear is recommended by the American College of Obstetricians and Gynecologists.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7. If mastectomy is not performed, then consider mammograms as recommended by the American Cancer Society.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BMD: bone mineral density.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, et al. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2009; 94:3132. Copyright &copy; 2009 The Endocrine Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_5_19549=[""].join("\n");
var outline_f19_5_19549=null;
var title_f19_5_19550="Mirena IUD PI";
var content_f19_5_19550=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F74378&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F74378&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mirena IUD",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This&nbsp;intrauterine device, called Mirena,&nbsp;is&nbsp;inserted into the uterus. While there it delivers the hormone levonorgestrel&nbsp;into the body to help prevent pregnancy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Berlex Laboratories. Copyright &copy; Berlex Laboratories.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_5_19550=[""].join("\n");
var outline_f19_5_19550=null;
var title_f19_5_19551="Osteonecrosis femoral head";
var content_f19_5_19551=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F69304&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F69304&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Osteonecrosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 318px; height: 322px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A plain film of the hip demonstrating features consistent with ischemic necrosis of the femoral head. These include lucent regions with associated sclerotic rims in the right femoral head (arrows), squared-off, straight margins, and mottled increased density due to destruction of the bony trabecula.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_5_19551=[""].join("\n");
var outline_f19_5_19551=null;
